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Zusammenfassung 
 
Während der Entwicklung von multizellulären Organismen empfangen die Zellen 
extrazelluläre Signale und übersetzen diese in eine angemessene, zelluläre Antwort wie zum 
Beispiel die Wahl eines korrekten Zellschicksals. Der Notch Signalweg ist einer von wenigen 
Haupt-Signalwegen, die während der Entwicklung eines Tieres für die Wahl eines 
Zellschicksals benutzt werden. Da der Notch Signalweg zu verschiedenen Zeiten und in 
verschiedenen Geweben benutzt wird, haben Defekte in diesem Signalweg weit reichende 
Folgen für die Entwicklung und können im adulten Organismus zu Krebs führen. Um 
Krankheiten und Krebs zu behandeln, die durch Fehlfunktionen im Notch Signalweg 
entstehen, ist es notwendig die Komponenten zu kennen, die verwendet werden, um das 
extrazelluläre Signal in eine angemessene zelluläre Antwort zu übersetzen. 
Der Notch Signalweg wurde während der Evolution vom Wurm zum Menschen stark 
konserviert. In C. elegans wird auch LIN-12, das Homolog von Notch, bei verschiedenen 
Entwicklungsschritten verwendet. C. elegans ist im Bereich der Entwicklungsbiologie ein 
sehr erfolgreicher Modellorganismus. Die Eigenschaften von C. elegans sowie die zur 
Verfügung stehenden Techniken um diesen Organismus zu manipulieren machen diesen zu 
einem exzellenten Modell für genetische, zellbiologische und biochemische Studien. 
Der lin-12 Notch Signalweg wird, wie das Gegenstück in Vertebraten, für binäre 
Zellschicksals-Entscheidungen benutzt. Während der Entwicklung der Vulva, dem 
eierlegenden Organ, stellt lin-12 Notch sicher, dass nur eine Zelle das primäre (1°) 
Zellschicksal annimmt und von zwei Zellen mit sekundärem (2°) Schicksal umgeben ist. 
Während der Entwicklung der Gonaden, dem oozyten- und spermienproduzierendem Organ, 
stellt der lin-12 Notch Signalweg sicher, dass von zwei äquipotenten Zellen nur eine das 
Ankerzell-Schicksal (AC) annimmt, indem die zweite Zelle zur Annahme des ventralen 
Uterus-Schicksals (VU) gezwungen wird. Während die Kernkomponenten und verschiedene 
transkriptionelle Zielgene des lin-12 Notch Signalweges bekannt sind - wobei einige 
Komponenten erst während dieser Arbeit publiziert wurden, gibt es experimentelle Hinweise, 
dass wichtige Komponenten der zellulären Antwort auf Aktivierung des lin-12 Notch 
Signalweges noch unbekannt sind. Während alle bis jetzt bekannten transkriptionellen 
Zielgene die Aufgabe haben, die Determination des 1° Schicksals zu verhindern, kennt man 
keine Zielgene, welche einer Zelle das 2° Schicksals instruieren. 
Um neue Komponenten des lin-12 Notch Signalweges zu finden wurden in dieser Arbeit 
klassische und reverse genetische Screens durchgeführt. Grundsätzlich basieren diese Screens 
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auf einer neuartigen Selektionsstrategie um Defekte in der lin-12 Notch-abhängigen 
Signalübertragung zu identifizieren, welche die Entwicklung der Vulva von C. elegans 
beeinflussen. 
Im klassischen genetischen EMS Screen konnten mehrere Mutanten isoliert und kartiert 
werden. In fünf Mutanten ist lin-11 betroffen, welches voraussichtlich ein Zielgen des lin-12 
Notch Signalweges in der gonadalen Entwicklung ist. Im Weiteren wurde ein Allel von dep-1 
gefunden, welches bekanntermaßen während der Vulvaentwicklung parallel zu lin-12 Notch 
agiert. Außerdem wurde eine Mutante auf einen subchromosomalen Bereich, der maximal 
585 Kandidatengene enthält, kartiert. 
In einem revers-genetischen RNA Interferenz (RNAi) Screen wurden mögliche Zielgene des 
lin-12 Notch Signalweges auf deren Rolle in der Vulvaentwicklung getestet. Von positiven 
Kandidaten wurde das Expressionsmuster analysiert. Aufgrund der durch RNAi verursachten 
Defekte und dem Expressionsmuster wurden voraussichtlich zwei Zielgene des lin-12 Notch 
Signalweges gefunden. TTR-11 ist vermutlich eine Protease, welche in der Vulva und den 
Gonaden den lin-12 Notch Signalweg positiv reguliert, indem es direkt den LIN-12 NOTCH 
Rezeptor aktiviert. C39F7.2 agiert vermutlich als eine Ubiquitin-Ligase und ist während der 
Gonadenentwicklung am lin-12 Notch Signalweg beteiligt. 
Zudem deuten die Resultate des RNAi-Screens und der Expressionsanalyse darauf hin, dass 
der Transkriptionsfaktor EGL-43 an der Entwicklung von Vulva und Gonaden beteiligt ist. 
Jedoch unterstützten weitere Analysen eine direkte Regulation der Transkription von egl-43 
durch den lin-12 Notch Signalweg nicht. Hingegen ist egl-43 notwendig, um in bestimmten 
Gonadenzellen das -Zellschicksal zu induzieren, und wirkt in diesem Zusammenhang 
parallel oder unterhalb des LIN-12 NOTCH Rezeptors. 
Des Weiteren präsentiert diese Arbeit egl-43 als eine neue Komponente des Signalweges, der 
die Invasion der Ankerzelle (AC) steuert. Der Vorgang der Ankerzell-Invasion in C. elegans 
wurde erst kürzlich als ein Modell für zelluläre Invasion etabliert, und erst vier Gene sind in 
diesem Signalweg bekannt. Diese Arbeit zeigt, dass egl-43 durch den Transkriptionsfaktor 
egl-43 Fos transkriptionell aktiviert wird. Als Folge dessen aktiviert egl-43 die Effektoren der 
Invasion zmp-1 und cdh-3. 
Generell erfolgt zelluläre Invasion während der normalen Tierentwicklung und auch bei der 
Metastasierung von malignen Krebszellen. Das Studium der zellulären Invasion in C. elegans 
ist aus verschiedenen Gründen ein viel versprechender Ansatz. Zum Beispiel erlaubt C. 
elegans die zelluläre Invasion einer einzelnen Zelle zu studieren. Zudem scheinen die 
Signalwege, welche die zelluläre Invasion regulieren, grundsätzlich vom Wurm bis zum 
 7 
Menschen konserviert. Dies wird von der Tatsache unterstützt, dass in Würmern und 
Vertebraten Transkriptionsfaktoren der Fos Familie beteiligt sind und ähnliche Komponenten 
regulieren. Deshalb scheint es vernünftig Erkenntnisse über die zelluläre Invasion in C. 
elegans in Vertebraten Systemen zu testen. 
EGL-43 gehört zu der Familie der EVI1 Proteine. Alle Mitglieder dieser Familie kommen als 
eine Isoform vor, welche die PR-Domäne enthält (PRD1-BF1/RIZ1), und eine oder mehrere 
Isoformen, in welcher diese Domäne fehlt. Während die molekulare Rolle von EVI1, der 
Isoform ohne PR-Domäne, untersucht wurde und bekanntermaßen an Leukämie beteiligt ist, 
ist die Rolle der Isoform mit PR-Domäne, MDS1-EVI1, unbekannt. Diese Arbeit begründet 
die Hypothese, dass Mds1-Evi1, analog zu egl-43L, an der zellulären Invasion beteiligt ist. 
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Summary 
 
During development of multicellular organisms, cells translate extracellular signals into 
appropriate responses including correct differentiation choices. The Notch signaling pathway 
is one of a handful of major pathways that are used for cell fate choices during animal 
development. Since the Notch pathway is used at different times and in different tissues, 
defects in this pathway have broad effects on development and can also lead to cancer in the 
adult organism. In order to treat diseases and cancer caused by malfunctions of the Notch 
pathway, it is necessary to know what components are used to translate the extracellular 
signal into an appropriate response. 
The Notch signaling pathway has been highly conserved during evolution from worms to 
humans. In C. elegans, LIN-12, which is a Notch homolog, is used during various steps of 
development. C. elegans is a very successful model organism in the field of developmental 
biology. The unique properties of C. elegans and the number of tools available to manipulate 
this organism make it an excellent model for genetic, cell biological and biochemical studies.  
As its vertebrate counterpart, the lin-12 Notch pathway is involved in several binary cell fate 
decisions in C. elegans. During development of the vulva, the egg laying organ, lin-12 Notch 
is used to ensure that only one cell adopts the primary (1°) cell fate and is flanked by two 
secondary (2°) fated cells. During development of the gonad, the oocyte- and sperm-
producing organ, the lin-12 Notch pathway ensures that of two equipotent cells only one 
adopts the anchor cell (AC) fate by forcing the other cell to adopt the ventral uterine (VU) 
fate. While the core components and several transcriptional targets of the lin-12 Notch 
pathway are known – note that some components were only found while this work was 
ongoing, there is experimental evidence that important components mediating the cellular 
response to lin-12 Notch signaling are still unknown. While all transcriptional targets found 
so far are supposed to inhibit acquisition of the 1° vulval cell fate, no targets are known that 
instruct the 2° cell fate. 
In order to find new components of the lin-12 Notch signaling pathway, forward and reverse 
genetic screens were performed in this work. In general, these screens are based on a novel 
selection strategy to identify defects in lin-12 Notch signaling that affect vulval development 
of C. elegans. 
In the forward genetic EMS screen, several mutants were isolated and mapped. In five 
mutants, the lin-11 gene, a predicted lin-12 Notch target during gonad development, has been 
affected. In addition, one allele of dep-1, a gene known to act in parallel with lin-12 Notch, 
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was found. Furthermore, one mutant has been mapped to a subchromosomal region 
containing a maximum of 585 candidate genes. 
In the reverse genetic RNA-interference (RNAi) screen, putative transcriptional targets of the 
lin-12 Notch pathway were tested for their role in vulval development. For positive 
candidates, the expression pattern was analyzed. Based on RNAi mediated defects and 
expression studies, two putative lin-12 Notch targets were identified. The predicted protease 
TTR-11 is possibly positively regulating lin-12 Notch signaling in the vulva and the gonad by 
direct activation of the LIN-12 NOTCH receptor. The predicted ubiquitin ligase C39F7.2 is 
possibly involved in lin-12 Notch signaling during development of the gonad. 
Moreover, the RNAi screen and expression analysis indicated that the transcription factor 
EGL-43 is involved in vulval and gonadal development. But, further analysis did not support 
a direct regulation of egl-43 transcription by lin-12 Notch signaling. However, egl-43 is 
necessary to induce in specific gonadal cells the -cell fate, and in this regard egl-43 acts in 
parallel with or downstream of the LIN-12 NOTCH receptor. 
In addition, this work identifies egl-43 as a new component of the anchor cell (AC) invasion 
program. The process of AC invasion in C. elegans has recently been established as a model 
for cellular invasion, and only four genes of this pathway have so far been found. This work 
shows that egl-43 is transcriptionally activated by the transcription factor fos-1 Fos. As a 
consequence, egl-43 activates transcription of invasion effector genes such as zmp-1 and 
cdh-3. 
In general, cellular invasion occurs during normal animal development and also in 
metastasizing, malignant cancer cells. The study of cellular invasion in C. elegans is a 
powerful approach for several reasons. First, C. elegans allows studying cellular invasion at 
single cell resolution. Furthermore, the pathways controlling invasion seem to be conserved 
from worms to humans. This is supported by the fact that in worms and vertebrates, 
transcription factors of the Fos family are involved in cellular invasion regulating similar 
components. Therefore, it is reasonable to test findings from cellular invasion in C. elegans in 
vertebrate systems. 
EGL-43 belongs to the family of Evi1 proteins. All members of this family occur as one 
isoform that contains and another or several isoforms that lack a PR-domain (PRD1-
BF1/RIZ1). While the molecular role of the PR-lacking isoform Evi1 has been studied in 
leukemia, the function of the PR-containing isoform Mds1-Evi1 is unknown. This work raises 
the possibility that Mds1-Evi1 is, like its counterpart in the Nematode egl-43L, involved in 
cellular invasion. 
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Abbreviations 
 
1°   primary 
2°   secondary 
AC   anchor cell 
ACANA ACcurate ANchoring Alignment 
ACeDB  A C. elegans Database 
ACEL anchor cell-specific enhancer of lin-3 
AML acute myeloid leukemia 
AP1   activator protein-1 
Apf   adjacent primary fate 
BACE ß-site AßPP cleaving enzymes 
ChIP   chromatin immunoprecipitation 
Chr.   chromosome 
coIP   co-immunoprecipitation 
CSL   CBF1/Su(H)/LAG-1 
CtBP1 C-terminal binding protein 1 
Dpy   dumpy: shortened body 
DSL   DELTA/SERRATE/LAG-2 
DTC distal tip cell 
DU dorsal uterine 
E(spl)   enhancer of split 
ECM   extracellular matrix 
EGF   epidermal growth factor 
EGF epidermal growth factor 
Egl   egg-laying defective 
EMS   ethane methyl sulfonate 
EMSA   enzyme mobility shift assay 
EMT   epithelial to mesenchymal transition 
EpoR erythropoietin receptor 
Evi1   ecotropic viral integration site 1 
EVT   extravillous trophoblast 
FLP   fragment length polymorphism 
FRE fos-1-responsive site 
GEF guanine nucleotide exchange factor 
GFP   green fluorescent protein 
HDAC   histone deacetylase 
HGF   hepatocyte growth factor 
HSC hematopoietic stem cell 
HSN   hermaphrodite-specific neurons 
IGFII   insulin-like growth factor II 
IL3 interleukin-3 
JNK c-Jun N-terminal kinase 
LBS lag-1 binding sites 
Lin lineage defective 
LST lateral signal target 
MAPK mitogen-activated protein kinase 
MDS myelodysplastic syndrome 
Mds1   myelodysplasia syndrome 1 
Mel1   Mds1-Evi1-like gene 1 
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Muv multivulva 
NICD Notch intracellular domain 
NuRD nucleosome remodeling and histone deacetylase 
PGC primordial germ cell 
PI3K phosphoinosite-3-kinase 
PNS   peripheral nervous system 
PR PRD1-BF1/RIZ1 domain 
Prdm16  positive regulatory domain 16 
PVD   sensory neuron 
Pvl   protruding vulva 
RAS rat sarcoma 
RNAi   RNA interference 
Rol   roller: rolling movement 
Rpn1 ribophorin 1 
RTK receptor tyrosine kinase signaling pathway 
SBE Smad binding elements 
SET Suvar3-9, Enhancer-of-zeste, Trithorax 
SGP somatic germline precursor 
SM   sex myoblast 
Sma   small: small body size 
Smad mothers against DPP proteins 
SMC   smooth muscle cells 
SNP   single nucleotide polymorphism 
SOP sensory organ precursor 
SPh somatic primordium of the hermaphrodite 
SS somatic sheat and spermatheca precursor 
ST   syncytiotrophoblast 
Su(H)   suppressor of hairless 
SynMuv synthetic multivulva 
TGF-ß   transforming growth factor-ß 
TIMP   tissue inhibitors of matrix metalloproteins 
TRE TPA response element 
Unc   uncoordinated 
URS upstream regulatory sequence 
utse uterine seam cell 
VPC   vulval precursor cell 
VU ventral uterine 
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1 General Introduction 
 
1.1 Establishment of C. elegans as a model for developmental biology 
 
The Nematode Caenorhabditis elegans is, compared to humans, a simple organism whose 
biology has been studied now for more than 30 years. Sydney Brenner basically established 
this organism in 1974 as a genetic model organism by describing how to isolate, complement 
and map mutants of C. elegans [1]. The mutants found in this work were named and classified 
based on their obvious phenotypes. Since the initial idea of Sydney Brenner was to study the 
neuronal system of an organism that is less complex than that of Drosophila melanogaster, 
most of the mutants identified in this screen were defective in movement. These mutants were 
classified as uncoordinated (Unc). Other mutant classes showed defects in the size or shape of 
the worm (Sma for small: small body size, Rol for roller: rolling movement, Dpy for dumpy: 
shortened body). 
 
The next milestone for the establishment of C. elegans as a model organism was done by John 
Sulston and Robert Horvitz by describing the complete somatic cell lineage [2]. Therefore, it 
is known how many times and when each cell divides, which cell undergoes apoptosis and to 
what tissue each cell will contribute. Interestingly, the somatic cell lineage of C. elegans 
follows an invariant, sex-specific pattern of cell divisions. This knowledge allowed screening 
for mutants that differ in their cell lineage from the wild-type pattern. Mutants of this class 
were called Lin for lineage defective [3]. 
 
In 1998, another important hurdle was taken when the C. elegans sequencing consortium 
presented more than 99% of the C. elegans genomic DNA sequence [4]. The data was 
integrated into the web platform A C. elegans Database (ACeDB) and made available to the 
worm community [5]. In a broader context, C. elegans was the first multicellular organism 
whose genome was completed. The experience and the developed tools from this project 
helped the Human genome project to determine the sequence of the human genome. 
 
In 2001, the Wormbase, a new and more comprehensive web-based platform for the model 
organism C. elegans appeared [6]. Until today the content and breadth of data present in 
Wormbase has largely increased. Wormbase provides information like sequence information, 
General Introduction 
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genome annotations, genetic and protein interaction data, phenotype descriptions, gene 
expression data and gene phylogeny information. The data comes from large-scale 
experiments but also from single experiments of smaller publications. In addition, Wormbase 
started to integrate sequence information from closely related Nematodes such as C. briggsae 
and C. remanei. This allows researchers to find, for example, regulatory sequence elements 
by looking for sequences that are conserved among these Nematodes. 
 
1.2 Benefits of C. elegans as a model organism 
 
The reason why so much effort was and still is put into the exploration of C. elegans biology 
is that this organism has many excellent properties making it an attractive model organism. In 
the following paragraphs I will try to mention the most important advantages and also the 
limitations of C. elegans. 
 
First of all, it is very easy and, compared to other model organisms, cheap to maintain strains 
of C. elegans in a laboratory environment. C. elegans is grown between 15° and 25°C on agar 
plates and feeds from E. coli bacteria grown on the agar. Interestingly, C. elegans can be 
frozen at -80°C and even decades later these strains can be thawed and continue to grow. 
 
Several features make it an excellent genetic organism. C. elegans is sexually dimorphic. It 
exists as male and hermaphrodite. The hermaphrodite produces oocytes and also contains a 
limited amount of sperm. Therefore, one can maintain a homozygous viable mutation by just 
growing hermaphrodites that will self-fertilize and give rise to genetically identical progeny. 
There is no need to maintain a strain by setting up crosses between a male and a female every 
generation (e.g. like for D. melanogaster). But, since males do exist one can also cross a male 
with a hermaphrodite and thereby, for example, test the interaction of two different mutations. 
The generation time of C. elegans is only 3  days and allows quickly addressing genetic 
questions. Once the larva hatches from the egg it passes through four larval stages (L1-4) until 
it becomes a fertile adult animal. Also the fact, that a single hermaphrodite gives rise to 
approximately 200 descendants allows to test in a single experiment a significant number of 
animals for a specific phenotype. 
 
In the field of developmental biology, scientists examine how the genome directs 
development of a single cell, the fertilized oocyte into a complex organism and how cells are 
General Introduction 
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influencing each other during the path of development. Because C. elegans has an invariant 
somatic cell lineage, it is relatively easy to study how mutations in certain genes affect this 
development. For this purpose, live-microscopy with Nomarski optics is used to look at single 
cells inside the organism. Since C. elegans has no pigmentation it is transparent and it is 
possible to directly look at every cell in any focal plane of the living worm without any 
special treatment. It is also possible to remove one specific cell from the cell lineage and 
observe how this affects development. This is done in ablation experiments, where the cell is 
destroyed by a laser pulse [2]. 
 
C. elegans has also strong tools to study cell biological questions. For example, to understand 
the function of a specific gene, it is important to know when and in what cell type a specific 
gene is active. For this purpose, DNA constructs that express green fluorescent protein (GFP) 
under the regulatory elements of the gene of interest, also called transcriptional reporters, are 
generally used in model organisms. In C. elegans, it is sufficient to inject such DNA 
molecules into to gonad in order to get progeny that expresses the gfp reporter. Some of these 
animals will also inherit this construct to their progeny and form a so-called transgenic line. 
The injected DNA has been shown to be maintained as an extrachromosomal array that has a 
concatemeric structure [7]. About 50% of the transgenic animals do not contain the array in 
every single cell, because, during mitosis only one of two cells receives a copy of the array, 
and thus the array is lost in the remaining lineage of a cell. This deficit is helpful to study the 
cellular focus of action of a gene [8]. In mutant animals where the phenotype can been 
rescued by a specific extrachromosomal array one can study this question by analyzing the 
correlation between loss of the array in a certain cell and appearance of the phenotype. In 
other words, one can study in what cell is a gene necessary to fulfill a specific role during 
development. 
 
Basically, the function of a gene can be deduced by analyzing the developmental defects in a 
mutant where this gene is knocked out. It is admirable to have this information for every 
single gene, but to date, there is no complete knockout library for C. elegans. There are two 
consortiums, “The C. elegans Gene Knockout Consortium” and the “National Bioresource 
Project for the Experimental Animal Nematode C. elegans” that work on this goal by 
randomly inducing mutations in the genome and screening for deletions in every gene. But 
this work is far from completeness (National Bioresource Project: 2610 mutants, Gene 
Knockout Consortium: 1994 mutants; December 2007). Instead of knocking down a gene by 
General Introduction 
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introducing somatic mutations it is also possible to silence a gene by the RNA interference 
technique (RNAi). It has been shown that injection of double stranded RNA that corresponds 
to the coding region of a gene into the gonad of adult hermaphrodites can efficiently knock 
down the targeted gene in the injected animal and their progeny [9]. Later studies have shown 
that it is also possible to get an RNAi effect by simply feeding C. elegans with recombinant 
E.coli strains that produce double stranded RNA. For this purpose the Ahringer Lab has 
produced a genome-wide library of RNAi clones that target more than 85% of the predicted 
genes of C. elegans [10]. This tool is very powerful, since one can quickly perform 
comprehensive RNAi screens for a very specific phenotype. 
 
The last beneficial property of C. elegans I want to mention is at the same time also one of the 
most important criteria for the scientific value of a developmental organism. One of the main 
goals of developmental biology is to understand general concepts of development and to 
apply the knowledge gained in simple organisms, such as C. elegans to more complex 
organisms, especially to Homo sapiens. Interestingly, genome studies have shown that about 
36% of the C. elegans proteins have human counterparts [4]. This is a surprisingly high 
number, if one compares the anatomical complexity of H. sapiens and C. elegans. In support 
of this, many classical signaling pathways used during animal development are conserved 
from worm to human. For example, the core components for the Notch, RAS and the Wnt 
pathway that are conserved in the animal kingdom have also been found to regulate 
development of C. elegans. Another example is the study of genetic control of apoptosis in C. 
elegans by Sydney Brenner, Robert Horvitz and John Sulston. This work has elucidated a 
central dogma that was found to also exist in vertebrates and has been awarded with the Nobel 
Prize in Physiology or Medicine in 2002 [11]. Last but not least, Andrew Fire and Craig 
Mello have described that introduction of dsRNA into C. elegans causes RNAi and proposed 
that there is an underlying mechanism of general biological importance to be discovered. 
Indeed, this finding created a new field that is studied in animals as well as plants and was 
rewarded with the Nobel Prize in Physiology or Medicine in 2006 [12]. 
 
In summary, the anatomical properties of C. elegans, the available tools to manipulate C. 
elegans, the conservation of fundamental components controlling development and the 
relatively small ethical boundaries make C. elegans an excellent model organism.  
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But due to the worm’s anatomy that is simpler than that of H. sapiens there are clear 
limitations to what aspects of development can be studied in C. elegans. In general, tissues 
that are present and can be studied are epithelia, intestine, muscle and neurons. But more 
complex organs like eye, heart or liver are missing and thus cannot be studied. Nevertheless, 
C. elegans proves to be a very valuable model organism. Since some highly conserved 
signaling pathways are used in completely different steps of animal development one can 
study development of a simple organ and learn also about development of a complex organ. 
 
1.3 Vulval and gonadal development in C. elegans – A paradigm for cell-
cell signaling 
 
One of the best described organs of C. elegans is the vulva, the worm’s mating and egg-laying 
apparatus. The mature organ is made of only 22 cells that adopt during development a 
complex pattern of different cell fates. Interestingly, several highly conserved signaling 
pathways regulate the pattern formation. During vulval development, cells are strongly 
communicating and influencing each other’s cell fate. 
 
1.3.1. Vulval development in C. elegans 
 
During the first larval stage (L1), twelve epithelial cells are born and line up along the ventral 
side of the animal. In the C. elegans cell-lineage, they are named Pn.p cells, where “n” stands 
for the cell number from one to twelve [2]. Six out of these cells have the ability to form 
vulval tissue (P3.p to P8.p) and thus form a vulval equivalence group [13]. The other cells 
join the hypodermal syncytium hyp7 by fusion except for P12.p, which gives rise to the 
hypodermal tissue hyp12. In the adult animal, only three out of six vulval precursor cells 
(VPC) contribute to the vulva, namely P5.p, P6.p and P7.p. P6.p adopts the primary (1°) and 
P5.p & P7.p the secondary (2°) vulval cell fates and undergo several rounds of divisions. The 
remaining three VPCs (P3.p, P4.p and P8.p) adopt a tertiary (3°), non-vulval cell fate and fuse 
after one round of division with the hypodermal syncytium hyp7. 
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1.3.1..a Activation of RAS signaling induces vulval development 
 
Vulval development starts in the late L2 or early L3 stage, where the anchor cell (AC), a 
specialized cell in the neighboring gonadal tissue, induces differentiation of VPCs (Fig.1). 
The AC secretes the growth factor LIN-3 EGF [14], which activates a conserved receptor 
tyrosine kinase (RTK)/rat sarcoma (RAS)/mitogen-activated protein kinase cascade (MAPK)  
signaling pathway by binding to the receptor LET-23 EGFR present on the basolateral surface 
of VPCs. The LET-23 EGFR receptor is localized to the basolateral surface of the VPCs and 
thus facing the AC due to the action of a scaffolding complex containing LIN-2 CASK, LIN-7 
VELIS and LIN-10 MINT [15, 16]. Activated LET-23 EGFR recruits the adaptor protein 
SEM-5 GRB2 [17] and the RAS guanine nucleotide exchange factor (GEF) SOS-1 [18]. This 
leads to the activation of the small GTPase LET-60 RAS, which in turn activates a MAP 
kinase cascade consisting of LIN-45 RAF, MEK-2 MEK and MPK-1 MAPK [19-26]. Studies 
in other systems suggest that activated MPK-1 MAPK then enters the nucleus and changes 
transcription by phosphorylating transcription factors [27]. In the absence of Ras signaling, 
the transcription factors LIN-1 ETS [28] and LIN-31 HNF3 [29] are believed to form a 
complex that inhibits vulval induction [30]. Once LIN-31 HNF3 is phosphorylated by MPK-1 
MAPK, it dissociates from LIN-1 ETS and may activate vulval target genes. Recent work has 
shown that also LIN-1 ETS has a positive function in vulval development [31]. LIN-1 ETS is 
necessary in P6.p to promote expression of 1° specific genes such as EGL-17 during the L3 
stage. Since P6.p is closest to the AC, this VPC receives the highest amount of LIN-3 EGF 
and activation of Ras signaling is maximal. As a consequence P6.p adopts the 1° cell fate. 
 
1.3.1..b Lateral inhibition ensures the 2°1°2° pattern of vulval cell fates 
 
In order to form a wild-type vulva, a 1° cell has to be flanked by two 2° fated VPCs. For this 
purpose, P6.p sends a lateral signal to P5.p and P7.p that inhibits acquisition of the 1° and 
promotes the 2° cell fate (Fig.1). The lateral signal is constituted by LAG-2, APX-1 and 
DSL-1, which are ligands for the LIN-12 Notch receptor. They all belong to the conserved 
family of DELTA/SERRATE/LAG-2 proteins (DSL) and are transcriptionally activated by 
the RAS pathway [32]. Thereby, the LIN-12 NOTCH receptor is activated in P5.p and P7.p. 
Interestingly, it has been shown that the LIN-12 NOTCH receptor has to be removed from the  
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Fig.1: The inductive and the lateral signal define the 2°1°2° pattern of vulval cell fates. 
The scheme displays signaling events between the vulval cells P6.p and P7.p. The same lateral interaction occurs 
between P6.p and P.5p. The AC secretes the growth factor LIN-3 EGF (grey area). This leads to maximal 
LET-23 EGFR and LET-60 RAS signaling in the nearest vulval cell, P6.p. The pathway activity is enhanced by 
a positive feedback loop (EPS-8). At the same time the LIN-12 NOTCH pathway is inhibited via SUR-2 
activation. As a consequence P6.p adopts the 1° cell fate. Moreover, P6.p produces the lateral signal, consisting 
of the DSL ligands APX-1, DSL-1 and LAG-2. Thereby, the LIN-12 NOTCH pathway is activated in the 
neighboring vulval cells. LIN-12 NOTCH activates its transcription factor LAG-1 CSL. LIN-12 NOTCH 
signaling is enhanced by positive feedback loops (transcriptional activation indicated by dotted lines and 
MIR-61). The LIN-12 NOTCH pathway has two effects. On one hand, it drives transcription of negative 
regulators of the LET-23 EGFR pathway and thereby inhibits acquisition of the 1° cell fate (in red). On the other 
hand, LIN-12 NOTCH signaling induces by an unknown mechanism the 2° cell fate (blue arrow). Note that for 
simplicity reasons not all pathway components and regulators mentioned in the text are shown. 
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apical cell surface of P6.p and its descendants. Otherwise, DSL ligands are not able to activate 
the LIN-12 NOTCH receptor [33]. Based on vertebrate data the Notch intracellular domain 
(NICD) is released from the membrane upon LIN-12 NOTCH activation by an 
intramembraneous cleavage event. The NICD then enters the nucleus and changes 
transcription by interacting with the Notch transcription factor LAG-1. LAG-1 is a founding 
member of the Notch family of transcription factors, called CSL family (CBF1 of H. 
sapiens/Su(H) of D. melanogaster/LAG-1 of C. elegans). LAG-1 CSL has been shown to 
transcriptionally activate target genes like lip-1, ark-1, dpy-23 and the lst-genes [34-36]. 
Interestingly, all of the LAG-1 target genes found to date are negatively regulating the 
RTK/RAS/MAPK signaling pathway. Lateral signal induced phosphatase-1 (LIP-1), for 
example, dephosphorylates MPK-1 and thereby weakens the inductive RAS signal in P5.p 
and P7.p. But, mosaic analysis has shown that the LET-23 EGFR receptor is not necessary in 
P5.p and P7.p to adopt the 2° cell fate [37, 38]. On the other hand, activation of the LIN-12 
NOTCH pathway is sufficient to force VPCs to adopt the 2° cell fate. In lin-12(gf) animals, 
where the receptor is constitutively active independently of a ligand, all VPCs adopt the 2° 
cell fate [39]. Therefore, it is very likely that the LIN-12 NOTCH pathway has two roles in 
vulval development. One is to activate genes that promote the 2° cell fate and the other is to 
activate genes that negatively regulate the RTK/RAS/MAPK pathway. In support of this 
hypothesis, Ambros et al. has shown that the effect of  lin-12 Notch activity on vulval cell fate 
decisions is dependent on the cell cycle phase [40]. Before the S-phase the lin-12 Notch 
receptor promotes the 2° versus 1° cell fate and after the S-phase the 2° versus the 3° cell fate. 
 
1.3.1..c Feedback loops consolidate the 2°1°2° pattern of vulval cell fates 
 
During early vulval development, several feedback mechanisms ensure the establishment of a 
stable 2°1°2° pattern of cell fates. Activation of the RTK/RAS/MAPK signaling pathway 
leads to upregulation of LET-23 on the basolateral cell surface, thereby making the cell more 
sensitive to LIN-3 EGF. This has been shown to be mediated by the EGFR substrate protein 
EPS-8, which blocks endocytotic removal of LET-23 EGFR from the basolateral membrane 
[41]. In addition, activation of RTK/RAS/MAPK downregulates LIN-12 NOTCH levels via 
SUR-2 by endocytotic removal of the receptor from the cell surface [42]. This step has been 
shown be essential for proper lateral signaling. Since, P6.p acquires highest levels of LIN-3 it 
will have the highest LET-23 and the lowest LIN-12 level compared to the other VPCs and 
maintain a 1° cell fate.  
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In contrast, in P5.p and P7.p, where RTK/RAS/MAPK signaling is low due to lateral 
inhibition by LIN-12 NOTCH, the LET-23 receptor is not stabilized at the plasma membrane 
because EPS-8 levels are low. In addition, the LIN-12 NOTCH pathway is strengthened by 
the two following effects. On the one hand, LIN-12 NOTCH signaling seems to 
transcriptionally activate its own core components (e.g. lin-12 and lag-1; [43]). And on the 
other hand LIN-12 NOTCH signaling inhibits a repressor of lin-12 by upregulation of mir-61 
[44]. The microRNA mir-61 inhibits expression of the GEF vav-1. In conclusion, this makes 
P5.p and P7.p less sensitive to RAS signaling and promotes maintenance of the 2° cell fate. 
 
1.3.1..d Negative regulation of vulval induction 
 
Several components have also been found to negatively regulate vulval induction. One such 
group is called the synthetic multivulva genes (SynMuv, [45]). They are classified into the 
group of SynMuv A, B and C based on their genetic interactions. Per definition, a synthetic 
phenotype appears by mutations in different genes and this is because the affected genes have 
redundant functions. In the case of the SynMuv genes, the multivulva phenotype does only 
develop if hypomorphic mutations in two components that belong to different SynMuv 
classes are present in the same animal. In general, most of the SynMuv genes have vertebrate 
homologues that are involved in transcriptional regulation. The class B group has members 
that form in mammalians the nucleosome remodeling and histone deacetylation complex 
(NuRD), which is involved in gene silencing. The class C contains components similar to the 
mammalian Tip60 chromatin remodeling complex, which has histone acetylating activity and 
thereby activates gene expression [46]. It has been shown for the SynMuv A and B pathway 
that the reason for the SynMuv phenotype is excessive expression of LIN-3 EGF from the 
hypodermal tissue hyp7 [47, 48]. Thus, the SynMuv A and B pathways keep P3.p, P4.p and 
P8.p from acquiring vulval cell fates by repressing ectopic LIN-3 expression. 
 
Other negative regulators are gap-1, a GTPase activating protein for LET-60 RAS [49], sli-1 a 
c-CBL like gene acting on let-23 [50], ark-1 [36] an Ack related kinase that also acts at the 
level of let-23, unc-101 a component of clathrin associated complexes [51] and DEP-1 DEP1 
a tyrosine phosphatase that inactivates LET-23 EGFR [52]. Interestingly, also negative 
regulators other than the SynMuv genes do show synthetic interactions amongst each other. 
Loss of only one negative regulator gives a wild-type vulva. But loss of at least two negative 
regulators gives a multivulva (Muv) phenotype. A possible explanation is that only removal 
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of at least 2 negative regulators elevates RTK/RAS/MAPK signaling activity beyond the 
necessary threshold for vulval development. 
 
1.3.1..e The threshold model of 1° cell fate induction 
 
In order that VPCs adopt the 1° cell fate, the level of RTK/RAS/MAPK signaling activity has 
to cross a certain threshold value. The pathway activity can, for example, be monitored by 
looking at gfp-reporters for 1°-specific targets, such as egl-17 Fgf, that are upregulated upon 
inductive signaling. In wild-type animals, reporters for egl-17 are expressed in the 1° cell 
lineage (P6.p and its descendants) and absent from the 2° cell lineage (P5.p, P7.p and their 
descendants) during the L3 stage [35, 53]. In contrast, Yoo et al. reported that a loss-of-
function mutation of lip-1, a negative regulator of the RTK/RAS/MAPK pathway, causes 
ectopic egl-17 expression in P5.px and P7.px [35] but vulval development is wild-type. This 
indicates that the activity of the RTK/RAS/MAPK pathway is elevated but not sufficiently to 
cause a 2° to 1° cell fate change or ectopic vulval induction. Although Yoo et al. did not 
mention the egl-17::cfp expression in P3.p, P4.p and P8.p of lip-1(lf) mutants, there is genetic  
evidence that the RTK/RAS/MAPK pathway activity is elevated in all VPCs of lip-1(lf) 
animals. If lip-1(lf) is combined with overexpression of mpk-1 P3.p, P4.p and P8.p are 
ectopically induced, whereas each single alteration does not affect vulval development [34]. 
This indicates that RTK/RAS/MAPK activity has to reach a certain threshold to cause vulval 
development. 
 
1.3.1..f Execution of vulval cell fates and morphogenesis 
 
After specification of the vulval cell fate pattern, vulval cells follow a cell fate-specific 
division pattern [54]. 1° and 2° vulval cells undergo three rounds of cell divisions. While 1° 
cells give rise to 8 cells, only 7 are born in 2° lineages (Fig.2). In addition, the last round of 
cell division shows cell type-specific orientations of the division planes. Cells of the 1° 
lineage all divide transversal to the anterior-posterior axis of the animal. In the 2° lineage the 
2 distal cells divide longitudinal, the next proximal cell divides transversal and the most distal 
cell does not divide. The two 2° lineages are generated as mirror images towards each other. 
Thereby, the vulva is a symmetrical structure with the plane of symmetry residing 
perpendicular to the anterior-posterior axis in the middle of the 1° lineage. By the end of the  
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Fig.2: Vulval cell lineage and morphogenesis. 
A) The VPCs (vulval precursor cells) are born during L1 stage and remain quiescent until the late L2 stage. After 
vulval induction at the L2/L3 stage P6.p adopts the 1° and P.5p and P7.p adopt the 2° cell fate. During the first 
two rounds of divisions 1° and 2° cells divide identically along the longitudinal axis. During the third round of 
division all cells of the 1° lineage divide transversally giving rise to eight cells. These cells have the subfates 
VulE or VulF. In contrast, the third round of divisions is asymmetric for the 2° lineage. While the outer two cells 
divide longitudinal, the neighboring cell divides transversally and the fourth cell does not divide. The subfates of 
the 2° cells are VulA, VulB1, VulB2, VulC and VulD. Afterwards, cells that have the identical fate on each side 
of the vulval midline send cellular protrusions to each other. Cells of a specific subfate form together a toroidal 
ring. Thereby, a stack of seven rings, which creates the vulval lumen, is formed. B to F) The Nomarski picture 
show the vulval cells at the developmental stages that are also labeled in (A). 1° cells are underlined in white and 
2° cells in black and anterior is to the left. B) Pn.p or one-cell stage. C) Pn.px or two-cell stage. D) Pn.pxx or 
four-cell stage. E) Pn.pxxx or eight-cell stage. Vulval cells just started to form a vulval invagination. 1° cells are 
not visible, since they are in another focal plane. F) Christmas-tree structure: Formation of the toroid stack is 
complete. 1° cells are not indicated here, since they are in another focal plane. 
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L3 stage, all vulval cell divisions are finished and 22 cells are born in total. The 1° and 2° cell 
lineage consists of cells with different sub-cell fates. VulA, B1, B2, C and D are formed by 
the 2° and VulE and VulF by the 1°cell lineage. This classification is based on the fact that 
cells of the same sub-cell fate will later form a toroidal ring together. In addition, it has been 
shown that individual sub-cell fates express different sets of vulval cell fate markers [55]. 
Cells of the same sub-cell fate are located in symmetrical positions relative to the future 
vulval center and send cellular processes towards each other. As a consequence, 7 toroidal 
rings are formed. Afterwards, intratoroidal cell fusions take place and the vulval rings become 
multinuclear. During process formation the vulval cells also migrate towards the centre of the 
vulva. Thereby, the toroids form a stack with two rings formed by 1° descendants on top 
(VulE and F) and 5 rings formed by 2° descendants (VulA, B1, B2, C and D) on the bottom. 
At this stage, the AC sits on top of the vulval structure and connects the vulva to the uterus. In 
the L4 stage, the AC fuses to the multinuclear uterine seam cell (utse) and thereby the uterine 
and the vulval lumen form a continuous tube. In addition, the VulF cells attach to the uterine 
uv1 cells and ensure stable connection to the uterine tissue. Finally, the vulval structure 
undergoes eversion. The lumen is blocked by vulval tissue and eggs can only leave the animal 
if the vulval muscles are contracted and opening the vulval passage. 
 
1.3.2. The AC coordinates development of gonadal and vulval tissues 
 
In the adult worm, the gonad is a tube-like structure that produces oocytes and contains a 
limited amount of sperms. During maturation, the oocyte migrates through the gonad towards 
the vulval opening. After passing the spermatheca, a sperm containing chamber, the fertilized 
oocyte reaches the uterus. Opening of the vulva then allows eggs from the uterine lumen to 
reach the outside world. Since the uterus and the vulva opening are connected, eggs can be 
laid and hatch outside of the adult animal. But, because the gonad and the vulva are generated 
from separate tissues it is obvious that the development has to be coordinated. It has been 
shown that the AC, a specialized cell in the gonad, coordinates vulval and gonadal 
development and ensures a proper connection between them. 
In the middle of the L2 stage, one AC is selected via the AC/VU decision (Fig.3 A and B). 
After birth, the AC moves to a central position in the uterus surrounded by three VU and two 
DU cells. Unlike the AC, the VU and DU cells start to proliferate. The AC now dictates and 
thereby coordinates vulval and gonadal development. In late L2/L3, the AC induces vulval 
development by secreting an EGF ligand (Fig.3 C; vulval signaling and development is  
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Fig.3 The AC coordinates development of gonad and vulva. 
In A) to E) the schematic drawings on the left side display gonadal and vulval cells at the indicated stages. For 
simplicity reasons not all P5.p and P7.p descendants are shown in C) to E) and the DU cells (dorsal uterine) are 
only shown in A). At each stage, a Nomarski and a gfp-picture of a representative animal are shown on the right 
side. A) The future AC (anchor cell) is selected between two cells of the somatic gonad by reciprocal LIN-12 
NOTCH signaling (blue arrow). The other cell will adopt the VU fate (ventral uterine). At this stage the gonadal 
and vulval tissues are separated by two basal laminae (red lines). Expression of a gfp-reporter for lin-3 is 
expressed in both cells (arrowheads) until the AC is selected. lin-3::pat-1TM::gfp is a transcriptional reporter for 
lin-3 where the transmembrane domain of pat-1 localizes the GFP to the plasma membrane [56].B) The AC 
induces vulval development. Now that the AC/VU decision has taken place the gfp-reporter for lin-3 is only 
expressed in the AC itself (arrowhead). C) The AC activates the invasion program, which is controlled by fos-1. 
Observation of him-4::gfp, a translational reporter for the extracellular component hemicentin, shows that the 
basal laminae between the gonadal and the vulval tissues are still intact. D) The AC (arrowhead) has dissolved 
the underlying basal laminae and invades the vulval tissue in between the P6.p descendants. The basal laminae, 
stained by him-4::gfp show a clear gap underneath the AC (arrowhead). E) The AC (arrowhead) induces six out 
of twelve VU cells to adopt the -cell fate. 
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described in detail in a previous paragraph). After this induction step, the vulval tissue 
continues to proliferate and differentiate independently of the AC. Thus, initiation of vulval  
development depends on the developmental stage of the gonad. Until the second division of 
the vulval Pn.p cells, the gonadal and vulval tissues are separated by a sheath of extracellular 
matrix (Fig.3 C). In order to connect the uterus to the vulva this barrier has to be removed. 
Therefore, the AC activates a fos-1 dependent invasion program around the Pn.px stage. By 
the Pn.pxx stage the basement membranes are already degraded and the AC invades the 
vulval tissue in between the 1° fated cells (Fig.3 D). In the late L3 stage, the AC patterns the 
uterus. At this point, the VU cells have undergone two rounds of divisions giving rise to 12 
cells. The AC sends an inductive LIN-12 NOTCH signal to the six VU cells that are directly 
surrounding the AC (Fig.3 E, [57]). As a consequence, these cells adopt the -cell fate. The 
remaining cells adopt the alternative -fate and will form part of the uterine walls. -cells are 
destined to undergo one round of division. Only few genes have been found so far to be 
involved in - cell specification or maturation. Interestingly, based on their protein structure 
they are all supposed to act as transcription factors. The zinc-finger transcription factor lin-29 
is necessary for LAG-2 expression in the AC [58]. Thus, in lin-29 mutants -cells are not 
formed and as a consequence a thick layer of tissue separates the uterine and vulval lumen. 
Other genes, like lin-11, a LIM-domain protein, and egl-13, a Sox-family transcription factor, 
are necessary for execution of the -cell fate [59]. lin-11 acts downstream of lin-12 Notch to 
ensure proper positioning and fusion of the -cells to the AC [59, 60]. The same defects are 
observed in egl-13 mutants. In addition, -cells of egl-13 mutants undergo one extra round of 
division [61, 62]. Very recently it has been shown that the expression of egl-13 in -cells is 
coordinately regulated by FOS-1 FOS and LIN-12 NOTCH [63]. 
 Afterwards, eight of twelve -cells fuse with the AC and form the uterine seam cell 
syncytium (utse). It has been shown that fusion of the AC is different than most cell fusions in 
C. elegans. While almost all cell fusions depend on the fusogen eff-1, the AC depends on a 
related fusogen, called aff-1 [64]. Interestingly, aff-1 expression is regulated by the 
transcription factor fos-1 Fos, the same gene that also regulates AC invasion. Thereby, the 
timing of AC invasion and fusion between AC and utse is coordinated. The final utse tissue 
connects the uterus to the lateral seam cells. The remaining four cells of the -cell lineage are 
induced by a signal originating from the vulval cells. The 1° vulval cells secrete LIN-3 EGF, 
activate LET-23 EGFR on the surface of four -cells and thereby instruct the uv1 fate. These 
cells form later a physical connection between the vulval VulF cells and the uterus. 
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1.3.3. Gonadal development 
 
At the L1 larval stage, the primordial gonad of C. elegans consists of 4 cells, named Z1-4. Z2 
and Z3 are the primordial germ cells (PGC) and give rise to the germline. Z1 and Z4 are 
somatic germline precursors (SGP) and give rise to five somatic structures: the uterus, the 
distal tip cells (DTC), the gonadal sheat, the spermatheca-uterine valve and the spermatheca 
[65]. The SGP cells undergo three rounds of asymmetric divisions, and the resulting twelve 
cells form the somatic primordium of the hermaphrodite (SPh). At this stage the gonad has an 
elongated shape with one DTC at each end. The DTCs are necessary for proliferation of the 
germ cells and for guiding the growing gonad arms during later development. All the other 
somatic cells are clustered in the middle of the SPh. On the ventral side there are 4 cells of 
which two are destined to become ventral uterine (VU) cells and two have equal potential to 
adopt the AC or the VU fate. VU cells will later form the ventral part of the uterus wall as 
well as spermathecal and spermathecal-uterine valve cells. Dorsal to the VU cells are two 
dorsal uterine (DU) cells that become finally part of the dorsal uterus wall and form also 
spermathecal and spermathecal-uterine valve cells. The uterine cells are flanked by two pairs 
of somatic sheat and spermatheca precursor (SS) cells [66]. 
The proximal-distal asymmetry that is present in the SPh structure is established by a Wnt 
pathway. It has been shown that pop-1 Tcf/Lef1 is asymmetrically segregated among Z1 and 
Z4 progeny cells and loss of pop-1 leads to a symmetric structure of the gonad [67]. 
 
 
1.4 Notch signaling mediates lateral specification or inductive signaling 
during animal development 
 
Studies in D. melanogaster and C. elegans have shown that the Notch pathway is used in two 
different kinds of cell-cell interactions [68]. During inductive signaling, the Notch pathway is 
used amongst non-equivalent cells. There, one cell instructs a cell fate in a second cell that is 
different from its own. In contrast, during lateral inhibition the Notch pathway is used to 
select one cell from a group of equivalent cells. One cell activates the Notch pathway in its 
neighboring cells and thereby inhibits that they adopt the same cell fate as the signal-sending 
cell. Since signaling has been found to occur in both directions between the emerging cell 
types, this process is also called lateral specification [69, 70]. 
 
General Introduction 
 27 
During development of D. melanogaster, the sensory organ precursor (SOP) cell is specified 
via lateral specification. There, the Notch pathway ensures that from an equivalence group, 
called the proneuronal cluster, only one cell adopts the neuronal SOP fate. The other cells are 
inhibited by Notch signaling from the future SOP cell and adopt an epidermal fate. At the 
molecular level, Notch activity inhibits acquisition of the neuronal fate by repressing the 
expression of the proneuronal genes achaete and scute [71].  
During pattern formation of the D. melanogaster compound eye, Notch is used as an 
inductive signal. It has been shown that photoreceptor cells activate the Notch pathway in 
neighboring cone cell precursors. Thereby, the cone cell precursors express the cone cell-
specific transcription factor D-Pax2 and adopt the cone cell fate [72]. 
 
1.4.1. Classical examples for lateral inhibition in C. elegans are found during 
vulval development and the AC/VU decision. 
 
During development of the somatic gonad in the L2 stage, two VU cells that have the same 
potential to adopt the AC fate are present. Initially, both cells produce the ligand LAG-2 and 
its receptor LIN-12 NOTCH [69]. It is believed that a small difference in LIN-12 NOTCH 
signaling is amplified and determines one cell to become an AC and the other a VU cell. 
Detailed analysis has shown that the cell that is born first acquires most of the times the VU 
fate [73]. HLH-2 DAUGHTERLESS, the transcription factor for lag-2 Dsl, is the earliest 
known marker for the presumptive AC. The uneven distribution of HLH-2 
DAUGHTERLESS between the two cells is thought to be due to a negative feedback loop of 
LIN-12 NOTCH signaling. The present model proposes that the cell that is born first has 
earlier activity of LIN-12 NOTCH and this post-transcriptionally downregulates HLH-2 
DAUGHTERLESS. Thereby, the presumptive AC is not significantly affected by lateral 
inhibition. As a consequence the presumptive AC expresses HLH-2 DAUGHTERLESS, thus 
presents higher LAG-2 amounts on its cell surface and induces more strongly the LIN-12 
NOTCH pathway in the presumptive VU cell. Feedback mechanisms then consolidate this 
initially small difference. In the signal receiving cell, the expression of LIN-12 NOTCH is up- 
and LAG-2 is downregulated. In the signal sending cell the opposite is happening. Thereby, 
activation of the LIN-12 NOTCH pathway inhibits acquisition of the AC fate. In support of 
this, hypomorphic mutants of lin-12 exhibit the 2 AC phenotype and hypermorphic mutants 
show a 0 AC phenotype. 
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In the example of the AC/VU decision, the bias that basically defines the outcome of the 
lateral signal is created by the timing of cell divisions. In contrast, during vulval development 
the bias is created by another signaling event that comes from outside the vulval tissue. In the 
L2 stage the lin-12 Notch gene is expressed in all VPCs [74, 75]. Then, the inductive signal 
weakens the LIN-12 NOTCH signaling activity in P6.p and induces the 1° cell fate. P6.p 
becomes now the signal sending cell by upregulating the DSL ligands LAG-2, APX-1 and 
DSL-1 [32]. Thereby, P6.p prevents acquisition of the 1° cell fate in P5.p and P7.p [34, 35, 
43, 44]. 
 
During development of the somatic gonad lin-12 Notch signaling has also an inductive 
function. The AC activates the LIN-12 NOTCH pathway in neighboring VU cells and thereby 
instructs the -cell fate. A detailed description about the mechanism and the context of this 
signaling event is given in the paragraph about gonadal development above. 
 
1.4.2. Molecular events during LIN-12 NOTCH signaling 
 
The lin-12 Notch pathway is generally used to receive an extracellular signal at the plasma 
membrane, to transmit it to the nucleus and translate it into a transcriptional response. How 
the signal is traveling all this distance has been studied in various organisms, such as D. 
melanogaster, C. elegans and M. musculus. Since the core components are highly conserved 
from C. elegans to H. sapiens, the signal might be transduced similarly in all the systems. 
 
Receptors of the LIN-12 NOTCH family (for example LIN-12 in C. elegans, NOTCH in D. 
melanogaster, NOTCH1 in M. musculus) are processed in a proteolytic cascade by three 
different cleavage events S1-3 [76-78]. 
The first cleavage is performed during normal maturation in the Golgi and is mediated by a 
furin-like convertase. S1 cleavage gives rise to a heterodimeric receptor that is presented on 
the cell surface. Work in mammalian cell culture proposes that furin cleavage is necessary for 
Notch1 activity and that the majority of receptor on the cell surface is heterodimeric [79]. The 
S1 cleavage by a furine protease happens also in D. melanogaster. But in contrast to 
mammals, furin cleavage is dispensable for Notch activity in Drosophila and most of the 
protein presented on the cell surface is unprocessed [80]. To date, the importance of S1 
cleavage for lin-12 Notch activity has not been studied in C. elegans. But, western blot 
analysis of the GLP-1 protein, which is highly similar to LIN-12, indicated that the S1 
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cleavage takes place. Besides the full-length protein, there are also two smaller fragments 
present [76].  
The second cleavage, S2 takes place upon receptor activation. When ligands of the DSL 
family bind to LIN-12 NOTCH the extracellular part is cut off. In D. melanogaster, the S2 
cleavage is mediated by the ADAM (a disintegrin and metalloprotease domain) 
metalloprotease Kuzbanian (kuz). Several lines of evidence support that kuz is responsible for 
S2 cleavage. RNAi against kuz in Drosophila S2 cells inhibits S2 cleavage of a Notch 
derivate (has ligand independent activity and lacks a part of the extracellular domain for 
technical reasons, [81]). In addition, kuz mutants show characteristic Notch-related 
phenotypes, supporting the necessity of kuz for Notch signaling. Moreover, expression of the 
activated intracellular form of Notch can suppress the kuz 
-/-
 phenotypes in vivo supporting 
that kuz acts before the S3 cleavage [82]. Finally, kuz has been shown to act cell 
autonomously in the signal-receiving cell, which is in accordance with its proposed role as a 
S2 protease [83]. In mammalian cells the role of the kuzbanian homolog adam10 is 
controversial, since cell culture experiments showed that activated Notch1 is still processed in 
adam10
-/-
 cell lines [84]. But, experiments with cultivated murine cells propose that another 
protease, namely ADAM17/TACE (tumor necrosis factor- converting enzyme) is necessary 
for the S2 cleavage of Notch1 [84, 85]). However, strikingly similar phenotypes of adam10 
kuz
-/-
 mutants and Notch
-/-
 mutants underscore the importance of adam10 kuz in Notch 
signaling. In C. elegans, the S2 cleavage has not been proven by biochemical experiments. 
But, there is genetic evidence that both, the kuzbanian homolog sup-17 and the tace 
homologue adm-4 are positive regulators of lin-12 signaling and act before the S3 cleavage 
[86]. Interestingly, these two proteases act redundantly or separately in different lin-12 Notch 
events. 
The small extracellular stub produced by the S2 cleavage serves as a substrate for S3, the last 
cleavage event. In this step, the receptor is cleaved in the intramembraneous part and thereby 
the NICD is released into the cytoplasm. There is evidence from Drosophila, C. elegans and 
mammalian cell culture that this event is dependent on presenilin proteins. Initially, sel-12, 
one of the C. elegans presenilin homologs was found to interact with the lin-12 Notch 
pathway during vulval development and the AC/VU decision. Since presenilin was known to 
be responsible for the -cleavage of the receptor amyoloid precursor protein (APP), it was 
likely that presenilins provide a similar function for lin-12 Notch receptors. Interestingly, 
reduction of sel-12 function can suppress lin-12 gain-of-function alleles that have activating 
mutations in the extracellular part but not truncated forms consisting only of the soluble 
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intracellular part [87]. This data indicated that sel-12 Presenilin acts upstream or at the level 
of receptor activation. The study of Drosophila Presenilin mutants showed that the Notch 
receptor is normally localized at the cellular level but accumulates in an abnormally long form 
[88]. In addition, Psn mutants show typical Notch-related phenotypes, like defects in wing 
margin formation and specification of the SOP cell fate. In accordance with, it was shown that 
in vivo expression of full-length Notch or a membrane-bound form lacking the extracellular 
part leads only to Notch-dependent effects if presenilin is functional. In contrast, expression 
of the soluble NICD leads to Notch activity independent of presenilin function [89]. Similar 
results were obtained in mammalian cell culture experiments. Efficient production of NICD 
from a membrane-bound Notch1 derivate that lacks the extracellular domain happens only in 
the presence of Presenilin1 [90]. 
Once the NICD is released, it is supposed to enter the nucleus, to interact with CSL 
transcription factors and thus to cause a transcriptional response. Studies in C. elegans, 
Drosophila and mammalians have shown that the soluble intracellular part of Notch, the 
NICD, is sufficient for signaling [91, 92]. The extracellular part of the protein seems to be the 
regulator of this intrinsic activity. Drosophila NICD binds the CSL transcription factor 
suppressor of hairless (Su(H)), which as a consequence activates genes located in the 
enhancer of split (E(spl)) locus. Similarly, activation of mammalian Notch1 leads to 
transcription from the Hes1 locus, which is the mammalian counterpart to the E(spl) locus in 
Drosophila(Jarriault et al. 1995). In C. elegans, the CSL family transcription factor lag-1 
seems to act in a similar way, since it recognizes the same consensus motif in target genes like 
Su(h) and Cbf1 [34, 43]. 
 
1.4.3. Components of the LIN-12 NOTCH pathway in C. elegans 
 
The C. elegans genome contains at least two Notch-like receptors, namely lin-12 and glp-1. 
Although these receptors are involved in different developmental decisions, they seem to be 
interchangeable. For example, glp-1 under the control of lin-12 regulatory elements can 
rescue developmental defects in lin-12 loss-of-function animals [93]. Thus, lin-12 and glp-1 
seem to share common ligand and effector molecules. While mutations in lin-12 and glp-1 
generally affect different tissues, there is one exceptional glp-1 allele, glp-1(q35), that gives 
rise to a Muv phenotype comparable to a lin-12(gf) allele [94]. Investigators speculate, that 
this allele leads to inappropriate activation of glp-1 in the vulval cells. Therefore, since lin-12 
and glp-1 are interchangeable and they are involved in different developmental steps, their 
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activity must be cell-specifically regulated. In this respect, only lin-12 has been shown so far 
to be necessary for development of the somatic gonad and the vulva. 
 
lin-12, the C. elegans homolog of D. melanogaster Notch, has been cloned in a screen for 
vulval lineage defects [39]. In another forward genetic screen, investigators were looking for 
genes that are commonly used by lin-12 and glp-1 signaling. Therefore, mutants that showed 
a lag-phenotype (lin-12 and glp-1) were isolated. Animals with a lag phenotype die as L1 
larvae and have developmental defects like loss of excretory cell, loss of the rectum and a 
twisted nose. Thereby, the DSL ligand lag-2, the CSL transcription factor lag-1 and the  
transcription factor lag-3 Mastermind that is possibly in a complex with activated lag-1 was 
found [95]. At this point, it is worth mentioning that the knowledge about lag-3 from C. 
elegans allowed the discovery that the related mouse gene Mastermind acts as a cofactor of 
Cbf1 [96]. 
Gene Name(s) 
C. elegans 
Homolog Lin-12 Interaction Putative function 
lag-1 Cbf1, Su(h) Positive CSL transcription factor 
sel-3/lag-2 Delta, Serrate Positive Ligand for lin-12 
sup-17 Kuzbanian Positive Needed for ectodomain 
shedding of lin-12 (redundant 
with adm-4 Tace) 
sel-5 Gak1 Positive Putative serine/threonine 
kinase, acts before or during 
release of NICD 
sel-8/lag-3 Mastermind Positive Part of lag-1/NICD 
transcriptional complex 
 sel-7 - Positive Novel nuclear protein 
 sel-4 - Positive Uncloned gene 
sel-6/emb-4  Aqr Positive Spliceosomal, intron-binding 
protein 
 sel-11 - Positive Uncloned gene 
 sel-12 Presenilin Positive lin-12 processing gamma 
secretase 
 sel(ar40)  Negative Uncloned gene 
 sel-1 Ibd2 Negative Putative involvement in protein 
degradation 
 sel-2 Neurobeachin/Lrba Negative Involved in endosomal 
trafficking 
 sel-9 P24 Negative Putative role in trafficking of 
lin-12 to the cell membrane 
 sel-10 Cdc4 Negative Fbox protein, ubiquitin 
mediated degradation of lin-12 
Table 1: lin-12 Notch interactors found in forward genetic screens in C. elegans 
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In order to find more components that interact with the lin-12 Notch pathway, several screens 
have been performed. Investigators mutagenized animals that harbor hypomorphic or gain-of-
function alleles of lin-12 and screened for suppression of or enhancement of the vulval 
phenotype [97, 98]. Therefore, the genes from these screens were named sel-genes, for 
suppressor or/and enhancer of lin-12. Most of the sel mutants seem to be modulators of lin-12 
Notch activity but are not core components of the pathway (Table 1). Based on genetic 
interactions, domain structure and homology to vertebrate proteins, these components are 
possibly involved in processing (sup-17 Kuzbanian, sel-5 Gak1, sel-12 Presenilin), 
degradation (sel-1 Ibd2, sel-10 Cdc4) and trafficking (sel-2 Neurobeachin/Lrba, sel-9 P24) of 
lin-12 Notch.  
Interestingly, in none of the screens performed so far a direct target of the LIN-12 NOTCH 
pathway has been found. This suggests that the LIN-12 NOTCH pathway activates a variety 
of redundant effector genes to instruct the 2° cell fate in vulval cells. 
 
1.5 Scientific work is seldom a linear path 
 
In this work several approaches have been undertaken to find target genes of the lin-12 Notch 
pathway in C. elegans during vulval and gonadal development. Several candidates have been 
found, and the corresponding data will be presented. During detailed analysis of one 
candidate gene, egl-43 Evi1, a strong defect in AC invasion was found. During this process, 
the AC acquires invasive behavior that is comparable to the behavior of a metastatic cancer 
cell. Since the knowledge gained from studying such processes in C. elegans is potentially of 
high interest for studies in vertebrates, the role of egl-43 Evi1 in AC invasion was studied in 
detail. In the following paragraph, I will therefore give an introduction into the field of 
cellular invasion during normal animal development and during cancer. 
 
1.6 Invasion during Development and Cancer 
 
Cancer is worldwide one of the most frequent causes of death. According to the World Health 
Organization (WHO) approximately 20% of all death cases in Europe in the year 2002 were 
due to cancer. 
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Cancer arises from pre-cancerous tumor cells. Tumor cells are abnormal cells that do not 
respond correctly to developmental control mechanisms. Thus, these cells do not differentiate 
properly and proliferate excessively. A fundamental classification of tumors depends on the 
behavior of the tumor cells. While benign tumors proliferate and remain in the tissue of 
origin, malignant tumors (synonym for cancer cells) adopt the ability to evade the tissue of 
origin and invade other tissues to form metastases. Metastases formation is the most common 
cause of death in cancer. The formation of metastases is life-threatening since it can disturb 
the normal function of affected organs and lead to loss of blood (e.g. blood appears in the 
urine from bladder cancer). Cancer cells are able to form metastases since they are able to 
cross barriers present in between cells and among tissues, called the extracellular matrix. 
 
The extracellular matrix (ECM) is found as interstitial matrix in between cells and as 
basement membranes lining epithelial and endothelial cells. The ECM is made of many 
different components such as proteoglycans, glycoproteins and hyaluronic acid, while the 
major component is the proteoglycan collagen. Due to its complex and varying composition, 
it can fulfill different functions. It serves as support tissues for other cells, as a barrier that 
prevents cell mixing during development and it can also regulate intercellular communication. 
 
The ECM is also present in the Nematode C. elegans, but there are some differences. Since 
the worm has no connective tissue, there is also no structure such as the interstitial matrix. 
But, the worm also contains two types of ECM, the worm specific cuticle and basement 
membranes. While vertebrate’s basement membranes consist of the basal lamina and the 
lamina fibroreticularis, investigators found in C. elegans a structure similar to the vertebrate 
basal lamina. The vertebrate basal lamina can be further subdivided into 3 different layers 
when observed under the electron microscope. In C. elegans the basal lamina appears as one 
uniform layer. It covers the surface of the gonad, the intestine, the pharynx and the 
hypodermis. Importantly, for many components that are present in vertebrates basement 
membranes homologous genes have been found in C. elegans [99]. One such component is 
him-4 Hemicentin that forms a barrier between the vulval and gonadal tissue during larval 
development. Interestingly, the HIM-4 protein is also produced by the AC and is necessary 
for the AC to efficiently invade the vulval tissue [100]. 
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1.6.1. Various cell types use the cell invasion program during normal animal 
development 
 
During blastocyst implantation, the embryo builds a physical connection between itself and 
the maternal endometrium. This is provided by the trophoblast cells, which are cells forming 
the surface of the blastocyst. First, the trophoblast cells adhere the blastocyst to the uterine 
cells by forming cellular protrusions that reach into the endometrial epithelia. The surface of 
the endometrium is formed by the decidual cells that are newly formed and removed every 
menstruation cycle. Afterwards, the trophoblast cells give rise to two different cell types that 
are both important to invade the endometrium. The syncytiotrophoblast (ST) cell is made by 
fusion of trophoblast cells and mediates fetal and maternal exchange of nutrients. In addition, 
the ST cell starts invasion by secreting lytic enzymes (Serine proteases, cathepsin, 
plasminogen activators and matrix metalloproteinase [MMP]), which digest the extracellular 
matrix surrounding the decidual cells. Then, decidual cells detach and the syncytiotrophoblast 
cell can reach and penetrate the underlying basal lamina. As a result the invasive protrusions 
reach the stroma and the embryo is firmly connected to the endometrium 
(www.embryology.ch). The trophoblast cells differentiate also into extravillous trophoblast 
cells (EVT). EVT cells are highly invasive cells that penetrate into the endometrial tissue, 
invade maternal arteries and thereby provide the embryo with blood [101]. During invasion, 
EVT cells produce pro-invasive proteins like MMPs and downregulate production of anti-
invasive proteins like cell adhesion molecules (e.g. integrin and e-cadherin). 
 
During neurulation, neural crest cells (NCC) are formed dorsal to the neural fold. Once the 
neural tube is formed NCCs undergo an epidermal to mesenchymal transition (EMT) and start 
to migrate towards their final location in the body. Finally, NCCs give rise to a high variety of 
cells, such as neurons and glia from the peripheral nervous system (PNS), skeletal elements, 
tendons and smooth muscles. Migration of neural crest cells depends on the extracellular 
matrix and interactions of integrins with laminin and fibronectin [102]. Moreover, migrating 
NCCs have been shown to secrete matrix modifying enzymes, such as plasminogen 
activators, thereby modulating the ECM [103]. A subpopulation of NCCs develop into 
melanocytes, the melanin-forming pigment cells. Once melanocytes reach the ectoderm they 
start to dissolve its basal lamina and invade the skin [104]. 
 
The ability of cells to cross basal laminae is also of great importance for the immune 
response. When macrophages that reside in a tissue recognize pathogens they are activated 
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and start to recruit leukocytes from nearby blood vessels. Chemokine signals from the 
macrophage strengthen the interaction between leukocytes and the endothelial cells of the 
blood vessel. Integrins presented on the surface of leukocytes allow tight binding to the blood 
vessel wall. Finally, the leukocytes start to express proteases that allow to cut the basal lamina 
in the blood vessel and to migrate into the affected organ. This step is called extravasation of 
leukocytes. 
 
Since it is obvious that unwanted invasion of cells can cause serious damage to an organism, 
activation of invasion must be tightly regulated in space and time. A central part of 
controlling invasive behavior is regulation of matrix modifying enzymes, such as MMPs, 
serine proteases and cathepsin. MMPs are a family of homologous proteases that all depend 
on Zn-ions for their catalytic activity [105]. They are secreted as inactive proenzymes and 
activated by hydrolysis. For example, plasmin, a blood component that degrades blood 
plasma proteins, is also known to activate MMPs. Active MMPs can be inhibited by tissue 
inhibitors of matrix metalloproteins (TIMP). Thereby, MMPs are regulated at various levels. 
MMPs are grouped based on their substrate specificity as gelatinases, collagenases and 
stromyelysins. 
 
On the other hand also the ECM influences adhesion, migration and invasion of a cell by 
interacting with its integrin receptors that are present on the cell surface. Matrix components 
like laminin and fibronectin are known to mediate these interactions. There are several 
examples for matrix components that regulate MMP expression. It has been shown that 
certain matrix components promote MMP secretion. 
 
Trophoblast implantation is an example for cellular invasion that has been extensively studied 
at the genetic level. There, invasive behavior is controlled by growth factors, their binding 
partners and matrix proteins. Invasion is promoted, for example, by the insulin-like growth 
factor II (IGFII) and inhibited by transforming growth factor-ß (TGF-ß) signaling. TGF-ß is 
thought to exert its effect as an anti-invasive signal in different ways. TGF-ß upregulates 
integrins, which might lead to stronger cell-matrix interaction and thus inhibit cell migration. 
In addition, it regulates important matrix proteins. Tissue inhibitor of metalloproteinase-1 
(TIMP-1) and plasminogen activator inhibitor-1 (PAI-1) are up- and urokinase-like 
plasminogen activator (uPA) is downregulated [106], which leads to lower MMP activity. 
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During C. elegans development, the AC, a specialized cell in the C. elegans gonad, acquires 
at a specific time point of development the ability to invade the neighboring vulval tissue. So 
far, investigators have found only few components that are necessary for the AC to acquire 
the invasive ability. The transcription factor fos-1, which is the C. elegans homologue of the 
Fos proto-oncogene is necessary in the AC for invasive behavior [100]. Further, fos-1 has 
been shown to positively regulate expression of three matrix related components in the AC 
(Fig.4). The cadherin homolog cdh-3 is involved in cellular adhesion and thereby affects 
hypodermal morphogenesis [107]. Zincmetallo protease-1 (zmp-1) is structurally similar to 
Mmp genes and may therefore act as a matrix degrading enzyme [108]. him-4 is homologous 
to the poorly characterized vertebrate matrix component hemicentin. In C. elegans, HIM-4 is 
a component of the ECM that organizes epithelial cell adhesions into fine line-shaped 
junctions [109]. 
 
C. elegans as a model to study cellular invasion has only recently been established [100]. The 
discovery of fos-1 as a regulator is interesting since the vertebrate homolog Fos is involved in 
invasive types of cancer. If rat fibroblasts are transformed with v-fos, the viral homolog of the 
cellular proto-oncogene c-fos, these cells become invasive [110] . Moreover, the 
 
Fig.4: fos-1a regulates AC invasion in C. elegans. 
The transcription factor fos-1a Fos is necessary for transcriptional activation of the AC invasion effectors, cdh-3, 
zmp-1 and him-4 [100]. But it is unknown whether fos-1a Fos directly regulates these target genes. Moreover it 
is unknown what factors regulate fos-1a Fos itself. 
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heterodimeric transcription factor activator protein-1 (AP1), which consists of fos and jun, 
positively regulates MMP-9 expression in cancer cells [105]. Since studies of C. elegans 
development are able to shed light on conserved signaling pathways (e.g. RTK/RAS/MAPK, 
Notch signaling), it is promising that by studying AC invasion in C. elegans, new insights can 
be gained to better understand the invasive behavior of cancer cells in vertebrates. 
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2 Questions of this thesis 
 
At the beginning of my PhD thesis, it was known that the lin-12 Notch pathway is important 
for organogenesis of vulval and gonadal tissues. But, there were still many fundamental 
questions to answer. 
 
For example, during vulval development lin-12 Notch was known to mediate the lateral, 
inhibitory signal and to act downstream of the inductive signal [1]. But, how the lateral signal 
is transmitted from P6.p to its neighbors, P5.p and P7.p was not shown so far. Only in 2004, 
Chen et al. showed that the lateral signal originates from P6.p and consists of three 
Delta/Serrate/lag-2 family members (DSL; [2]). 
 
Also, very little was known about the transcriptional response upon lin-12 Notch activation in 
P5.p and P6.p. So far, lip-1 was the only target known to be transcriptionally upregulated by 
the lin-12 Notch signal [3]. The phosphatase lip-1 is a negative regulator of the 
RTK/RAS/MAPK pathway by inactivating mpk-1 Mapkkk. Interestingly, single mutants of 
lip-1 show no defects in lateral signaling during vulval development. Thus, the output of the 
lateral signal seems to be mediated by several components acting in parallel. Nevertheless, 
weak ectopic expression of a 1° cell fate marker can be seen already in lip-1(lf) single 
mutants, indicating a weak reduction of lateral inhibition that does not lead to a 
morphologically visible defect [4]. 
 
In addition, analysis of different mutants suggested that the lateral signal must not only 
activate inhibitors of the RTK/RAS/MAPK pathway, but also specify the 2° cell fate in P5.p 
and P7.p. First of all, in lin-12(gf) mutants all and in lin-12(lf) none of the VPCs adopt the 2° 
cell fate [1, 5]. Therefore, the lin-12 Notch pathway is necessary and sufficient to specify the 
2° cell fate. Moreover, analysis of mosaic animals for the let-23 Egfr receptor showed that let-
23 is not necessary in P5.p and P7.p for formation of the 2° lineage [6]. Since the 
RTK/RAS/MAPK pathway is not necessary for 2° cell fate specification, its attenuation by 
components like lip-1 can therefore only be part of the response to lin-12 Notch signaling in 
P5.p and P7.p. In other words, these results suggest that in addition to inhibition of the 
RTK/RAS/MAPK signaling pathway, the lin-12 Notch pathway has also an instructive action 
for acquisition of the 2° cell fate. During the time of this PhD Yoo et al. found new targets of 
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the lateral signal [4, 7]. Since all this targets are inhibiting the RTK/RAS/MAPK pathway, 
still no component is known that instructs the 2° cell fate. 
 
In order to fill these gaps I designed several screens with different aims. 
 
1) Finding new components of the lin-12 Notch pathway in vulval development 
 
For the purpose of finding generally new components of the lateral Notch signaling pathway, 
I performed a forward genetic screen by EMS mutagenesis for animals with defects in the 
specification of the 2° vulval cell fate. In such a screen one can potentially identify 
components that are up- or downstream of the lin-12 Notch receptor. 
 
2) Finding new target genes of the lin-12 Notch pathway during vulval development 
that mediate the inhibitory or instructive function of the lateral signal 
 
For this purpose, I tested a list of candidate Notch target genes assembled by M. Sohrmann & 
T. Berset (PhD Thesis, Thomas Berset 2005) in a reverse genetic screen by RNAi for their 
involvement in acquisition of the 2° vulval cell fate. 
 
During analysis of one of the candidates from the RNAi screen, I realized that knockdown of 
egl-43 Evi1 by RNAi produces a strong defect in a tissue that is neighboring the vulval tissue, 
the gonad. In egl-43 Evi1 RNAi animals, the gonadal anchor cell (AC) is defective in 
invading the vulval tissue. 
 
3) Testing the regulation of egl-43 Evi1 by lin-12 Notch 
 
Since lin-12 Notch signaling is not only involved in vulval development but also important 
for generation and execution of the AC fate, I decided to analyze whether gonadal defects in 
egl-43 Evi1 RNAi animals are linked to defects in lin-12 Notch signaling. 
 
4) What is the interaction of egl-43 Evi1 with the genes known to be involved in AC 
invasion 
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In 2005 Sherwood et al. described the first components of a pathway that regulates AC 
invasion [8] and thereby established AC invasion in C. elegans as a model to study cellular 
invasion. At this point, only four components were known to be part of the pathway that 
regulates AC invasion. Therefore, I wanted to know whether egl-43 Evi1 is also part of the 
fos-1 Fos pathway and position egl-43 Evi1 relative to fos-1 Fos. 
 
Invasive cellular behavior is a well-studied process in vertebrate systems. The importance of 
these studies lies in the fact that the major difference between a benign and a malignant tumor 
is that the later adopts invasive abilities. Thus, the knowledge gained in C. elegans about the 
genetic program controlling AC invasion can help to understand the analogous process in 
vertebrate cancer systems. In the future, this knowledge is the basis for developing 
pharmaceuticals against cancer. 
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3 Screens for components of the lin-12 Notch pathway during 
vulval development 
 
Abstract 
 
In C. elegans the evolutionary conserved lin-12 Notch pathway is involved in several binary 
cell fate decisions during development. For example, the lin-12 Notch pathway is necessary 
and sufficient for specific vulval cells to adopt the 2° cell fate as well for specific gonadal 
cells to adopt the -cell fate. Although the lin-12 Notch pathway has been extensively studied 
in C. elegans, there is experimental evidence that there are still large gaps in our knowledge. 
While the core components and some regulators of the pathway only few target genes of the 
pathway are known. 
Until now, genetic screens for components of the lin-12 Notch pathway were based on the 
identification of morphological defects. In this work, a new strategy is used to identify 
candidate genes. Due to functional redundancy, defects in lin-12 Notch pathway components 
have been found to cause no morphological but defects in acquisition of the 2° vulval cell 
fate. Thus, a gfp-reporter for a 2°-cell fate specific gene was used to identify interesting 
candidates. 
In a first approach, an EMS mutagenesis screen was performed to find all kinds of pathway 
components. This led to the identification of five alleles of lin-11, a proposed target of the 
gonadal lin-12 Notch pathway and one allele of dep-1, a gene reported to act in parallel to 
lin-12 Notch in the vulva. In addition, the identity of one candidate gene, zh52 is still 
unknown, but has been mapped to a region containing a maximum of 585 genes. 
In a second approach, an RNAi screen was performed to identify target genes of the lin-12 
Notch pathway. For the screen, a candidate list was used with genes that contain clusters of 
consensus sequences for the transcription factor lag-1/CSL, which acts downstream of lin-12 
Notch, in the promoter (list was generated by T. Berset and M. Sohrmann). Of 86 candidate 
genes tested, RNAi against eight genes led to defects in acquisition of the 2° cell fate. Seven 
of these candidates are not known being involved in lin-12 Notch signaling. Analysis of 
transcriptional reporters for these candidates proposes that two of them, ttr-11 and C39F7.2 
are involved in vulval and/or gonadal lin-12 Notch signaling. 
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3.1 General introduction 
 
In 1983, the lin-12 Notch locus was identified in C. elegans [1]. The analysis of mutant 
phenotypes indicated that lin-12 Notch is needed for binary cell fate decisions in the gonad 
and the vulva. Subsequently, several forward genetic screens have been performed to 
elucidate new core components or regulators of the lin-12 Notch pathway [2, 3]. Candidate 
mutant animals were selected if the vulval phenotype of lin-12(rf) or of lin-12(gf) was 
suppressed. But, like the example of lip-1 shows, a lin-12 Notch pathway mutant does not 
necessarily give rise to a visible defect in vulval development [4]. This is most likely the case 
because of functional redundancy between the lin-12 Notch targets. Therefore, losing the 
function of such a gene might not sufficiently alter the phenotype of a lin-12 mutant. As a 
consequence, such components cannot be found by looking at vulval development with a 
standard light microscope. Interestingly, single mutants of lip-1 or the lst-genes show weak 
defects in cell fate specification when the expression of a 1° specific cell fate marker is 
investigated [5]. Defects in vulval induction are only visible if downregulation of such a 
lin-12 Notch target is combined with a mutation affecting vulval induction, such as a loss-of-
function mutation in gap-1. Therefore, it seems to be more sensitive to screen for mutants that 
show aberrant cell fate marker expression than to look for changes in vulval morphology. 
 
Based on these observations I designed and performed different screens. In general, 
transcriptional gfp reporters for egl-17 were used as a read-out for acquisition of the 2° cell 
fate. The FGF ligand egl-17 has been shown to attract the sex myoblasts (SM) to the vulval 
region [6]. The SM cells are the precursor cells for uterine and vulval muscles. They are born 
in the posterior part of the animal and migrate towards the vulval region. Transcriptional 
reporters for egl-17 are expressed in the developing vulva and gonad. Importantly, mutants 
for egl-17 show defects in SM migration but vulval development per se is not affected. egl-17 
is first expressed in 1° and later in a subset of 2° cells (Fig.5A). The early, 1° specific 
expression depends on the inductive signal and can be seen in P6.p and its descendants 
(Fig.5B and C). After three rounds of divisions, the egl-17 expression fades in 1° cells and 
appears in the 2°, VulC and VulD cells (Fig.5 D-G). Expression in the 2° lineage depends on 
lin-12 Notch signaling and on proper specification of the 2° cell fate. 
 
In the following paragraphs, I will describe in detail the design and the results from these 
screens 
Screens for components of the lin-12 Notch pathway - General introduction 
 49 
 
 
 
Fig.5: egl-17::gfp is a marker for 1° and 2° 
cells. 
A) The diagram shows the complete lineage 
of Pn.p cells from their birth in the first larval 
stage (L1) until the L4 stage. egl-17::gfp is 
first specifically expressed in 1° and later 
specifically in 2° vulval cells. Upon induction, 
egl-17::gfp (green line) appears in P6.p and its 
descendants. Once all 22 vulval cells are 
formed, egl-17::gfp fades from the 1° lineage 
and appears in a subset of 2° vulval cells 
(VulC and VulD). B) and C) At four-cell stage 
egl-17::gfp is only expressed in 1° vulval cells 
(P6.pxx). D to G) When the vulval cells form 
a Christmas tree structure egl-17::gfp is absent 
in 1° cells and present in specific 2° cells. The 
VulC and VulD cells are present in different  
focal planes. (D) and (E) focus on VulD, while (F) and (G) on VulC cells. Stars in (E) label out-of-focus 
fluorescence from VulC cells. Arrows in (D) to (G) point at gfp-positive cells of the 2° lineage. 
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3.2 Forward genetic screen 
 
3.2.1. Introduction 
 
A forward genetic screen in C. elegans is a powerful tool to identify genes that are involved in 
a specific step of animal development. Usually, animals are randomly mutagenized by a  
 
Fig.6: Workflow scheme of forward genetic screen for genes involved in specification of the 2° cell fate. 
L4 stage worms were mutagenized by EMS treatment. In addition to the loss-of-function allele lip-1(zh15) the 
strain contains a transcriptional reporter for egl-17. For the manual screen an egl-17::gfp and for the worm sorter 
screen a more intensive egl-17::yfp version was used. Mutagenesis of P0 animals gives rise to F1 animals that 
are heterozygous for a desired mutation (m/+) and most often phenotypically wild-type. Animals of the F2 
generation that are homozygous for the desired mutation (m/m) show defects in marker expression and 
eventually also defects in vulval morphology, such as a protruding vulva (Pvl) phenotype. Defects in marker 
expression comprise only slight reduction in expression or even complete loss of expression. For simplicity only 
one example of marker defect, an asymmetrical loss of the marker expression, is illustrated. For identification 
and isolation of interesting mutants two alternative methods were used. On the one hand, mutants were observed 
with a dissecting microscope and isolated with a worm pick. On the other hand, a worm sorter was used to scan 
and isolate desired mutants. 
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chemical mutagen. In this work, ethane methyl sulfonate (EMS), a classical mutagen that was 
already used by Sydney Brenner in his pioneer screens for C. elegans mutants, has been used. 
EMS is an alkylating agent that chemically modifies nucleotides in the genome and leads to 
mispairing during DNA replication. In 95% of the cases, EMS creates G/C to A/T transitions 
[7]. 
For mutagenesis, L4 animals where treated with EMS (Fig.6). This creates mutations in the 
gametes of the mutagenized parental generation (P0). In the first generation (F1), animals are 
heterozygous for point mutations generated by mutagenesis. Since most mutations are not 
dominant but recessive, the majority of the heterozygous mutant animals show no 
phenotypical abnormalities. For this reason, the second generation (F2) of mutagenized 
animals is observed during screening. In addition, there are different ways how to grow the F1 
generation. In a clonal screen, each animal of the F1 generation is grown on a separate agar 
plate. The advantage is that strains of interesting mutants can be easily maintained even if 
these animals have a sterile phenotype. Since on such a plate 2/3 of the wild-type animals are 
heterozygous for the mutation of interest, one only has to single-out wild-type animals and 
check for segregation of the desired phenotype. The disadvantage is that a clonal screen is 
more labor intensive than a non-clonal screen and therefore limits the number of animals that 
can be screened. Since this screen has not been done before, the screen was performed in a 
non-clonal manner. Several animals from the F1 generation were grown on the same plate and 
interesting F2 animals were isolated and further grown. 
 
3.2.1..a Principle of automated FLP mapping procedure 
 
While these screens were performed, Zipperlen et al. developed a new assay for automated 
mapping of mutations [8]. Fortunately for this work, the mapping method, which is based on 
fragment length polymorphism (FLP), was ready to use when the mutants were isolated. The 
automated FLP mapping method uses PCR assays to detect polymorphisms between the 
isolates Bristol (strain name N2) and Hawaii (strain name CB4856) of C. elegans. In 
principal, the mapping strain Hawaii is crossed into the Bristol strain containing the mutation 
(Fig.7). Meiotic recombination events in the gonad of F1 animals generate chromosomes 
containing stretches of Bristol and Hawaii DNA. Animals that show the mutant phenotype in 
the F2 generation are used for genotyping. In the case of a recessive allele the mutation can be 
narrowed down to a genomic region where FLP assays indicate homozygous presence of 
Bristol DNA. This method theoretically allows mapping of a mutation to an interval of 3cM  
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or 0.9Mbp, respectively, by analyzing 48 animals from a single cross. Genotyping is done in 
two rounds of PCR assays. In the first round, assays are selected that allow determination of 
the chromosomal linkage (TIER1). For this purpose, two PCR assays are selected per 
chromosome, one on the left and one on the right arm of each chromosome. In the second 
round, assays are selected to narrow the genetic location down to a subchromosomal region 
(TIER2). For this step at least 8 PCR assays are chosen that cover the entire chromosome. 
 
3.2.1..b Generation of a Hawaii mapping strain with integrated egl-17::gfp respectively 
egl-17::yfp transgenes 
 
Since the mutations were generated in a Bristol strain containing an integrated reporter for 
egl-17 and the phenotype that was followed is a decrease in reporter expression, it seemed to  
 
Fig.7: Crossing scheme for FLP-mapping. 
The mutant strain that contains a recessive mutation of interest in a N2 background (variety Bristol) is crossed 
into the CB4856 strain (variety Hawaii). The cross-progeny is heterozygous for Bristol (including the recessive 
mutation) and Hawaii DNA content and thus phenotypically wild-type. In the F2 generation, animals 
homozygous for the mutation appear again and they are selected by isolating animals that show the phenotype. 
Since in the gonad of F1 animals meiotic recombination took place, regions that do not contain the mutation of 
interest can be replaced by Hawaii DNA in such animals. Finally, the Bristol and Hawaii DNA content of 
selected animals is determined by PCR assays. The PCR assays allow to discriminate between Bristol and 
Hawaii DNA by amplifying regions that are polymorphic between Bristol and Hawaii (Figure is adapted from 
Zipperlen  al., 2005, [8]). 
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be useful to generate a Hawaii mapping strain that contains the same integrated reporter. In 
case a mutation does only give rise to a change in reporter expression, but not any other 
visible phenotype using such a mapping strain is the only way to follow the mutation of 
interest. For this purpose, males were generated from the egl-17 reporter strain and crossed 
into the Hawaii strain. The male cross-progeny that contain the reporter were then crossed 
again into the Hawaii strain. After backcrossing the egl-17::gfp reporter 8 times and the 
egl-17::yfp reporter 10 times into the Hawaii strain hermaphrodites were cloned and the 
progeny homozygous for the reporter construct were selected. The resulting strains were 
tested by FLP mapping for their content of Hawaii DNA (Fig.8). In general, the strains are 
 
Fig.8: Summary of mapping results for egl-17-reporter transgenes in Hawaii background. 
A) Genotyping of an ayIs4[egl-17::gfp] I-containing strain after eight backcrosses of the transgene into the 
Hawaii background. Chromosome I still consists largely of Bristol DNA, while all other chromosomes are 
devoid of Bristol DNA. When ayIs4 was mapped in the N2 background by analyzing 48 lysates the transgene 
was found to be left of the assay ZH1-3(-1.04cM) (indicated by a box). In accordance to this result ayIs4 was 
published being located 1cM left of bli-3(-19.21cM, [6]), which is far to the left of ZH1-10(-12cM). 
B) Genotyping of an syIs90[egl-17::yfp] III containing strain after ten times backcrossing into the Hawaii 
background. In accordance with the known linkage of syIs90 only chromosome III still contains some Bristol 
DNA. While syIs90 in the N2 background was successfully mapped between the assays ZH3-8(-9.5cM) and 
ZH3-11(9cM) by analyzing 96 lysates (indicated by a box) the strain with syIs90 in the Hawaii background 
contains still N2 DNA  to the left of ZH3-12(15cM). (Hetero: contains Bristol DNA on one and Hawaii DNA on 
the other chromosome, ND: no data, since PCR assay did not work) 
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homozygous for Hawaii DNA on the chromosomes that do not contain the integrated 
transgene. Unfortunately, the mapping strains containing an egl-17::gfp or an egl-17::yfp 
transgene contain mostly Bristol DNA on the chromosomes where the transgene is integrated. 
Therefore, in the case a mutation is located on the same chromosome as the transgene a 
standard Hawaii strain has to be used for mapping. 
 
3.2.2. Results of the forward genetic screen 
 
The strain used for the non-clonal screen contained in addition to a transcriptional reporter for 
egl-17 the loss-of-function allele lip-1(zh15). Basically, there are two reasons for this. First, a 
change in 2° cell fate specification could not only result from defects in lin-12 Notch 
signaling but also from defects in the inductive signaling pathway. In order that such mutants 
are less likely to appear in this screen we strengthened the inductive RTK/RAS/MAPK 
pathway by a loss of lip-1 activity. Second, the output of the lin-12 Notch pathway seems to 
be highly redundant. Therefore, using a lip-1(lf) mutation for the screen gives the possibility 
that a second hit in a lin-12 Notch target gene leads to a defect in 2° cell fate specification. 
 
The actual screening was done in two ways. On the one hand, the pattern of egl-17::gfp 
expression was manually assayed with a UV dissecting microscope. On the other hand a 
worm sorter, which is a flow cytometer adapted for worms, was used to automatically select 
animals with reduced expression of an egl-17::yfp reporter (Copas Biosort, Union 
Biometrica). 
 
3.2.2..a Manual, non-clonal screen 
 
Animals of the F2 generation were observed at the L4 stage, where the egl-17::gfp reporter is 
normally expressed equally in the VulC and VulD cells of the 2° lineage. Animals that 
showed any kind of reduction in the reporter expression compared to lip-1(zh15); egl-17::gfp 
animals were isolated and checked whether the phenotype is inherited to this progeny. Based 
on the kind of change in gfp-expression, the mutants were categorized. Animals where the 
expression was generally reduced or completely lost were named “reduced” or “loss”. 
Mutants, where the gfp expression was reduced only on one side of the vulval invagination, 
were described as “asymmetric”. 
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Of 6000 examined F2 animals 184 mutants were isolated. 53% of them inherited the 
phenotype to their progeny (N=99). The rest did either not inherit the phenotype (30%; N=55) 
or died before giving rise to any progeny (16%; N=16). Interestingly, approximately 90% 
(N=89) of the animals that inherited the phenotype were lost after a few generations due to 
sterility or embryonic lethality. In the end, ten viable and fertile mutants could be recovered 
from this screen (Tab.2). Importantly, the mutants that were found support the basic idea of 
the screen that changes in cell fate do not necessarily lead to morphological defects. Many 
mutants show only weak or no defects in vulval morphology when observed with a dissecting 
microscope. 
 
3.2.2..b Non-clonal, high throughput screen using the Copas Biosort System 
 
The worm sorter (Copas Biosort, Union Biometrica) is ideal to analyze a large number of 
worms in a short time. Under optimal conditions, 20 worms/second can be processed. Since, 
the number of genomes analyzed is a critical parameter for a mutagenesis screen, the worm 
sorter can increase the chance to find the desired targets. The worms are provided as a 
suspension in the isotonic buffer M9 to the machine (Fig.9). Each worm runs through a flow 
cell where a red diode laser is used for size and density measurements and a blue/green laser 
to elicit green, yellow and red fluorescence. For each worm analyzed, the size and density as 
well as 2 fluorescent signals are recorded. The parameters size and density are used to select a 
specific stage of worms. For ease of sorting, young adult animals were chosen. Importantly, at 
this stage egl-17 is still expressed in 2° cells of wild-type animals. From this population, all 
worms were selected that show lower fluorescent signals than the original strain used for 
mutagenesis. If a worm meets all the chosen criteria, it was put into a single hole on a 6-well 
plate. Each hole of the 6-well plate contained standard solid, growth media. Thereby, no 
further manipulation of the worms was needed to grow them for several generations. In 
contrast to the manual screen, a strain containing egl-17::yfp that is more strongly expressed 
than the gfp construct was used. In pilot experiments, the egl-17::gfp expression turned out to 
be too weak for the sorter to reliably distinguish gfp positive and negative worms. In a single 
run 120’000 worms of the F2 generation were analyzed and ten mutants were isolated. 
Finally, two mutants turned out to be fertile and inherit the phenotype (Tab.2). 
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Fig.9: The Copas Biosort System is used to isolate specific mutants from a forward genetic screen. 
A) Schematic representation of the worm sorter components. First, the mutagenized worms are analyzed for size, 
density and fluorescent intensities. Second, worms are selected based on user-defined criteria. Finally, each 
candidate worm is put into a single well of a multi-well plate that contains solid nematode growth media (NGM) 
seeded with bacteria. 
B) The worm sorter is able to discriminate between syIs90[egl-17::yfp]-containing and non-fluorescent worms. 
In this test experiment, a mixed suspension of N2 and syIs90[egl-17::yfp]-containing worms of different 
developmental stages was provided to the sorter. Then, the sorter was calibrated to select worms of young adult 
stage (selection window in upper panel). Analysis of yellow fluorescence from these young adult worms shows 
that two populations can easily be discriminated. Inspection of these worms with a microscope showed that 
worms with high yellow fluorescence are indeed expressing egl-17::yfp, while worms with low yellow 
fluorescence do not express the egl-17::yfp transgene. 
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3.2.2..c Procedure for further characterization of mutants from forward genetic screens 
 
1. Backcross of mutants 
During mutagenesis, several mutations can accumulate in a single animal. In order to 
isolate the mutation that is responsible for the phenotype of interest and to get rid of 
phenotypically unrelated mutations, each mutant was crossed several times into a 
wild-type strain that contains the reporter construct. Animals with the desired 
phenotype were selected from the F2 generation and tested by PCR for the deletion 
allele lip-1(zh15). This allowed to test whether the phenotype depends on the presence 
of lip-1(zh15). 
 
2. Characterization of vulval phenotype by Nomarski microscopy 
As already mentioned before, 2° cell fate defects are theoretically possible due to 
direct defects in Notch signaling but also due to indirect defects affecting induction of 
the 1° cell fate. In order to exclude mutants that are most likely affected in the 
inductive signaling pathway, all mutants were analyzed at high resolution with a 
microscope. The mutants that are possibly affected in 2° cell fate acquisition were 
further analyzed by FLP mapping. 
 
3. FLP mapping of interesting mutants 
First, the automated FLP mapping method was used to determine the chromosomal 
and the subchromosomal position of mutations. Afterwards, when the 
subchromosomal position was narrowed down to the region between two neighboring 
FLP-assays, mapping was continued by manual mapping that was based on single 
nucleotide polymorphisms (SNP).  
 
4. Candidate approach for possibly affected genes 
The results from mapping allow generating a list of genes that are known in the 
candidate region. In the case that there were genes among the candidates that have 
been reported to cause a similar phenotype like the mutant these genes were directly 
tested by complementation crosses. During complementation assays, an allele of a 
candidate gene is combined with the unknown mutation by crossing (Fig.10). If the 
cross-progeny still shows the mutant phenotype the mutant is very likely an allele of 
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the candidate gene tested. If the cross-progeny does not show the mutant phenotype 
then either two different genes or two different functions of the same gene are 
affected. In the cases where complementation assays gave positive results, the 
proposed genomic regions were tested by sequencing. 
 
3.2.2..d Characterization of less promising mutants 
 
Two mutants (zh39 & zh44) were classified as less interesting based on characterization of the 
vulval phenotype with Nomarski optics. Therefore, these strains were not backcrossed or 
mapped. The alleles zh39 and zh44 show reduced proliferation of vulval cells pointing at a 
 
Fig.10: Crossing scheme for a complementation assay. As an example, a complementation cross between 
the zh41 allele and lin-11(n566) is shown. 
Males containing zh41 are produced by crossing males of a wild-type N2 strain into the zh41 strain. zh41/+ 
males are crossed into the lin-11(n566) strain where the lin-11 allele is cis-linked to a recessive allele of unc-13. 
Since unc-13(e1091) lin-11(n566) animals are strongly Unc, cross-progeny can easily be identified. If the allele 
tested, in this case zh41, is an allele of lin-11 then at maximum 50% of the progeny show a Pvl and/or a bag-of-
worms phenotype. If none of the progeny show the Pvl and/or bag-of-worms phenotype then the allele tested is 
not a lin-11 allele or affects another function then the lin-11(n566) allele does. 
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defect in the inductive signaling pathway. As a consequence, in these mutants the progeny 
hatches inside of the mother animal and give rise to a bag-of-worms phenotype. Thus, the  
defects in 2° cell fate marker expression are most likely not due to defects in lin-12 Notch 
signaling.  
Another class of mutants (zh42, zh43 and zh62) showed only very weak or no defects in the 
lip-1(zh15) background with respect to vulval morphology and reporter expression. zh42;lip-
1(zh15) animals developed a wild-type looking vulva. Expression of egl-17::gfp was 
eventually reduced in the M4 neuron and also in VulD cells relative to the VulC cells. In 
zh43;lip-1(zh15) animals, no abnormalities of vulval egl-17::gfp expression were observed at 
the L4 stage. Eventually, the vulval lumen was relatively small in zh43 animals. In some of 
the zh62;lip-1(zh15) animals observed, the number of gfp positive vulval cells at the late L4 
stage was reduced. But, vulval morphology seemed to be wild-type. The uterus structure was 
disorganized in zh62 animals. In general, since the penetrance of defects is low in these 
mutants, more animals would have to be observed to verify the eventual phenotypes. On the 
other hand, it seems only reasonable to work with an allele that gives rise to a weak defect if 
the defect occurs with a high penetrance. 
 
     Phenotype Vulval  
Allele LG Backcross(es) Gene Verified by 2° Marker Morphology Information (e.g. Gene/Phenotype) 
zh52 I 3 - - asy Pvl 
complements unc-73(e936) and 
lin-11(n566) 
zh40 I 1 lin-11 Compl. asy Pvl 
zh41 I 1 lin-11 Compl., Seq. asy Pvl 
zh51 I 1 lin-11 Compl. asy Pvl 
zh53 I 1 lin-11 Compl. asy Pvl 
zh54 I 1 lin-11 Compl. asy Pvl 
LIM Homeobox transcription factor, 
expressed in 2° cells 
zh38 II 3 dep-1 Compl., Seq. red Apf 
Dual-specificity phosphatase, acts 
parallel to lin-12 
zh65 - 1 - - loss wt 
Separated from zh38’s Apf-
phenotype after first backcross 
zh39 - 0 - - asy Vul Induction defect, bag-of-worms 
zh42 - 0 - - red Pvl Sick, Dpy, wt vulva at the L4 stage 
zh43 - 0 - - loss wt Bag-of-worms 
zh44 - 0 - - loss Vul Induction defect, bag-of-worms 
zh62 - 0 - - loss Pvl Bag-of-worms, wt at the L4 stage 
Table 2: Summary of alleles isolated from forward genetic screens 
asy: asymmetrical marker expression, Compl: complementation, LG: linkage group, loss: marker expression is 
absent, red: marker expression is reduced in intensity, Seq: sequencing, wt: wild-type. 
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3.2.2..e Identification of lin-11 alleles (zh40, zh41, zh51, zh53, zh54) 
 
Backcrossing of the zh41 mutant showed that the Pvl phenotype is generated independently of 
lip-1(zh15). At the L4 stage, the Christmas tree structure is abnormal, although all vulval cells 
seem to be present.  In addition, expression of the 2° cell fate marker egl-17::gfp is strongly 
reduced at the L4 stage (Fig.11, compare B and D). Often, the constrictions of 2° vulval cells 
were abnormal, which could reflect a defect in ring formation (Fig.11C). In order to visualize 
ring formation in the mutant, the cell junctions were stained with an antibody against ajm-1. 
Frequently, an aberrant pattern of vulval ring formation was visible at the L4 stage. This is 
best seen when animals were observed from a ventral view. In wild-type animals, the vulval 
cell junctions form concentric rings that meet on the left and right side of the animal 
(Fig.11E). In zh41 animals, a separate, large junctional ring appears that contains a cluster of 
smaller rings in its middle (Fig.11F). FLP mapping of zh41 showed clear linkage to Chr.I 
(Fig.11H). Moreover, subchromosomal mapping positioned zh41 between the assays ZH1-
1(2.37cM) and ZH1-15(5.06cM) (Fig.11I). This region contains approximately 270 candidate 
genes. The phenotype and mapping information directed the attention to one of these 
candidates, lin-11. lin-11 is mainly expressed in the 2° cells of the vulva and has been shown 
to regulate egl-17 expression. Although lin-11 is a marker for 2° vulval cells, its vulval 
expression is most likely regulated by a Wnt signal via the LIN-17 Frizzled receptor and not 
directly by lin-12 Notch [9]. In lin-11 mutants, the 2° cells were reported to fuse excessively 
and therefore give rise to large junctional rings that resemble strongly the phenotype in zh41 
animals (Fig.11, compare F and G). Adult lin-11(n566) animals exhibit a Pvl and a bag-of-
worms phenotype. Thus, zh41 and lin-11(n566) were tested in a complementation assay. 
Since the zh41 allele was not able to complement lin-11(n566), the lin-11 locus was 
sequenced in zh41 animals (Tab.3). Sequencing identified a point mutation in exon seven, 
which encodes the DNA-binding Homeobox domain that creates a missense mutation (L274F, 
Fig.11J). Four other mutants (zh40, zh51, zh53 and zh54) showed also a Pvl phenotype 
independently of lip-1(zh15) and mapped to Chr.I (data not shown). Each of these single 
mutants did also not complement the Pvl phenotype of lin-11(n566) in complementation 
crosses (Tab.3). Therefore, these mutants are most likely also alleles of lin-11. 
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Fig.11: zh41 is a new allele of lin-11. 
A) In wild-type animals the vulva forms a 
symmetrical invagination at the L4 stage. C) In 
contrast, in zh41 animals the Christmas-tree shows 
abnormal branches (arrowhead). In addition, a 2° cell 
fate marker that is normally expressed at the L4 stage 
is strongly reduced in zh41 animals (compare B and 
D). The focal planes in A to D contain the VulD cells. 
Arrows in A to D point at VulD cells. The stars in B 
label out-of-focus fluorescence from VulC cells. 
E to G) Ventral view of vulvas at the L4 stage. The 
cell junctions of vulval cells are either 
immunostained with MH27 (E and F), an antibody 
against the cell junction component ajm-1, or labeled 
by ajm-1::gfp (G). E) In wild-type animals, cell 
junctions of 2° vulval cells form concentric rings. On 
the left and right side of the animal, the cell junctions 
meet in one spot (arrowheads). F) In zh41 mutants the 
pattern of ring formation is abnormal. In the center of 
a separate, large ring multiple smaller rings are 
clustered. G) A very similar phenotype like in zh41 
mutants is found in lin-11(n389) animals (picture 
adapted from Gupta et al., 2003). The large vulval 
ring (large arrow) is formed by fusion of 2° cells. The 
smaller rings in the middle (small arrows) are made 
by 1° cells. H) Chromosomal linkage of zh41 to Chr.I 
by FLP-mapping. Chr. I shows exclusively a high 
Bristol content indicating linkage of zh41 to Chr.I.  
I) Subchromosomal mapping of zh41 by FLP-
mapping on Chr.I. Informative recombinants (in 
yellow boxes) position zh41 between the assays ZH1-
1 and ZH1-15 (indicated by a yellow, dotted line). 
J) Sequencing the coding region of lin-11 revealed a 
miss-sense mutation in exon 7 (L274F), which 
encodes the DNA-binding homeobox domain. 
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3.2.2..f zh38 corresponds to the dep-1(zh34) allele 
 
In the mutant initially named “n1”, expression of egl-17::gfp varied strongly from animal to 
Genotype bag wt lost 
lin-11(566) unc-13(e1091)/+ 0 55 2 
zh40/lin-11(566) unc-13(e1091) OR +/lin-11(566) unc-13(e1091) 27 31 0 
zh41/lin-11(566) unc-13(e1091) OR +/lin-11(566) unc-13(e1091) 18 28 0 
zh51/lin-11(566) unc-13(e1091) OR +/lin-11(566) unc-13(e1091) 7 6 1 
zh52/lin-11(566) unc-13(e1091) 0 92 0 
zh53/lin-11(566) unc-13(e1091) OR +/lin-11(566) unc-13(e1091) 30 62 13 
zh54/lin-11(566) unc-13(e1091) OR +/lin-11(566) unc-13(e1091) 62 61 2 
Table 3: Complementation assays of mutants that map to Chr.I with a lin-11 allele 
bag: bag-of-worms, wt: wild-type, lost: animals that could not be observed since they left the agar surface and 
dried up. 
 
Fig.12: zh38 is an allele of dep-1. 
A) In L4 stage, wild-type animals some cells of the 2° lineage (P5.pxxx, P7.pxxx) remain attached to the ventral 
cuticle. Arrows point at VulD cells. B) In the same animal, egl-17::gfp, a marker for the 2° cell fate, is visible in 
VulD cells. In addition, out-of-focus fluorescence from VulC cells is visible (stars in B). C) In zh38; lip-1(zh15) 
animals all descendants of P5.p and P7.p are detached from the cuticle, which indicates a transformation from 2° 
to 1° fate and is called an adjacent primary fate (Apf) phenotype. Nevertheless, egl-17::gfp expression is still 
visible in P5.p and P7.p descendants (D). Similar morphological defects have already been reported for 
dep-1(zh34) in the lip-1(zh15) background (E, picture adapted from Berset et al., [10]). Arrows point at 
presumptive VulD cells. F) FLP-mapping of zh38 by selection of animals with an Apf-phenotype shows linkage 
to Chr.II and Chr.IV, where dep-1 and lip-1 are located, respectively. 
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animal. In some animals, the reporter was expressed and in others expression was completely 
absent even in the M4 neuron. In addition, the “n1” mutant shows a unique vulval phenotype 
among all the mutants isolated in this screen. Observation of adult animals with a dissecting 
microscope showed a flat, broad vulval protrusion. In contrast, in typical Pvl mutants the 
protrusion is a small, round structure that resides outside of the worm’s body. Moreover, 
Nomarski microscopy of L4 animals showed that the descendants of 2° the cells were often 
detached from the cuticle pointing at a cell fate change from 2° to 1° (Fig.12C). This 
phenotype has already been described for the dep-1(zh34); lip-1(zh15) double mutant 
(Fig.12E, [10]). Since in this phenotype there are neighboring 1° cell fates, the defect was 
named adjacent primary fate (Apf). After the first backcross the Apf- and the loss-of-reporter-
expression-phenotype could be separated, and the two alleles were named zh38 and zh65, 
respectively. Moreover, when animals without reporter expression were observed with 
Nomarski optics, the vulva at the L4 stage appeared completely wild-type. PCR analysis 
showed that the Apf phenotype of zh38 depends on lip-1(zh15). In contrast, the zh65 
phenotype seems not to depend on the lip-1(zh15) allele. Moreover, the defect of reporter 
expression in zh65 animals is not limited to 2° vulval cells but affects all tissues where 
egl-17::gfp is normally expressed. Since genes are often differently regulated in different 
tissues, it is unlikely that the zh65 allele specifically affects the lin-12 Notch pathway. 
Therefore, the zh65 allele was not further investigated. However, FLP-mapping of the Apf-
phenotype showed linkage to Chr.II and Chr.IV (Fig.12F). Since initial analysis showed that 
the Apf-phenotype depends on lip-1, the easiest explanation is that zh38 is on Chr.II and the 
linkage to Chr.IV is due to the dependence of lip-1. Since dep-1(zh34), which is also located 
on Chr.II, has been found as the only candidate in a forward genetic screen to cause an Apf 
phenotype in lip-1(zh15) background, the genomic region of dep-1 was directly sequenced in 
the zh38 mutant. Sequence analysis uncovered the identical base pair change like in 
dep-1(zh34) (data not shown). 
 
3.2.2..g Phenotypical characterization and mapping of zh52 
 
The zh52 single mutant showed under the dissecting microscope a small Pvl phenotype. In 
few cases, there were also multiple protrusions visible. The vulval phenotype did not depend 
but was enhanced by lip-1(zh15). Observation of vulval morphology with Nomarski optics 
showed strong defects in the Christmas tree structure. In such animals, the Christmas tree had 
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Fig.13: Characterisation of zh52. 
A) In wild-type, L4 stage animals the vulval 
opening is a symmetrical structure. At this 
stage, constrictions are visible in the vulval 
lumen. These branch-like structures are made 
of 2° vulval cells. B) In the same animal the 2° 
cell fate marker, egl-17::gfp is visible in VulD 
cells (arrows) and as out-of-focus fluorescence 
from the VulC cells (stars). C) In this zh52 
animal the Christmas-tree has no constrictions 
on the left side of the vulval opening and 
expression of the 2° cell fate marker egl-17::gfp 
is almost absent from the same vulval side (D). 
The arrow in (D) labels a presumptive VulD 
cell. E) FLP mapping locates zh52 on 
chromosome I. The higher Bristol content for 
the left then the right chromosomal arm reflects 
that the Hawaii strain used contains the 
egl-17::gfp transgene surrounded by Bristol 
DNA on the left arm of chromosome I (see also 
Fig.8 A). Each chromosome was tested by one 
PCR assay for the left (dark blue) and one for 
the right arm (light blue). F) FLP mapping of 
chromosome I positions zh52 between the 
assays ZH1-7(-8.05cM) and ZH1-1(2.79cM; 
area indicated by yellow, dotted box). 
Informative recombinants are shaded in yellow. 
The result of an assay is called “Hawaii” if the 
region is homozygous (red and dotted area) or 
only heterozygous (red area) for Hawaii DNA. 
The result “No Data” indicates that the PCR 
assay did not work. G) Further SNP analysis of 
informative recombinants from FLP mapping 
narrows the region down to 298 genes (or 585 
genes if single events are neglected). 
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on one side less constrictions and the egl-17::gfp expression was visible only in a reduced 
number of cells (Fig.13C and D). In addition, the gonad showed obvious migration defects 
and the gonadal lumen was absent (data not shown). Animals with such defects in marker 
expression at the L4 stage developed into adult animals that were strongly Egl (egg-laying 
defective) and form bags of worms.  
Initially, FLP mapping of zh52 was done by crossing the mutant with the egl-17::gfp 
containing Hawaii strain. The TIER1 assay showed linkage to chromosome where also the 
egl-17::gfp transgene is integrated (Fig.13E). Since chromosome I in the Hawaii strain 
consists mainly of Bristol DNA the standard Hawaii strain had to be used for mapping of zh52 
to a subchromosomal region. But this means also that the animals cannot be selected based on  
the gfp expression defect. Since the defects in vulval morphology and the expression  
phenotype correlated well animals that showed a Pvl or bag-of-worms phenotype were 
selected. TIER2 assay of these animals narrowed the mutation down to a region of 1’236 
genes (Fig.13F). The mapping interval is defined by recombination events in 9 independent 
animals (ZH1-07: 2.663Mb, -8.05cM) from the left side and by four from the right side (ZH1-
01: 8.417Mb, 2.79cM; Fig.13F). These lysates were then further used for mapping by SNP  
analysis (Fig.13G). Thereby, the region was narrowed down to a region of 298 candidate 
genes (between E01A2 [4.133Mb, -1.64cM] and C09D4 [5.485Mb, 0.06cM]). Since both 
boundaries of this interval are supported by only one animal this is not a very strong point. 
Thus, if only recombination events are taken into account that are defined by more than one 
animal the region consists of 585 genes (between Y54E10A [3.133Mb, -4.48cM] and C06A5 
[5.961Mb,0.49cM]). 
 
3.2.2..h Complementation assays with zh52 
 
After mapping zh52 to chromosome I complementation to the lin-11(n566) allele was tested. 
In support of the later mapping results, zh52 did complement the bag-of-worms phenotype of 
lin-11(n566) (Tab.3). Among the 585 candidates identified with FLP- and SNP-mapping is 
unc-73, which is homologous to the guanine nucleotide exchange factor (GEF) Trio. 
Interestingly, hypomorphic alleles of unc-73 develop similar phenotypes like zh52. In unc-
73(e936) animals, the Christmas tree structure is distorted and RNAi depletion of unc-73 
leads to migration defects of gonad arms [11, 12]. In adult unc-73 mutants, migration defects 
of the 2° vulval cells can also lead to formation of multiple protrusions similar to zh52. 
Importantly, the phenotype of ectopic protrusions in zh52 animals has not yet been 
Screens for components of the lin-12 Notch pathway - Forward genetic screen 
 66 
investigated with Nomarski optics at the L4 stage. Therefore, it is not clear whether the 
protrusions are due to migration defects of 2° cells or due to excessive induction of VPCs. 
However, in strong loss-of-function alleles of unc-73, already the migration of P-cells, the 
progenitor cells of VPCs is defective. During the L1 stage, the P-cells migrate from a lateral 
position down to the ventral side of the animal. Defects in P-cell migration lead to a reduced 
number of VPCs. To test whether zh52 is an allele of unc-73, a complementation cross was 
performed. The cross-progeny of the zh52/unc-73(e936) genotype did neither show a Pvl nor 
a bag-of-worms phenotype (Tab.4). In order to additionally test whether zh52 causes an early 
defect in P-cell migration, the cell junctions of zh52 animals were immunohistochemically 
stained against ajm-1 (data not shown). In all L2 animals observed, there were six Pn.p cells 
present, and anti-ajm-1 antibody staining showed a wild-type appearance of cell junctions. 
Thus, the complementation assay and the immunostaining of ajm-1 indicate that zh52 is not 
an allele of unc-73. 
 
3.2.3. Discussion 
 
A forward genetic screen was performed in C. elegans to find new components of the lin-12 
Notch pathway involved in vulval development. In contrast to previous screens, the selection 
criteria for mutants that are possibly affected in lin-12 Notch signaling was not primarily a 
morphological defect in vulval development but a defect in expression of a vulval cell fate 
marker. This screening strategy allowed us to isolate 12 homozygous fertile and viable 
mutants. Due to the weak morphological defects that most of these mutants showed, with the 
exception of dep-1(zh38), these mutants would most likely not have been isolated in screens 
for morphological defects. 
Genotype bag wt lost 
N2 0 38 2 
unc-73(e936) 15 25 0 
zh52 8 28 4 
unc-73(e936)/+ 0 39 0 
zh52/+ 1 20 5 
unc-73(e936)/zh52 0 25 1 
Table 4: Complementation assay of zh52 with unc-73(e936) 
bag: bag-of-worms, wt: wild-type, lost: animals that could not be observed since they left the agar surface 
and dried up. 
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3.2.3..a Validation of the screen: Technical issues 
 
The selection of mutants was done manually by using a dissecting microscope or 
automatically by using a worm sorter. Although manual sorting of mutants was much slower, 
it was more efficient than the automatic method. The main problem of the sorter for this 
specific screen is its sensitivity. Since the marker is expressed in only six cells of the vulva 
and the sorter measures the expression by integrating the intensity from the entire animal, the 
maximal change in reporter expression compared to background fluorescence is very low. 
There are several possibilities that allow improving the sensitivity issue. On the one hand, the 
marker expression could be improved by choosing reporters that produce a higher fluorescent 
intensity (stronger expression per cell and/or expressed in more cells). One could also think of 
producing an egl-17::dsRed variant since there is less background signal from 
autofluorescence in the red than the green channel. 
 
Generally, every reporter that is stably and specifically expressed in 2° vulval cells and acts 
downstream of the lin-12 Notch target genes could be used. Alternatively to egl-17, lin-11 
could be a useful candidate. Since lin-11 is a 2°-specific marker but is most likely not a direct 
target of lin-12 Notch, a reporter for lin-11 would allow to isolate different components of the 
lin-12 Notch pathway. But so far, the lin-11 reporters analyzed showed for unknown reasons a 
high degree of variability in vulval expression and in addition strong expression is also visible 
in the uterus. Since the promoter element is known that drives expression of lin-11 in the 
vulva new reporters could be easily built and tested [9]. 
 
On the other hand, the sorter could be technically improved. The “Profiler II” is an available 
upgrade that allows recording the fluorescent intensity of each worm along the length of the 
body. Thereby, the worm sorter could find changes in reporter expression by looking just at 
the vulval region. 
 
Once the sensitivity issues are solved, the advantage of the worm sorters speed compared to 
manual sorting could be used to perform highly saturated screens. Using a fluorescence 
microscope, about 100 worms can be analyzed in 10 minutes. In the same amount of time the 
worm sorter is theoretically able to analyze 12’000 worms. 
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3.2.3..b Validation of screen: identified mutants 
 
In general, the forward genetic screen identified genes that play a role in 2° vulval cells. 
 
Intriguingly, in at least five of the twelve mutants isolated, the lin-11 locus is affected. The 
reason for this strong bias cannot be explained easily. Generally, several alleles of the same 
gene are found in a genetic screen if the screen is several times saturated, meaning that the 
number of animals analyzed is high enough so that each gene must be hit several times based 
on probability. But, the following considerations propose that this screen covers the genome 
most likely only once. Around 480 animals of the P0 generation were mutagenized. These 
animals gave rise to approximately 3’200 animals (16 full-grown plates). After 4 days, the F1 
animals were gravid. Then, the F2 animals were collected from the F1 animals by bleaching. 
All F2 animals were distributed on 120 agar plates (100 animals/plate). Around 60 of these 
plates could be screened. This represents the progeny of 1’600 F1 animals (3’200animals/2), 
which is equal to 3’200 haploid genomes. It is assumed that with the EMS concentration used 
(50mM) approximately 2’000 haploid genomes have to be screened to create one null 
mutation in every gene [13]. Thus, the screen covered the genome only one and a half times. 
Another possibility to receive several mutants that affect the same gene is if the mutation 
happened in a progenitor cell of the gamete that divided and gave rise to gametes with the 
same DNA lesion. But, the possibility of receiving such mutants was reduced by 
mutagenizing late L4 animals, where the gonad is already fully developed. In support of this, 
sequencing of lin-11(zh40) shows that zh40 does not carry the same transition as zh41(data 
not shown). Another possibility is that only few genes that regulate egl-17::gfp expression can 
be affected by G/C to A/T transitions induced by EMS. Therefore, mostly lin-11 alleles would 
be found. Lastly, it seems that mutants of many genes other than lin-11 could not be 
maintained in this screen because the mutants were sterile or lethal (90%). Maybe, among the 
genes that affect egl-17::gfp expression lin-11 is one of only a few genes that is not necessary 
for fertility or sterility. 
 
Strikingly, approximately 90% of the initially isolated animals turned out to be sterile or 
lethal and could not be maintained due to the design of the screen. Therefore, it was attractive 
to perform this screen in a clonal fashion where lethal and sterile mutants can be isolated. 
Raphael Sacher, a former diploma student in our lab performed clonal screens under my 
supervision (diploma thesis, 2005). After screening the progeny of 600 F1 cloned animals, 95 
mutants could be isolated. So far, mapping and further characterization of some of these 
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mutants revealed alleles of known genes (unc-84, sem-5, lin-11). But, the sterile mutants and 
therefore most promising candidates have not been mapped so far. 
 
The identification of a dep-1 allele, which is acting in parallel with lin-12 Notch and shows 
synthetic interaction with lip-1 indicates that the screen is generally working. However, 
dep-1(zh34); lip-1(zh15) does only slightly affect the expression of an egl-17::gfp reporter 
(Thomas Berset, PhD thesis 2005). In contrast, in this work the initially isolated mutant that 
harbors the zh38 allele showed complete loss of egl-17::gfp expression. Later, the “loss of 
expression” (zh65) and the vulval morphology phenotype (zh38) could be separated. The 
reason for the loss of expression is unknown. Since the egl-17::gfp transgene was 
homozygous throughout the backcrossing, a simple loss of the transgene is unlikely. Another 
possibility is that the zh65 mutation generally suppresses reporter expression. 
 
Besides genes involved in the development of 2° vulval cells, this screen identified only two 
mutants (zh39, zh44) that seem to affect vulval induction instead of lateral signaling. 
However, it cannot be said whether the lip-1(zh15) background actually helped to minimize 
the isolation of such induction mutants since the corresponding data from screens in a wild-
type background is missing. The remaining candidates that were qualified as less interesting 
are zh42, zh43 and zh62. The reason for this qualification is their weak phenotypes in vulval 
morphology and/or reporter expression are of low penetrance, and this makes further 
characterization very labor intensive. In addition, mapping of a very weak phenotype is 
difficult because the danger of selecting false positive animals for FLP-mapping is high. As a 
conclusion, further characterization of these candidates is risky since the affected genes might 
not be identified or be unrelated to lateral signaling. 
 
zh52 is the most interesting allele among the remaining candidates from this screen. The zh52 
allele affects vulval morphology but initial formation of the vulval competence group seems 
to be unaffected. At the L4 stage, the Christmas tree shows strong defects in the formation of 
vulval rings. However, it is unclear whether the obvious defect in the Christmas tree structure 
is due to defects in the vulval lineage and/or migration defects. The appearance of additional 
protrusions could be a hint for migration defects of vulval cells, although this defect was not 
investigated with Nomarski optics. Interestingly, among the 585 candidate genes there are 
unc-73 and let-502 that are known to be involved in P cell migration, which are the 
progenitors of vulval cells. unc-73 has been reported not only to cause P-cell migration but 
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also later defects in the Christmas tree structure that are similar to zh52. However, based on 
results from complementation assays zh52 is not likely an allele of unc-73. let-502 p160Rock, 
a homologue of RhoA kinase, acts with unc-73 Trio in a rho-1 pathway that mediates P-cell 
migration. let-502 mutants show similar defects like unc-73 and zh52 in the Christmas tree 
structure. Therefore, let-502 is a reasonable candidate for the identity of zh52. However, a list 
of 585 genes is still quite large to test every theoretical candidate gene. Therefore, the 
candidate list should be shortened first. Moreover, the smaller candidate region that was only 
supported by one recombination event from each side should be tested with more animals 
from a new mapping cross. In order to more easily identify animals from the mapping cross 
that have undergone recombination close to the 5cM interval, zh52 can be cis-linked by 
crossing to visible markers. This approach has already been started in this work. zh52 was 
linked to a dpy-5(5.4Mb, 0.0cM) and a unc-11(3.8Mb, -2.51cM)  allele respectively in order 
to more easily detect animals of the F2 generation from the mapping cross that have 
undergone recombination close to zh52. Unfortunately, the results from these mapping 
experiments did not support the smaller, 1.7cM large candidate region. One possible 
explanation for the contradictions is that in the animals observed, multiple recombinations 
took place leading to a complex pattern that could not easily be interpreted by SNP-assays. 
Since in this approach desired animals are very rare and thus the plates containing the cross-
progeny had to be searched over a period of many days, it cannot be completely excluded that 
animals were selected that belong to the F3 generation containing complex patterns of 
recombination between Bristol and Hawaii DNA. Another possibility is that the dpy-5 and the 
unc-11 alleles show interactions with zh52 and thereby lead to selection of unwanted animals 
for mapping. In this case, zh52 has to be cis-linked with different markers for future mapping 
experiments. 
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3.2.4. Material and methods 
 
 
General methods and strains used 
 
Standard methods were used for maintaining and manipulating C. elegans [14]. Unless 
otherwise mentioned, the experiments were performed at 20°C. The C. elegans Hawaii strain, 
variety CB4856, was used as the reference strain for mapping experiments. All mutations 
were generated in an N2, variety Bristol background. Unless noted otherwise, the mutations 
have been isolated in this study and are listed below by their linkage group. LGI: lin-11(n566) 
[15], lin-11(zh40), lin-11(zh41), lin-11(zh51), lin-11(zh53), lin-11(zh54), zh52. LGII: 
dep-1(zh34) [10], dep-1(zh38), unc-13(e1091) [16], unc-73(e936) [16]. LGIV: lip-1(zh15) [4]. 
LG unknown: zh39, zh42, zh43, zh44, zh62, zh65. 
Integrated strains: ayIs4[egl-17::gfp]I [6], syIs90[egl-17::yfp]III [17]. 
 
 
Protocols EMS mutagenesis 
 
General remarks  
EMS (ethyl methane sulfonate) is carcinogenic and has to be handled with extreme care. All 
pipetting work using EMS has to be done in a hood. It is recommended to wear glasses, 
gloves and a lab coat. To prevent contamination of pipettes, filter tips are used. After 
mutagenesis, all plastic waste should be collected in a tray filled with a 5N NaOH solution to 
inactivate the EMS. Also, the surface of pipettes is treated with 5N NaOH for 
decontamination. In addition, to keep worms free of bacterial contamination autoclaved tips 
and Pasteur pipettes should be used. Centrifugation of worms is generally done at 1’300rpm 
(340g, Eppendorf Centrifuge 5810) for 3min. 
 
Solutions 
Bleach 
2.3ml dH2O 
2ml 4M KOH 
0.7ml NaHypochlorit 
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EMS solution 
2ml M9 
20l EMS (Sigma M0880-10G) 
-> [EMS]working solution=100mM 
 
Mutagenesis protocol used for manual screen 
 
Day 1: Mutagenesis 
Mixed stages of worms are collected in a 13ml Falcon tube by washing four full-grown plates 
with M9. The volume of M9 is reduced to 2ml by centrifugation and pipetting. 2l of EMS 
solution is added to the worm suspension and incubated for 4 hours on a tilt shaker at room 
temperature. For this purpose, the Falcon tube is sealed with Parafilm. The worms are washed 
3 times with M9 by filling the tube with M9, pelleting the worms by centrifugation and 
removing the supernatant with a pipette. Finally, the worms are suspended in 1ml of M9. 
Afterwards, the worm suspension is distributed to 7 agar plates containing bacterial lawn. 
 
Day 2: Isolation of animals (P0) that will throw mutagenized progeny (F1) 
Young adult and adult animals are picked onto fresh agar plates containing bacterial lawn. On 
each of the 16 plates, 30 animals are placed and grown overnight at 20°C. Animals that were 
at the L4 stage during mutagenesis are preferred and have reached by now the adult stage. 
 
Day 6: Synchronization of F2 generation 
Worms are washed off the plates with M9, collected in a 13ml Falcon tube and the volume of 
the suspension is reduced to 5ml. After adding 5ml of bleach solution to the worm suspension 
the Falcon tube is kept for 4min. on a tilt shaker and regularly vortexed. Afterwards, worms 
are washed 4 times with M9 and the volume is adjusted to 5ml. Overnight incubation of the 
suspension at 20°C on a tilt shaker allows mutagenized F2 animals to hatch. 
 
Day 7: Distribution of synchronized F2 animals on seeded agar plates 
Approximately 100 worms are aliquoted on a total of 120 plates. Worms are incubated at 
25°C for 40 hours. 
 
Day 9 to 11: Screening for defects in 2° cell fate-specific marker expression 
Screens for components of the lin-12 Notch pathway - Forward genetic screen 
 73 
2° cell fate-specific marker expression is observed in L4 animals with a UV dissecting 
microscope. Animals that show a defect in marker expression are picked on a separate growth 
plate and grown at 20°C. 
 
 
Mutagenesis protocol used for screening with worm sorter 
 
Day 1: Mutagenesis 
The mutagenesis is performed as described for the manual screen. After Mutagenesis worms 
are grown at 20°C for only 36h. 
 
Day 3: Synchronization of P0 generation 
Worms are collected in 13ml Falcon tubes by washing with M9. Now, the liquid volume is 
reduced to 5ml by centrifugation and pipetting. After addition of 5ml bleach solution, the 
Falcon tube is incubated for 4 min. on a tilt shaker at room temperature and is regularly 
vortexed. To remove all traces of bleach the worms are washed 4 times with M9 and the 
volume is finally adjusted to 5ml. Then, the worms are incubated for 8 hours on a tilt shaker 
at room temperature. Afterwards, the worm suspension is reduced to a volume of 1ml and 
distributed on seeded worm plates. The plates are now incubated at 20°C. 
 
Day 6: Synchronization of F1 generation 
Worms are washed off the plates with M9 and collected in a 13ml Falcon tube. After reducing 
the volume to 5ml an equal volume of bleach solution is added. The tube is incubated for 4 
min. on a tilt shaker at room temperature and regularly vortexed. Afterwards, the worms are 
washed 4 times with M9 and the volume is adjusted to 5ml. Finally, the tube is incubated over 
night on a tilt shaker at room temperature. 
 
Day 7: Distribution of synchronized F2 animals onto seeded NGM plates 
The worm suspension is reduced to a volume of 1ml and distributed onto seeded NGM plates. 
The plates are incubated at 25°C. 
 
Day 8: Screening for defects in 2° cell fate-specific marker expression 
The density of the worm suspension is determined by pipetting a few microliters on a glass 
slide and visual inspection with a dissecting microscope. The volume is adjusted to achieve a 
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density of approximately 1 worm per l M9. Before the worm suspension can be sorted with 
the Copas Biosort system the worm sorter has to be sterilized with 70% EtOH (follow 
sterilization protocol provided with the Copas Biosort). The animals isolated by the Copas 
Biosort system are individually isolated on 6-well plates. Each well contains agar and a 
bacterial lawn similar to a standard, seeded NGM plate. Afterwards, the isolated mutants were 
further grown at 14°C. 
 
 
Sorter settings 
 
The settings that were chosen in the Copas Biosort software to screen for animals with a 
defect in egl-17::yfp expression are shown in Fig.1. These settings were found by test 
experiments with mixed populations of N2 and egl-17::yfp animals. With this setup, 
fluorescent and non-fluorescent animals of young-adult stage could be easily distinguished 
and sorted by the Copas Biosort system. 
 
Fig.1: Screenshot of the Copas Biosort software showing the settings used for screening 
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Genotyping of lip-1(zh15) in backcrossed mutants 
 
The primers OIR1, 2 and 3 were designed to test for the presence of the lip-1(zh15) deletion 
in mutant animals after backcrossing. Genotyping of animals that harbor the zh15 deletion 
gives rise to a PCR product of 980bp and wild-type animals to a PCR product of 560bp. 
 
PCR mixture 
(Vtotal=20l) 
dH20      6.9l 
MgCl2  (50mM)    1l 
PCR Buffer (10X)    2l 
dNTP mixture (2mM each)   2l 
OIR1 (2uM)     2l 
OIR2 (2uM)     2l 
OIR3 (2uM)     2l 
Single worm lysate (total volume=100l) 2l 
Taq DNA Polymerase Invitrogen (5U/l) 0.1l 
 
PCR program 
Step Duration Temperature 
1 2min. 94°C 
2 1min. 94°C 
3 40s 58°C 
4 1min.30s 72°C 
5 -> 35 times step 2 - 4 
6 4min. 72°C 
7  12°C 
 
 
SNP mapping 
 
Once the sub-chromosomal position of a specific mutation was defined by automated FLP-
mapping (fragment length polymorphism, [8]), manual SNP-mapping was used to further 
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narrow down the candidate region. The information about SNPs between the varieties N2 and 
CB4856 was obtained from the online SNP-database at the Washington University in St.Louis 
(http://genome.wustl.edu/genome/celegans/celegans_snp.cgi, [18]). SNPs were selected that 
lie inside of the candidate region determined by FLP mapping. Afterwards, the worm lysates 
that showed maximal recombination from one side of the chromosome with FLP-mapping 
were further tested for these SNPs. SNPs were detected by amplification of the SNP-region 
by PCR (polymerase chain reaction) and subsequent restriction digestion. 
 
Single worm lysate 
For FLP-mapping, the mutant and the Hawaii mapping strain were crossed. Afterwards, 
cross-progeny from the F2 generation that showed the phenotype of interest were selected. To 
obtain the genomic DNA, a single worm was lysed in 10l of lysis buffer. Finally, the lysate 
was diluted with dH20 to a total volume of 100l. Lysates that maximally narrow down the 
candidate region on a specific chromosome were further used for SNP-analysis. The primers 
and restriction enzymes used for SNP-mapping of zh52 are shown in tables 1 and 2. 
 
1x Lysis buffer: 
50mM KCl 
10mM Tris (pH=8.2) 
2.5mM MgCl2 
0.45% NP-400 
45% Tween-200 
0.01% Gelatine 
200g/ml Proteinase K 
 
Lysis program on thermocycler 
Step Duration Temperature 
1 60min. 60°C 
2 15min. 95°C 
3  12°C 
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PCR mixture for SNP-analysis 
(Vtotal=20l) 
dH20      9l 
MgCl2  (50mM)    1l 
PCR Buffer (10X)    2l 
dNTP mixture (2mM each)   2l 
Primer Fwd (2uM)    2l 
Primer Rev (2uM)    2l 
single worm lysate (total volume=100l) 2l 
Taq DNA Polymerase Invitrogen (5U/l) 0.05l 
 
PCR program for SNP analysis 
Step Duration Temperature 
1 2min. 94°C 
2 1min. 94°C 
3 40s 60°C 
4 40s 72°C 
5 -> 30 times step 2 - 4 
6 4min. 72°C 
7  12°C 
 
Restriction digestion of PCR fragment for SNP analysis 
2l of the PCR reaction mixture were analyzed on 1% agarose gel to check for amplification 
of the correct fragment length. Afterwards, the restriction mixture containing 5-10U of the 
restriction enzyme among other things was directly added to the PCR reaction mixture 
(Vtotal=30l). After 2-3 hours of incubation at the temperature recommended by the 
manufacturer, 2l of the restriction mixture was analyzed on a 1% agarose gel. The nature of 
the SNP for a specific lysate was determined by comparison to control experiments with N2 
and CB4856 lysates. 
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SNP name Primer Fwd (5’ to 3’) Primer Rev (5’ to 3’) PCR Product (nt) 
Y54E10A CAGATTTTCATCAGATTTCCGC CGCAGCTATTCAATTTTTCCTG 200 
E01A2 GTGAACGTCGTGATGAGGAG TGAAGTGGTCCCGAATATATG 305 
T03A1 CCTGCAATCATTGAATCATTGG CTTTCTGAGTCTTCGACAGG 1076 
F57C9 ATGTGTCTGCAATGTGGTGG AAATCTCGCGGTCTCGAAAC 550 
C09D4 AATTCCGATGATGGAGACGG GGTTACCATTCCAAATAGTGC 450 
C06A5 CCTCGGAGGAATTTCAAACG AGCTCCGTAAAGCAGCTTC 290 
F21C3 AGATTGAGGCTGAAATATGGTG GTCGAGCAGCACCAGTTATTG 200 
Table 1: Primers used for SNP mapping of zh52  
 
Assay Physical position (Mb) Enzyme DNA being digested 
Y54E10A 3.132743 DraI Hawaii 
E01A2 4.124812 ClaI Hawaii 
T03A1 4.283135 SalI Hawaii 
F57C9 4.836188 SmaI Bristol 
C09D4 5.484646 AvaI Hawaii 
C06A5 5.961384 DraI Bristol 
F21C3 7.244369 HinfI Hawaii 
Table 2: Details about SNP assays used for mapping of zh52 
 
 
Sequencing of candidate genes 
 
Sequencing of the lin-11 locus 
The phenotypic properties and the FLP mapping of zh41 suggested that zh41 is an allele of 
lin-11. Thus, the lin-11 locus was sequenced in the zh41 strain that was already backcrossed 
once to an egl-17::gfp containing strain. For this purpose, single worm lysates were prepared 
for 2 zh41 worms (same protocol as shown for SNP mapping). In order to have a wild-type 
control experiment, single worm lysates were also prepared for egl-17::gfp; lip-1(zh15) 
animals, the original strain that was used for EMS mutagenesis. In zh41 and control animals 
all exons of lin-11 were amplified by several PCR reactions (Table 3). The PCR primers were 
designed to amplify 800 to 1000nt long fragments. The PCR products were purified on silica-
gel-membrane columns (QIAquick PCR Purification Kit, Quiagen) and each was eluted in 
10l of dH20. Afterwards, the DNA concentration was determined using the NanoDrop 
system. Each purified PCR fragment was sequenced from both ends by using the original 
PCR primers (Table 3). 
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   PCR mixture 
(Vtotal=30l) 
dH20      12.9l 
MgCl2  (25mM)    3l 
PCR Buffer (10X)    3l 
dNTP mixture (2mM each)   3l 
Primer Fwd (2uM)    3l 
Primer Rev (2uM)    3l 
Single worm lysate (volume lysate =10l) 2l 
Taq DNA Polymerase Invitrogen (5U/l) 0.1l 
 
PCR program 
Step Duration Temperature 
1 2min. 94°C 
2 1min. 94°C 
3 40s 52°C 
4 1min.10s 72°C 
5 -> 30 times step 2 - 4 
6 4min. 72°C 
7  12°C 
 
Primer Sequence (5’ to 3’) PCR product No. 
OIR9 GAGCTCTTGGAGATAGTTC 
OIR10 CTGGCTCACCTGGTCACC 
1 
OIR11 GAGGATCTGGTGAGACGAG 
OIR12 CGGCAACTATACAACGACAAC 
2 
OIR13 CCTCTCAACTTCCATACTG 
OIR14 CATGGTAGGTAGGCATGTG 
3 
OIR15 GGCGTCCAAGGCCTACTC 
OIR16 GCCTTCTCCATCATCGAG 
4 
OIR17 GTGGATGCTTGTGATGAGG 
OIR18 GCGTGTGGAAGGATGTGTC 
5 
OIR19 GCGTTCGCCGCAACACC 
OIR20 GGTCCTCTGTAGTTGACTAC 
6 
OIR21 GCCTACTTCCACCGATC 
OIR22 GAACACCTGCTTCTAACGC 
8 
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Primer Sequence (5’ to 3’) PCR product No. 
OIR23 CGCTTCTTCTCGTTCTC 
OIR24 CTACACGAACGTGGAATAC 
9 
Table 3: Primer combinations used for sequencing of lin-11 
 
Sequencing mixture 
20ng of DNA (for a PCR fragment of 1kb length) 
1l primer (10uM) 
fill up to 8l with dH20 
 
Sequencing of the dep-1 locus 
The vulval phenotype of zh38, its linkage to chromosome II and complementation crosses 
with dep-1(zh34) all suggested that zh38 might be an allele of dep-1. To determine the DNA 
lesion in zh38, the dep-1 locus was sequenced. The strain used for sequencing was already 
backcrossed 3 times to an egl-17::gfp containing strain. For this purpose, a single worm lysate 
was prepared from a single mutant worm (same protocol as shown for SNP mapping). In 
order to have a wild-type control experiment, single worm lysates were also prepared for 
egl-17::gfp; lip-1(zh15) animals, the original strain that was used for EMS mutagenesis. In 
zh38 and control animals, all exons of dep-1 were amplified by several PCR reactions (Table 
4). The PCR primers were designed to amplify 400 to 700nt long fragments. The PCR 
reactions were performed in triplicates. Thereby the result is not affected by sequencing 
errors. The PCR products were purified on silica-gel-membrane columns (QIAquick PCR 
Purification Kit, Quiagen), and each was eluted in 10l of dH20. Afterwards, the DNA 
concentration was determined using the NanoDrop system. The purified PCR fragments were 
sequenced by using the original PCR primers for the sequencing reaction (Table 4). 
 
PCR mixture (Vtotal=30l) 
dH20      11.9l 
MgCl2  (25mM)    3l 
PCR Buffer (10X)    3l 
dNTP mixture (2mM each)   3l 
Primer Fwd (2uM)    3l 
Primer Rev (2uM)    3l 
Single worm lysate (volume lysate =10l) 3l 
Taq DNA Polymerase Invitrogen (5U/l) 0.1l 
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PCR program 
Step Duration Temperature 
1 2min. 94°C 
2 1min. 94°C 
3 40s 58°C 
4 1min.10s 72°C 
5 -> 30 times step 2 - 4 
6 4min. 72°C 
7  12°C 
 
Primer Sequence (5’ to 3’) Primer(s) used 
for sequencing 
PCR product 
No. 
OTB44 ATGAGCTACCCGTGGAAACC 
OTB46 TTCCAAGCCAGTCCGATTCC 
OTB44 1 
OTB45 CGATACACTGGTAAGTCAGG 
OTB49 GCAGTGTCCAGCAATTATAGC 
OTB45, OTB49 2 
OTB47 TGTTCCAGAACGACCAACTC 
OTB50 TTCCATCCTACGATCACTCG 
OTB47 3 
OTB48 CCAGTGCCTGACAAATCGTG 
OTB51 CAAACTCCAAATCTTCCATCAG 
OTB51 4 
OTB52 CTAGTTAGACCATGAGACCAC 
OTB53 ATGTGTTTGAGTATCTCTGGG 
OTB52, OTB53 5 
Table 4: Primer combinations used for sequencing of dep-1 
 
 
C. elegans whole mount immunostaining 
 
Remarks 
 
- This protocol was established by Finney and Ruvkun (1990) and adapted by David M. 
Miller and Diane C. Shakes (1995). Further optimizations were done in the Stuart Kim 
lab and later in our lab by Alex Hajnal, Attila Stetak and Peter Gutierrez. 
Conclusively, this protocol is a product of many personal communications, 
adaptations and optimizations. This specific version of the protocol has been written 
by Peter Gutierrez. 
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- All spinning steps in this protocol are carried out at 1’000 rpm for 1 minute. 
- When removing the supernatant at any step in this procedure, always leave 1-2mm of 
liquid above the worm pellet to avoid losing worms. 
 
Protocol 
 
Day 1 
1.)  Collection of worms: 
 transfer worms from 1 small plate (6cm, confluent but not starved) to an 1.5ml 
Eppendorf tube with 1x PBS 
2.) spin down for 1min at 1’000rpm (all spinning steps in this protocol are carried out like 
this!; 100g with Eppendorf Centrifuge 5415D) 
3.) wash with 1xPBS until you got rid of the bacteria 
4.) add 1xPBS to final volume of 450l 
5.) 2 possibilities: store sample to continue another day or continue the same day: 
 Storage: 
 + 500l 2xRFB 
 invert tube one time 
 freeze in liquid N2 
 keep at -80°C for long term storage (stable for months...) 
 at the day of use: thaw and add 50l Paraformaldehyde and 
 continue with the freeze-thaw (see below) 
6.) Continuing the same day: Permeabilization & Fixation 
 + 50l Paraformaldehyde 
 + 500l 2xRFB 
 invert tube one time 
7.) Freeze-thaw 3 times in liquid N2 and warm tap water 
8.) Fix worms at 4°C on a rocker for 30 minutes 
9.) spin 
10.) wash 3 times with 1l 1xTTB 
11.) Permeabilization (reduction of disulfide bonds in cuticle): 
 + 1l TTB 
 + 40l 10% Triton X-100 
 + 10l b-Mercaptoethanol 
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12.) Put at 37°C for 6 hours rocking 
13.) Spin 
14.) wash 2 times with 4xBO3-buffer 
15.) “Finishing reduction reaction” 
 +990l 4xBO3-buffer 
 +10l DTT (1M) 
16.) Rocking 15 minutes (not longer!) at RT 
17.) wash 2 times with 4xBO3-buffer 
18.) Oxidation of –SH groups (prevents reformation of disulfide bonds) 
 +990l 4xBO3-buffer 
 +10l H2O2 (30%) 
19.) Rocking 15 minutes (not longer!) at RT 
20.) wash 2 times with 4xBO3-buffer 
21.) Blocking: 
 + 1l ABA-buffer 
22.) Rocking 15 minutes at RT 
23.) spin & remove supernatant carefully 
24.) Primary Antibodies: 
 + 200l ABA-buffer 
 + 10l aAJM-1 (mouse, alternative name: MH27) 
25.) Let rock O/N at 4°C 
 
Day 2 
26.) Wash 3 times 15 minutes with 1l PBS-T 
27.) spin & remove supernatant carefully 
28.) Secondary Antibodies: 
 + 200l ABA-buffer 
 + 2l aMouse 
29.) Wrap tubes in aluminum foil 
30.) Let rock for 2 hours at RT (in the foil/dark) 
31.) spin & remove supernatant carefully 
32.) DNA-staining: 
 + 1l PBS-T 
 + 1l Hoechst dye (10mg/ml) 
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33.) Let rock for 5 minutes at RT (in the dark) 
34.) wash 2 times 5 minutes with PBS-T (in the dark) 
35.) spin & remove supernatant carefully (as much as possible) 
36.) Mounting: 
 Add 20l Mowiol and mix quickly and subsequently mount 
 worms on slide and put cover slip with forceps. The volume is enough for two 
samples/coverslips on one slide. 
37.) Let samples “dry” in the dark O/N at RT or at 4°C 
38.) Long-term storage: 4°C in the dark. Samples may stay well for several weeks. Anyway 
I recommend to do the analysis of the samples as soon as possible. 
 
Day 3 
Analysis of sample 
Vulval AJM-1 staining (MH27 antibody) was observed in N2 and zh41 animals at the L4 
stage with a microscope at high resolution (Leica DMRA). 
 
Solutions 
1xPBS 
Instamed 9.55 g/l PBS Dulbecco w/o Ca
2+
, Mg
2+
 (Biochrom AG) 
 
Paraformaldehyde (make always fresh) 
100mg Paraformaldehyde 
+ 450l dH20 
+ 0.5l 12M NaOH 
vortex 
incubate at 60°C for about 10 min (vortex shortly every 2 minutes) 
+ 5l 1M HCl 
+ 50l 10xPBS 
 
2xRFB “Ruvkun Fixation Buffer” (always keep at -20°C) 
160mM KCl 
40mM NaCl 
20mM Na2EGTA 
10mM Spermidine HCl 
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30mM Na PIPES pH7.4 
50% Methanol 
 
1xTTB “Tris Triton Buffer” (keep at RT) 
100mM Tris HCl, pH 7.4 
1mM EDTA 
0.1% Triton X-100 
 
100xBO3-buffer 
5M H3BO3 
2.5M NaOH 
(->crucial: pH should not be lower than 9.5) 
 
4xBO3 buffer 
Dilute 100xBO3-buffer 1:25 
0.01% Triton X-100 
 
1xPBS-T 
1xPBS 
0.05% Triton X-100 
 
ABA-buffer 
2% BSA in 1xPBS-T 
-> you need 1.4l per sample per staining 
 
Mowiol 
Mowiol 4-88  2.4g 
Glycerol  6g 
ddH2O   6l 
0.2M Tris pH=8.5 12l 
DABCO  2.5% (w/v) 
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Equipment 
 
PCR machines: 
- BioRad MyCycler 
- MJ Research Inc., PTC-100 
 Table centrifuges 
- Eppendorf Centrifuge 5810 (for 15ml Falcon tubes) 
- Eppendorf Centrifuge 5415D (for 1.5ml Eppendorf tubes) 
Sequencing machine: 
- ABI Prism BigDye Terminator 
Spectrophotometer 
- NanoDrop ND-1000 
Microscopes: 
- Leica MS5 (low-resolution dissecting scope, standard worm handling) 
- Leica MZFLIII (dissecting scope equipped with a UV lamp) 
- Leica DMRA (high resolution Nomarski and fluorescence pictures) 
Camera: 
- Hamamatsu ORCA-ER (Nomarski and fluorescence pictures) 
Software: 
- Improvision, Openlab 3.1 (acquisition of microscopy pictures) 
- Adobe Systems Inc., Adobe Illustrator, Adobe Photoshop (picture processing) 
- Gene Codes Corporation, Sequencher (analysis of DNA sequences, PCR primer 
design) 
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3.3 Reverse genetic, RNAi screen 
 
3.3.1. Introduction 
 
The canonical lin-12 Notch signaling pathway translates extracellular signals into a 
transcriptional response. Upon binding of DSL ligands, the LIN-12 NOTCH receptor is 
processed and the Notch intracellular domain (NICD) is released into the cytoplasm. The 
NICD is believed to enter the nucleus and to interact with the Notch transcription factor that 
belongs to the Cbf1/Su(h)/lag-1 family (CSL; [19-21]). Finally, the activated CSL 
transcription factor alters transcription by binding to CSL consensus sites in target genes. 
 
Christensen et al. have shown that the C. elegans CSL protein LAG-1 binds in vitro to the 
consensus sequence RTGGGAA (R=A or G), which has previously been shown to be a 
Cbf1/Su(h) binding site [22]. Moreover, analysis of potential targets of LAG-1 (lin-12, glp-1, 
lag-1) shows that CSL consensus sites are enriched in the 5’-region or in the first introns of 
target genes. In support of this, the lin-12 Notch target lip-1 contains four CSL sites necessary 
for transcription in 2° vulval cells in a 2.6kb region upstream of the ATG [4]. While this work 
was ongoing, Yoo et al. presented ten lateral signal target genes (lst) as targets of the lin-12 
Notch pathway [5]. The lst-genes contain clusters of LAG-1 binding sites (LBS: 
YRTGRGAA; Y=T or C, R=A or G), which is similar to the CSL-site but more stringent. In 
addition, Yoo et al. reported that vulval lin-12 Notch targets like lip-1 and the lst-genes 
contain besides the LBS-sites 2 kinds of flanking motifs. Importantly, also for the lst-genes 
the proposed LIN-12 NOTCH targets were found by looking for clusters of LAG-1 binding 
sites in the 5’ region flanking a gene. In a random DNA-sequence, one CSL-binding site 
(RTGGGAA) per 4kb is expected. Analysis of the lin-12 Notch targets mentioned above 
showed that the density of putative LAG-1 binding sites is much higher. Based on the 
knowledge from the lip-1 promoter, Thomas Berset and Marc Sohrmann created a list of 
putative lin-12 Notch target genes (Thomas Berset, PhD thesis 2005). In a bioinformatics 
screen, the entire C. elegans genome was searched for genes that contain four or more LAG-1 
binding sites (RTGGGAA) in a 2.5kb long promoter region 5‘ to the ATG. The final list 
contains 106 candidate genes and was kindly provided by Thomas Berset. Interestingly, the 
bioinformatics screen was able to identify known lin-12 Notch targets like lip-1, lst-3, lst-4, 
ref-1 and lin-12 [4, 5, 22, 23]. 
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3.3.2. Results of the reverse genetic screen 
 
3.3.2..a General screening Parameters 
 
The RNA interference (RNAi) technique is a relatively simple method that allows 
downregulation of a specific gene. Afterwards, analysis of the RNAi-induced phenotype gives 
directly information about the functionality of the gene. Among the different techniques to 
perform RNAi-mediated knockdown in C. elegans, the feeding technique is an efficient and 
relatively fast method, which makes it well suited to be used in a screen of many candidates 
[24-26]. 
Similar to the forward genetic screen, the selection criteria for interesting phenotypes was a 
change in expression of egl-17::yfp in 2° cells. In addition, the strain used for screening 
contained the mutation rrf-3(pk1426), which makes the worms hypersensitive to RNAi 
knockdown [27, 28]. The screen was performed in the following way. rrf-3(pk1426); 
egl-17::yfp worms were synchronized, and L1 animals were grown on plates containing 
dsRNA-producing bacteria (Fig.14). The RNAi-producing bacterial strains are all from the 
feeding library made in the lab of Julie Ahringer [26]. On each RNAi plate that contains a 
bacterial strain producing dsRNA against one specific target mRNA, ten L1 animals were 
placed. Subsequently, animals of the P0 and F1 generation were screened with a dissecting 
microscope for defects in vulval morphology and marker expression at the L4 and adult 
stages, respectively. RNAi experiments that showed a phenotype at the L4 stage were 
repeated one more time to test whether the phenotype is reproducible. 
 
3.3.2..b Classification of positive candidates from RNAi screen 
 
From the list of 106 candidates, 86 genes could be tested by RNAi. For the 20 remaining 
genes there was either no RNAi clone present in the library or the library used was 
incomplete. For 17 of the 86 candidates tested, a phenotype was observed at least once. Eight 
positive candidates showed a reproducible defect in marker expression at the L4 stage. 
Interestingly, the three candidates that showed the strongest effect on marker expression 
showed also a morphological defect in the vulva (Pvl). Based on their effect on expression of  
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Fig.14: Workflow scheme for reverse genetic screen for genes involved in specification of the 2° vulval cell 
fate. 
The boxes show how the egl-17::yfp expression appears if worms are observed at low magnification with a 
dissecting microscope. The blue boxes show wild-type and the red boxes show mutant worms at the L4 and adult 
stages. While in wild-type animals the expression pattern is symmetrical relative to the vulval invagination in 
lin-12 RNAi animals the expression of the 2° cell fate marker is reduced on one side of the vulval structure. 
Since the RNAi effect is gene-specific all candidates that gave rise to a change in the expression pattern were 
quoted as interesting. At adult stage lin-12 RNAi worms develop a Pvl (protruding vulva phenotype) with an 
asymmetrical appearance of the 2° cell fate marker. RNAi against some candidate genes resulted in an abnormal 
scattering of yfp-expressing cells along the ventral side. This phenotype, although not observed in lin-12 RNAi 
experiments, could be due to defects in specification or execution of the 2° cell fate. 
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the 2° cell fate marker and vulval morphology, the positive candidates were grouped into 
three classes (Tab.5). 
 
1) Positive candidates that affect 2° marker expression and vulval morphology 
 
lin-12 
 
The strongest defect in marker expression was observed when lin-12 Notch was 
downregulated. In the affected animals, on one side of the Christmas-tree the expression was 
absent in cells of the 2° lineage that normally express egl-17::yfp (compare Fig.15 B and D). 
When such animals were observed at the L4 stage with a dissecting microscope, the 
egl-17::yfp expression appeared unequally distributed on the left and the right side of the 
vulva. Hence, this phenotype is described from now on as asymmetric expression. A defect in 
marker expression was not necessarily accompanied by defects in the morphological 
appearance of the Christmas-tree. The identification of lin-12 in this screen proves that the 
design of the screen is generally able to detect changes in lin-12 Notch signaling based on 
changes in 2°-specific marker expression. In addition, lin-12 RNAi animals exhibited a Pvl 
phenotype at the adult stage. 
 
  Defects in P0   Defects in F1    
Gene RNAi Clone Marker (%) Pvl(%) Marker (%) Pvl(%) Description 
lin-12 R107.8 40 30 20 0 Notch Receptor 
egl-43 R53.3 30 100 0 many Transcription Factor 
mcm-2 Y17G7B.5 30 30 - - Replication Factor 
ttr-11 F46B3.3 30 0 0 0 Peptidase 
ctg-1 H06O01.3 0 0 20 0 PI Transfer Protein * 
srd-49 R04B5.8 15 0 0 0 Receptor (GPCR) 
- C39F7.2 12.5 0 0 0 Ubiquitin Protein Ligase 
- T03G11.5 10 0 0 0 Exopolygalacturonase * 
- C56G2.3 0 0 4 <10 tRNA Methyltransferase § 
lst-3 Y37A1B.1 0 0 0 20 Predicted DNA-binding Protein * 
let-502 C10H11.9 0 0 0 <10 Protein Kinase * § 
- T07F12.1 0 10 0 0 Phosphoglycerate Mutase * 
- F41B4.1 0 0 0 0 Cell Adhesion Molecule * § 
ima-3 F32E10.4 0 0 0 0 Importin Alpha * 
gnrr-4 C41G11.4 0 0 0 0 7TM Receptor * 
cyp-14A2 K09A11.3 0 0 0 0 CytP 450 Related * 
ifa-1 F38B2.1 0 0 0 0 Intermediate Filament * 
Table 5: Positive candidates from RNAi screen 
abnormal marker expression visible at the adult stage: “§” asymmetric pattern of egl-17::yfp positive cells, “*” yfp-
positive cells are scattered along the ventral side of the animal 
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egl-43 
 
Similar defects in marker expression were also visible by RNAi knockdown of the zinc-finger 
transcription factor egl-43. While superficial analysis of egl-43 RNAi animals at the L4 stage 
suggested that all vulval cells are present, egl-17::yfp was expressed in fewer 2° cells than in 
control RNAi animals (compare Fig.15 B and f). Analysis of egl-43 RNAi animals with 
Nomarski optics showed various morphological defects in the vulval and uterine tissues at the 
L4 stage (Tab.6). Most frequently, the uterine tissue was defective. While in control RNAi 
animals the vulval and uterine tissues are separated by the uterine seam cell (utse), a thin 
laminar cell, in egl-43 RNAi animals a thick tissue was visible. Moreover, in egl-43 RNAi 
animals, the size of the uterine lumen was often reduced. Less frequently, the Christmas-tree 
structure at the L4 stage was disturbed and rarely the vulval lumen was exceptionally small. 
 
Fig.15: Knockdown of lin-12 or egl-43 by RNAi leads to defects in expression of the 2° cell fate marker 
egl-17::yfp. 
In (A), (C) and (E) the vulva of L4 stage animals is shown for different RNAi experiments with Nomarski 
optics. In all the pictures the focal plane was chosen that contains the VulC cells in wild-type animals. (B), (D) 
and (E) show the yfp-fluorescence in the corresponding region. In control RNAi animals, a vulval opening is 
visible (arrowhead in A) and egl-17::yfp is expressed in VulC cells (B). Note that the expression pattern is 
symmetrical relative to the vulval opening. In lin-12 RNAi animals a normal vulval opening can develop (C) 
although the 2° cell fate marker is absent from one side of the vulva (D). RNAi knockdown of egl-43 can lead to 
mispositioning of vulval cells (E) and to absence of expression on one side of the vulval midline (F). The area in 
pictures (E) and (F) outlined by a dotted line label weak egl-17::yfp expression in presumptive gonadal cells. 
The yellow fluorescence is pseudo-colored green in all the fluorescent pictures (B, D and F). 
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Like in lin-12 RNAi experiments, adult egl-43 RNAi animals developed a highly penetrant 
Pvl phenotype and were egg-laying defective (Egl). 
 
Affected tissue Phenotype egl-43 RNAi Vector RNAi 
Vulval lumen small 2.7% 1/37 0% 0/44 Vulva 
Christmas-tree structure abnormal 10.8% 4/37 0% 0/44 
Uterine lumen small 29.7% 11/37 0% 0/44 Uterus 
Thick uterus-vulva connection 43.2% 16/37 0% 0/44 
Tab.6: Morphological defects of vulval and uterine tissues in egl-43 RNAi animals at the L4 stage. 
Results were combined from two independent experiments. Note that a single animal can appear simultaneously 
in different categories. 
 
mcm-2 
 
RNAi against mcm-2, a putative replication factor, leads to asymmetric expression of 
egl-17::yfp in the vulva of L4 stage animals. Moreover, mcm-2 RNAi-treated animals did not 
give rise to any progeny. This is probably due to defects in fertility or early embryonic 
development (data not shown). 
 
2) Positive candidates that show defects in 2° marker expression only 
 
In contrast to the first group, RNAi against these candidates resulted in asymmetrical 
egl-17::yfp expression but not in a of Pvl phenotype. 
 
ttr-11 
 
The observation that RNAi knockdown of TTR-11 led to asymmetrical expression of 
egl-17::yfp similar to what has been observed in lin-12 RNAi experiments suggested that this 
gene supports lin-12 Notch signaling (data not shown). Moreover, analysis of the protein 
structure proposes that TTR-11 contains a protease domain similar to ß-site AßPP cleaving 
enzymes (BACE). BACE proteins have been reported to process the APP protein, which is 
involved in Alzheimer disease. Interestingly, no BACE homolog has been reported in C. 
elegans so far. Moreover, both families of APP and NOTCH receptors are cleaved in similar 
manners upon activation. Thus, it is possible that TTR-11 is involved in proteolytic 
processing of the LIN-12 NOTCH receptor upon activation. 
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ctg-1, srd-49, C39F7.2, T03G11.5 
 
This group of candidates does not, based on protein homology, show an obvious link to 
LIN-12 NOTCH signaling. Nevertheless, these candidates could influence LIN-12 NOTCH 
signaling by regulating the stability of core components (ubiquitin-ligase). Others could 
influence LIN-12 NOTCH signaling by changing the plasma membrane composition 
(phosphatidylinositol transfer protein). In support of this, bre-5, a gene necessary for the 
synthesis of the lipid raft component glycosphingolipid, has been found as positive regulator 
of LIN-12 NOTCH signaling [29]. It is also possible that these candidates are involved in 
different signaling events downstream of the LIN-12 NOTCH signaling pathway (G-protein 
coupled receptor). 
 
3) Positive candidates that show defects in marker expression at the adult stage only 
 
RNAi against most of these candidates did not affect egl-17::yfp expression at the L4 stage in 
2° vulval cells or lead to morphological defects in adult animals. Often, defects in marker 
expression were visible at the adult stage only. In some cases, the egl-17::yfp expressing cells 
were present but abnormally scattered along the ventral side of the animal (data not shown). 
This could indicate that specification of 2° cells is not affected but that later defects in vulval 
morphogenesis lead to mispositioning of 2° vulval cells. 
RNAi against let-502 or F41B4.1 led to scattering of egl-17::yfp positive cells and in addition 
to asymmetric expression patterns. Thus, in these animals, both specification of 2° cells and 
vulval morphogenesis could be affected. Interestingly, lst-3, which has been reported to be a 
target of the lin-12 Notch pathway and to negatively regulate RTK/RAS/MAPK signaling, 
was identified as a positive candidate in this screen. RNAi against lst-3 produced a Pvl 
phenotype and an asymmetric expression pattern of egl-17::yfp at the adult stage. A possible 
reason why the marker expression defect was only visible at the adult stage is that eventually 
the RNAi knockdown was not efficient enough. 
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3.3.2..c gfp-reporter screen for positive candidates from RNAi screen 
 
Seven of the 17 positive candidates from the RNAi screen are genes that influence acquisition 
of the 2° vulval cell fate and have not been implicated in lin-12 Notch signaling so far (group 
1 and 2 except lin-12). To test more specifically, whether these candidates are targets of the 
lin-12 Notch pathway, transcriptional reporters were built and the expression pattern during 
vulval development was analyzed. So far, transcriptional targets of lin-12 Notch in the vulva 
showed two different types of expression [5]. One group was weakly and equally expressed in 
all VPCs before vulval induction. Once the AC induced vulval development, the expression 
was strongly reduced in P6.p and only slightly in P5.p and P7.p, reflecting inhibition of basal 
lin-12 Notch activity by activation of the RTK/RAS/MAPK signaling pathway. Shortly 
afterwards, the expression was strongly upregulated in P5.p and P7.p, indicating lin-12 Notch 
activation by the lateral signal from P6.p. This pattern remained throughout later vulval 
development with P6.p descendants lacking and P5.p and P7.p descendants showing strong 
expression. In contrast, in 3° cells the expression remained at a basal level throughout 
development. In the second group, the expression is strong in all VPCs before vulval 
induction. The inductive signal again strongly downregulates expression in P6.p and to a 
lower extent in P5.p and P7.p. Then, the lateral signal upregulates again expression in P5.p 
and P7.p. Afterwards, expression in P6.p remains absent and the 2° and 3° cells keep on 
expressing the lin-12 Notch target gene. 
 
3.3.2..d Design of transcriptional reporter constructs 
 
To investigate the expression pattern of candidate genes, transcriptional gfp reporters were 
produced. For egl-43 the reporter was made by cloning 2.5kb of the upstream regulatory 
sequence (URS) including the first nucleotides from the egl-43 coding region into a 
nls::gfp::lacZ vector (pPD96.04) from the Fire laboratory [30]. For the remaining candidates, 
the reporters were made by the fusion PCR method [31]. There, the promoter region including 
the URS up to the next predicted gene and the first few nucleotides from the gene of interest 
are amplified by PCR. In a second PCR reaction, the nls::gfp::lacZ coding region from 
pPD96.04 was amplified. In the fusion PCR step, the full-length reporter was produced by 
running a PCR on both products with nested primers. Since the promoter region is amplified 
with a 3’-primer that includes an overlap to the   gfp-containing PCR fragment the two PCR 
products are fused during PCR. 
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3.3.2..e gfp expression pattern of candidate genes 
  
The final reporter constructs were injected and independent transgenic lines that inherit the 
reporter construct to the progeny were isolated. For each construct, three to four independent 
lines were tested for gfp expression with a fluorescence microscope (Tab.7). Interestingly, 
most reporters drive expression in the vulva (except egl-43). Based on the observed 
    Expression pattern 
Reporter 
for 
Predicted 
function 
Vulva Gonad Other Details 
ttr-11 Protease    
Gonad: 
-uterine cells surrounding the AC 
Vulva: 
-sometimes visible in 2° cells at the Pn.px and 
Pn.pxx stages 
C39F7.2 
Ubiquitin 
protein ligase 
   
Gonad: 
-distal and ventral gonadal cells at the L2 
stage 
-stronger in dorsal uterine cells at Pn.px, 
-all uterine cells except AC at Pn.pxxx 
-at late L4, upregulation in uterine cells close 
to vulva (maybe uv3 cells) 
Vulva: 
-strong in VulB2 at the late L4 stage 
egl-43 
Transcription 
factor 
-   
Gonad: 
-expressed in VU and DU cells at the late L2 
stage 
-expression appears also in AC at the L3 stage 
srd-49 
GPCR 
receptor 
 -  
Vulva: 
-complex pattern during the L4 stage in 
specific cells of 1° and 2° cells 
ctg-1 
PI transfer 
protein 
 -  
Vulva: 
-often in VulC during the L4 stage 
-weak in 3° cells at the L4 stage 
T03G11.5 
Exopoly-
galacturonase 
 -  
Vulva: 
-during L3 visible in 1° cells 
-complex pattern during the L4 stage (seen in 
VulA/C/E and VulF) 
mcm-2 
Replication 
factor 
   
Ubiquitous expression: 
-equally expressed in 1° and 2° vulval cells 
Table 7: Summary of expression patterns for positive candidates from RNAi screen. 
Candidates are grouped based on their expression pattern. Candidates in green show in the uterine and/or the 
vulval tissue an expression pattern that fits to a lin-12 Notch target. Candidates in yellow show an expression 
pattern that is not easily interpretable. The candidate in white is expressed throughout the animal body. 
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expression patterns, the ttr-11 and C39F7.2 genes seem to be the most interesting candidates. 
 
ttr-11 
 
Reporters for ttr-11 showed sometimes expression in the developing vulva during the L3 
stage (Pn.px and Pn.pxx). If vulval expression was seen, then it was always exclusively in the 
2° cells. Thus, ttr-11 shows an expression pattern like a transcriptional target of the lin-12 
Notch pathway. Further support comes from the analysis of the expression pattern in the 
gonad. There, the reporter was visible during the L3 and L4 stages in ventral uterine cells that 
are direct neighbors of the AC but absent in the AC itself. During gonadal development, the 
lin-12 Notch pathway is used two times for cell fate decisions. First, during the AC/VU 
decision the AC inhibits an equipotent VU cell from adopting the AC fate by activating the 
LIN-12 NOTCH receptor in the VU cell. Later, the AC uses the lin-12 Notch signal to induce 
the -cell fate in the neighboring VU cells. Thus, it is very likely that the protease TTR-11 is a 
lin-12 Notch target during vulval and gonadal development. 
 
C39F7.2 
 
gfp-reporters for C39F7.2 did not show expression in vulval cells until the late L4 stage. At 
this time, the reporter is strongly expressed in VulB2 cells. To date, it is not known whether 
lin-12 Notch is still active at this late stage of vulval development. At least the finding that 
transcriptional reporters for lin-12 Notch are still expressed in 2° cells at the late L4 stage 
suggests that lin-12 Notch is still active at this time [32]. However, the C39F7.2 promoter 
drives   gfp-expression also in the developing gonad. The expression has been found to follow 
a complex pattern from the L2 until the L4 stage. Most interestingly, during the L4 stage, 
when lin-12 Notch is active in the gonad, gfp-expression was seen in uterine cells surrounding 
the AC. Thus, C39F7.2 could be a transcriptional lin-12 Notch target during gonadal 
development. 
 
srd-49, ctg-1, T03G11.5 
 
These three candidates did not show a vulval expression pattern that is expected for a pure 
lin-12 Notch target. In fact, during the time of vulval development srd-49 and T03G11.5 were  
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dynamically expressed in some 1° and 2° cells (data not shown). At the L4 stage, T03G11.5 
and ctg-1 showed exclusive expression in some 2° cells. But as already mentioned above it is 
not known whether lin-12 Notch signaling is still active at this late stage of vulval 
development.  
 
egl-43 
 
 gfp-reporters did not show any expression in vulval cells during specification of vulval cell 
fates. However, egl-43::gfp showed an interesting expression pattern in the developing 
somatic gonad (Fig.16). gfp expression was never seen in gonads of early L2 animals. Later, 
shortly after generation of the AC the reporter showed expression in ventral uterine (VU) and 
dorsal uterine (DU) cells and persisted throughout the L4 stage. Expression in the AC 
appeared during the mid-L3 stage. Thus, it is possible that the expression in VU cells reflects 
activation by the lin-12 Notch pathway. In support of this, lin-12 Notch has been reported to 
be expressed in VU cells and all of its descendants [32]. 
 
mcm-2 
 
Transcriptional reporters for the replication factor mcm-2 showed that this gene is 
ubiquitously expressed (Fig.16). In a more detailed analysis, it was tested whether mcm-2 is 
upregulated in 2° vulval cells compared to other vulval cells (Pn.p to Pn.pxx stage). The 
Fig.16: Expression of transcriptional reporters for selected candidates from the RNAi screen for genes 
involved in specification of the 2° cell fate. 
(A, B) gfp-expression of ttr-11p::gfp is occasionally seen in some 2° vulval cells (arrows with dotted line). 
While expression is absent in the AC (arrowhead in A and B) it is visible in ventral uterine cells (VU, arrows in 
A, B, C and D). The stars in (B) and (D) label expression in an unidentified, non-vulval cell. Transcriptional 
reporters for C39F7.2 show expression in dorsal and ventral uterine cells (encircled areas) but not in the AC 
(arrowhead) during vulval development (E, F). Expression in vulval cells is not visible until the L4 stage. There, 
the VulB2 cells, which are part of the 2° cell lineage, strongly express gfp (arrows in G and H). egl-43p::gfp is 
absent from the vulval tissue but is strongly expressed in the gonadal tissue. At early L3 stage gfp-expression is 
visible in ventral and dorsal uterine cells but absent from the AC (arrow in I and J). Shortly afterwards 
expression appears in the AC (arrowhead) and persists in VU cells (K,L). mcm-2p::gfp is broadly expressed in 
the entire worm. During vulval development mcm-2p::gfp is expressed in descendants of the 2° (encircled areas 
in M and N) as well the 1° lineage (encircled area in O and P). 
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results from this experiment indicated that mcm-2 is unlikely to be a lin-12 Notch target (data 
not shown). 
 
3.3.3. Discussion 
 
3.3.3..a Design of the screen 
 
In this work,106 candidate genes have been tested for their involvement in lin-12 Notch 
signaling. The candidate list consists of genes that contain clusters of CSL-binding sites in 
their promoter region (Thomas Berset, PhD thesis 2005). In a first experiment, the candidates 
have been individually knocked down by RNAi to test their functionality in generation of 2° 
vulval cells. The design of the screen includes a new strategy to identify lin-12 Notch target 
genes. Instead of checking RNAi treated animals for morphological defects in vulval 
development, a 2° cell fate-specific marker was evaluated. Thereby, specification of the 2° 
vulval cell fate was directly tested. The information gained from this strategy turned out to be 
very useful. While only three candidates showed strong morphological and marker expression 
defects, 14 candidates showed only defects in marker expression. Thus, using the 2° cell fate 
marker increased the sensitivity of the screen. 
 
Especially, for RNAi experiments the sensitivity is an important issue. The efficiency in 
knocking down a specific gene by RNAi is highly dependent on the target gene. Moreover, 
using a sensitive assay as readout helps to identify candidates that give only a mild defect due 
to incomplete knockdown. Generally, if a specific RNAi experiment does not produce a 
phenotype then the target gene can still be involved in the developmental process under 
investigation. Moreover, the strength of defects a specific RNAi experiment generates does 
not necessarily say something about the absolute importance of this component in the 
observed process. In support of this, analyzing gfp reporters for the positive candidates from 
the RNAi screen showed that not necessarily the strongest candidate from the RNAi 
experiment is most likely involved in lin-12 Notch signaling. As a conclusion, the RNAi 
screen was used to roughly discriminate between most likely interesting and most likely 
uninteresting candidate genes. 
 
Another important issue for RNAi experiments is the specificity. The RNAi effect depends on 
complementarity between the exogenously provided RNA and the target mRNA. If there are 
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other genes in the genome that are highly homologous to the target region, then RNAi can 
lead to non-specific defects. Up to date, there is no hard rule to predict the off-target effect of 
a specific RNAi experiment. But as a rule-of-thumb, if an mRNA contains at least 80% of 
identity over a stretch of 200 nucleotides, then off-target effects are expected (source 
wormbook.org). The best way to exclude disturbing off-target effects is to confirm the RNAi 
phenotype by analyzing mutants for the target gene. If mutants are not available, it is also 
informative if a second RNAi experiment that targets another region in the gene of interest is 
used to confirm the initial RNAi phenotype. 
 
3.3.3..b Positive candidates from RNAi screen 
 
RNAi against eight of 17 candidates produced defects in marker expression comparable to 
RNAi against lin-12 itself, which has also been found in this screen. For the nine other 
candidates, RNAi knockdown led to defects in marker expression visible at the adult stage 
only. It is possible that these genes affect lin-12 Notch signaling but that the knockdown was 
not efficient enough, leading to early defects. This is supported by the fact that lst-3, a lin-12 
Notch target known to affect 2° cell fate specification, is among these candidates [5, 22]. 
Thus, it might be worth to analyze mutants and/or to build transcriptional reporters also for 
these candidate genes. This would help to judge whether these genes are involved in lin-12 
Notch signaling. 
 
Besides the one-sided reduction of egl-17::yfp expression, many candidates showed 
exclusively or in combination with the former phenotype another vulval phenotype. In adult 
animals, the egl-17::yfp expressing vulval cells were not clustered at the vulval midline but 
scattered along the ventral side of the animal. This mispositioning of vulval cells could be due 
to migration defects. The guanine nucleotide exchange factor (GEF) UNC-73 has been shown 
to mediate migration of P-cells, the progenitors of vulval cells [33]. unc-73 is controlling P-
cell migration via the RAC proteins MIG-2 and CED-10 and the C. elegans RHO homolog 
RHO-1 [11]. Downstream of RHO-1 the signal for P-cell migration is supposed to propagate 
via let-502, the RhoA effector kinase [11]. Long after P-cell migration, the vulval cell fates 
are specified, and the 1° and 2° cells undergo short-range migrations towards the vulval 
midline. Although the vulval cells are migrating, they always stay in contact with their 
immediate neighbors via cell junctions. Interestingly, in mutants of unc-73, mig-2 and ced-10 
migration defects are not only visible for P-cells but also later for vulval cells. In animals 
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where P-cell migration was perfectly executed, the 2° cells can fail to migrate properly 
towards the 1° lineage. As a consequence, the 2° cells do not integrate into the Christmas-tree 
structure and form ectopic invaginations [33]. Interestingly, in this screen let-502 RNAi 
animals exhibit mispositioning of 2° vulval cells in adult animals. This suggests that let-502 
is, like unc-73, mig-2 and ced-10, necessary for P-cell migration and later migration of vulval 
cells. To date, it is not known whether lin-12 Notch signaling directly controls migration of 2° 
vulval cells towards the vulval midline. The more specific question whether let-502 is a lin-12 
Notch target during migration of vulval cells is currently investigated by Sarfarazhussain 
Farooqui, a PhD student in our lab. Additionally, the results from the RNAi screen suggest 
that let-502 is also involved in specification of 2° cells. Besides the mispositioning of 2° 
vulval cells, the marker was also asymmetrically expressed. Though, it is possible that 
mispositioning of P5.p and P7.p descendants leads to attenuated reception of the lateral signal 
and to defects in formation of the vulval cell fate pattern. Therefore, the role of let-502 during 
vulval development needs to be studied in detail. 
 
For the other candidates showing this phenotype, there is no signaling function known that 
can easily explain the mispositioning of 2° cells. Thus, analyzing mutants for these 
candidates, if available, would help to describe their function in vulval development. 
 
3.3.3..c Expression analysis of candidate genes 
 
The seven candidates giving defects in marker expression similar to RNAi against lin-12 were 
selected for expression analysis. Transcriptional reporters for all candidates except egl-43 
showed expression in the vulva. This suggests that the vulval defects observed in the RNAi 
screen are due to a cell-autonomous role of these genes in the vulval cells itself. Moreover, 
analysis of the timing of reporter expression revealed two candidates, ttr-11 and C39F7.2, that 
are expressed as expected of a typical lin-12 Notch target. 
 
ttr-11 
 
ttr-11 is in many respects a highly interesting candidate gene. RNAi against ttr-11 results in 
2° cell fate-specific marker expression defects resembling those produced by lin-12 RNAi. 
Transcriptional reporters for ttr-11 support the model that ttr-11 is transcriptionally regulated 
by lin-12 Notch signaling in the vulva and also in the developing uterus. ttr-11 encodes a 
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putative protease with homology to the family of BACE proteins. BACE proteins are 
involved in processing of the APP receptor. The C. elegans App homolog apl-1 seems not to 
be involved in vulval development. APP and Notch receptors are processed in a similar 
fashion upon activation. Thus, it is possible that ttr-11 processes the LIN-12 NOTCH receptor 
upon activation. In this model, ttr-11 is part of a positive feedback loop for lin-12 Notch 
signaling. Activation of the lin-12 Notch pathway leads to transcriptional upregulation of a 
positive regulator of LIN-12 NOTCH itself. 
 
C39F7.2 
 
While RNAi against C39F7.2 led only to rare defects in marker expression, the results for the 
gfp-reporter analysis are clearer. While C39F7.2 is expressed in a subset of 2° vulval cells 
after cell fate specification, its expression in the gonad is more promising. Expression has 
been seen in the VU cells, including its descendants the -cells, but not in the AC. This 
pattern could reflect transcriptional activation of C39F7.2 by lin-12 Notch signaling induced 
by the AC. Based on sequence analysis, C39F7.2 might act as an E3 ubiquitin ligase. 
Interestingly, smo-1, the ubiquitin like modifier SUMO in C. elegans is involved in 
development of the somatic gonad and generation of the vulva-uterus connection [34]. More 
specifically, the LIM-domain transcription factor lin-11 needs to be sumolyated in order to 
fulfill its role during specification of the gonadal -cells. Thus, an attractive model to test is 
whether C39F7.2 is the E3 ubiquitin ligase necessary for sumolyation of lin-11. But first, 
more phenotypical information should be collected. It would be interesting to see whether 
mutants of or RNAi against C39F7.2 show defects in uterus development like smo-1 mutants 
do. In smo-1 mutants, a reporter for egl-13 is ectopically expressed, indicating mis-
specification of -cells during gonadal development. In addition, the AC is not fusing to the 
-cells leading to absence of the utse tissue. Second, it should be tested whether lin-12 Notch 
signaling is necessary to drive expression of C39F7.2 reporters. This could be done by 
analyzing reporter expression in lin-12(lf) mutant backgrounds and also by mutating the CSL-
sites in the promoter region. Interestingly, smo-1 is necessary for expression of LIN-11. Thus, 
it is possible that lin-12 Notch is regulating expression of lin-11 by direct regulation of 
C39F7.2 transcription. 
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egl-43 
 
While a transcriptional reporter for egl-43 did not show expression in the vulva, there was an 
interesting pattern visible in the uterine tissue. The expression in VU cells, which are known 
to express the lin-12 Notch receptor, suggests that egl-43 is upregulated by lin-12 Notch 
signaling. The fact, that egl-43::gfp expression is later also visible in the AC, where lin-12 
Notch activity is low, suggests that egl-43 expression is regulated by different signaling 
pathways. The expression analysis supports a role of egl-43 in the uterine tissue. In 
accordance, RNAi knockdown of egl-43 leads to penetrant defects in the vulva-uterus 
connection and uterus structure. Although egl-43::gfp expression was not visible in the vulva, 
RNAi knockdown of egl-43 leads to defects in the expression pattern of a 2° vulval cell fate 
marker. Thus, the vulval defects could be due to a non-autonomous role of egl-43 in vulval 
development, or the reporter used for analysis lacks the promoter elements driving vulval 
expression. Due to the interesting expression pattern in VU cells and the strong defects in 
uterine and vulval development the role of egl-43 was investigated in more details. These 
results are presented in the next chapter. 
 
mcm-2 
 
RNAi against mcm-2 leads to strong defects in 2°-specific marker expression and to the 
development of a penetrant Pvl phenotype. In contrast, analysis of transcriptional reporters for 
mcm-2 showed a ubiquitous expression pattern and no enhancement of expression in vulval or 
gonadal cells, where lin-12 Notch signaling is high. Therefore, the RNAi defects are unlikely 
related to specific defects in lin-12 Notch signaling. More likely, downregulation of the 
replication factor mcm-2 generally affects dividing cells. Remarkably, animals treated with 
mcm-2 RNAi did not produce any progeny. This could indicate that during development, a 
pool of MCM-2 protein was used up and RNAi only inhibited new protein synthesis giving 
rise to first defects during vulval development. In adult animals, the MCM-2 pool is 
completely used up, and germ cells are unable to divide and give rise to the next generation. 
 
Finally, from the initial candidate list of 106 genes, 20 genes were not tested by RNAi 
experiments since the RNAi clones were not available. Thus, these candidates should be 
investigated by generating RNAi clones and/or analyzing available mutants. Since in the 
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RNAi screen performed more than 10% of the candidates showed interesting phenotypes, it 
might be worth to test the remaining 20 genes. 
 
In summary, the RNAi screen and the following gfp-reporter analysis revealed several 
candidates that could be involved in lin-12 Notch signaling in the vulval and uterine tissues. 
The most promising candidates are the proposed protease, ttr-11 and the putative ubiquitin-
protein ligase, C39F7.2. 
 
3.3.3..d Possible improvement for future reverse genetic screens 
 
This RNAi screen identified among 86 putative lin-12 Notch targets eight candidates that 
showed defects in 2° cell fate-specific marker expression similar to lin-12 RNAi. 
Transcriptional analysis of these candidates showed that seven of them are expressed in the 
vulva, indicating a role in vulval development. Finally, two candidates showed an expression 
pattern that is expected for a lin-12 Notch target. To improve the screen, it would be helpful 
to choose candidates for the initial RNAi screen not only by presence of a cluster of CSL sites 
in the promoter but also to select for CSL-clusters that are conserved between C. elegans and 
C. briggsae. Enhancer/promoter elements that are conserved between these closely related 
Nematode species are more likely to be involved in transcriptional regulation. 
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3.3.4. Material and methods 
 
 
General methods and strains used 
 
Standard methods were used for maintaining and manipulating C. elegans [14]. Unless 
otherwise mentioned, the C. elegans Bristol strain, variety N2, was used as the wild-type 
reference strain and experiments were performed at 20°C. The mutations used in this study 
are listed below by their linkage group. LGIII: rrf-3(pk1426) [27], unc-119( e2498) [35]. 
Integrated strain used in this study: syIs90[egl-17::yfp]III [17]. 
Extrachromosomal arrays (all this study): zhEx157[pIR3, punc-119(+)], zhEx158[pIR3, punc-
119(+)], zhEx195.1,.2&.9[ctg-1p::gfp, lin-48p:.gfp], zhEx196.3,.6&.7[srd-49p::gfp, lin-
48p::gfp], zhEx197.4,.12&.17[T03G11.5p::gfp, lin-48p::gfp], 
zhEx198.4,.6&.11[C39F7.2p::gfp, lin-48p::gfp], zhEx199.4&.5[mcm-2p::gfp, punc-119(+)], 
zhEx200.4,.11&.12[ttr-11p::gfp, punc-119(+)]. 
 
 
Candidate genes for RNAi screen 
 
In table 1, the putative lin-12 Notch targets identified in the bioinformatics screen by Thomas 
Berset and Marc Sohrmann are shown (Thomas Berset, PhD thesis 2005). For RNAi 
experiments the RNAi library created by the Lab of Julie Ahringer (JA) was used [26]. In 
total, RNAi clones for 86 of 106 putative lin-12 Notch target genes were available in the JA 
library. 
 
Clone Name JA Library CGC Name Plate Well RNAi Clone Availability 
B0205.2 srz-85 18 G3 X 
C03A3.3   193 G2 X 
C03B1.12 lmp-1 185 G7 X 
C05B10.1 lip-1 101 E8 X 
C06A6.1   103 H12 X 
C10H11.9 let-502 5 E4 X 
C17E4.10   15 F12 X 
C18H9.7 rpy-1 47 G4 X 
C24A11.5   6 G8 X 
Screens for components of the lin-12 Notch pathway - Reverse genetic, RNAi screen 
 106 
Clone Name JA Library CGC Name Plate Well RNAi Clone Availability 
C28A5.2   71 A4 X 
C28A5.3 nex-3 71 A5 X 
C39F7.2   127 F2 X 
C41G11.4 gnrr-4 184 G4 X 
C47C12.3 ref-2 188 B3 X 
C48D1.1   116 B10 X 
C49G7.9   135 B1 X 
C56G2.3   75 E4 X 
C56G2.5   75 E6 X 
C56G2.7   75 E8 X 
D1069.2 cpn-2 31 G7 X 
E03G2.4 col-186 201 B10 X 
F07A5.5 sue-1 11 F11 X 
F13D2.2 gnrr-6 193 E11 X 
F18E9.2 nlp-7 189 E10 X 
F20H11.6   76 B5 X 
F21D12.2   49 D1 X 
F22F7.7   129 C2 X 
F32E10.4 ima-3 103 D2 X 
F33E2.6   22 F3 X 
F34D10.6   69 E10 X 
F35D11.11 dyf-14 42 G1 X 
F37B1.2 gst-12 62 C5 X 
F38B2.1 ifa-1 193 G3 X 
F40F4.1 fbxb-71 180 F8 X 
F41B4.1   186 E6 X 
F46B3.3 ttr-11 173 E7 X 
F47A4.5   191 D12 X 
F54E7.5 sdz-21 74 A3 X 
F55E10.2   189 B7 X 
F56F3.6 ins-17 71 B2 X 
F58A6.6 srb-16 44 A4 X 
F59G1.4   46 A1 X 
H06O01.3 ctg-1 10 G11 X 
H06O01.4   10 G12 X 
K04G7.2   77 B11 X 
K06B4.5 nhr-196 162 D1 X 
K07E8.3 sdz-24 32 D8 X 
K07E8.8   32 D12 X 
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Clone Name JA Library CGC Name Plate Well RNAi Clone Availability 
K08D12.b (K08D12.4)   94 C7 X 
K09A11.3 cyp-14A2 197 A3 X 
K10G6.3 sea-2 41 F1 X 
K12H6.12   38 D5 X 
M01A8.1   81 H8 X 
R04B5.8 srd-49 149 B5 X 
R107.8 lin-12 81 E7 X 
R11G10.2   156 G3 X 
R53.3 (R53.3a) egl-43 55 D4 X 
T01E8.2 ref-1 55 H7 X 
T03G11.5   183 H9 X 
T04A6.2   78 C1 X 
T07F12.1   183 D9 X 
T08B6.6 str-166 98 C7 X 
T09F3.1   56 B12 X 
T10B9.5 cyp-13A3 55 A3 X 
T19D12.1   47 E11 X 
T19F4.1   141 B3 X 
T22D1.6   101 F9 X 
T23F11.4   71 E2 X 
T25D3.4   31 D6 X 
T27F6.4   22 D3 X 
W02H5.j (W02H5.2)   130 G5 X 
Y113G7A.12   172 E12 X 
Y17G7B.1 acbp-6 59 D12 X 
Y17G7B.5 mcm-2 59 E4 X 
Y37A1B.1 lst-3 117 E10 X 
Y37A1B.2a   117 E11 X 
Y37D8A.4   87 G7 X 
Y41E3.1   118 F7 X 
Y49F6B.l (Y49F6B.6)   40 B1 X 
Y4C6A.g (Y4C6A.3)   99 D9 X 
Y50D7_164.a (Y50D7A.4)   90 F11 X 
Y50E8.j (Y50E8A.8)   159 G1 X 
Y51H7B_5.a (Y51H7BR.6) sru-41 65 G11 X 
Y51H7B_5.b (Y51H7BR.6) sru-41 65 G12 X 
Y71H9A.1 twk-44 194 C8 X 
ZK1086.1 obr-3 197 H12 X 
ZK673.5   56 C12 X 
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Clone Name JA Library CGC Name Plate Well RNAi Clone Availability 
B0212.2   95 E8 X¶ 
F28A12.4   145 G10 X¶ 
ZK994.6   145 D3 X¶ 
B0563.1   190 E3 -- 
C06A6.2   104 A1 -- 
C10F3.6 fut-8 139 B10 -- 
C25E10.12   146 F10 -- 
C43F9.7   110 E2 -- 
C48C5.3   190 B12 -- 
F15A2.3 srd-51 197 D10 -- 
F20H11.1   76 A12 -- 
F31E8.4   48 A7 -- 
F42D1.2   199 E6 -- 
F56A8.3   88 D1 -- 
T13H2.4 pqn-65 183 A8 -- 
Y60A3A.8   - - -- 
Y60A3A.9   - - -- 
Y66A7A.7   86 B10 -- 
Y71H9A.2 sto-6 194 C9 -- 
ZK858.3 clec-91 15 B8 -- 
Table 1: List of all putative lin-12 Notch target genes identified in a bioinformatics screen by Thomas 
Berset and Marc Sohrmann. 
The table indicates for each target gene where the corresponding RNAi clone is located in the Julie Ahringer 
(JA) RNAi library by the plate number and well name. The JA library does not provide RNAi clones for all 
candidate genes. Available clones are labeled with “X” and unavailable clones with “--". Three clones, namely 
B0212.2, F28A12.4 and ZK994.6 are missing in our copy of the JA library (X¶).  In most cases, the name of the 
RNAi clone and the sequence name are identical (e.g. ZK858.3). In the other cases the sequence name identified 
in the bioinformatics screen is indicated in brackets (e.g. Y51H7B_5.b (Y51H7BR.6)). Note that Y51H7BR.6 was 
tested by two different RNAi clones available in the JA RNAi library. 
 
 
RNAi protocol 
 
The JA feeding library is based on bacterial strains that produce dsRNA against specific 
mRNAs of C. elegans upon induction by IPTG [26]. Each bacterial strain contains a vector 
with an insert that targets one specific mRNA. Transcription of this sequence is under the 
control of two T7 promoters flanking the insert. These vectors are maintained in the E. coli 
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strain HT115(DE3), which expresses the T7 polymerase upon induction by IPTG. As a 
consequence presence of IPTG leads to transcription of the C. elegans specific sequence. 
 
 
Preparation of RNAi plates and bacteria 
 
RNAi producing bacteria were picked from the frozen JA RNAi library and grown overnight 
on double selective bacterial plates at 37°C ([ampicillin]=50g/ml, [tetracycline]=12.5g/ml). 
The liquid culture for the RNAi experiment itself was prepared by growing RNAi producing 
bacteria in 2xTY media containing 50g/ml ampicillin and IPTG (Isopropyl -D-1-
thiogalactopyranoside) at a concentration of 1mM. Afterwards, RNAi plates are seeded with 
200ul of the bacterial culture and kept for at least 24h at room temperature for drying and 
induction of dsRNA production. The RNAi plates are NGM plates (Nematode growth 
medium) that additionally contain 50g/ml ampicillin and IPTG at a concentration of 5mM.  
 
 
Performing the RNAi experiment 
 
Day 1 
Worms are washed off 2-3 full-grown NGM plates containing mixed stages of egl-17::yfp 
rrf-3(pk1426)III worms with bleach solution. The suspension of worms in bleach solution is 
distributed as small drops onto several NGM plates that lack bacterial food and incubated at 
20°C. 
 
Day 2 
After 12hrs., synchronized worms are distributed onto RNAi plates that contain a bacterial 
lawn of a specific RNAi clone. On each RNAi plate, 10 synchronized animals are placed. 
Afterwards the plates are incubated at 20°C. 
 
Day 4 
After 48hrs. of incubation, the expression pattern of egl-17::yfp is analyzed in L4 animals (P0 
generation) with a dissecting microscope equipped with a UV-lamp. Note that the optimal 
time of observation depends on the specific RNAi experiment since in some cases RNAi 
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negatively affects developmental speed. 8h later the egl-17::yfp expression is observed in 
adult animals with a UV dissecting microscope. 
 
Day 6 to 8 
The expression pattern of egl-17::yfp is evaluated in animals of the F1 generation at the L4 
and adult stages. Per RNAi experiment approximately 20 animals are observed at each stage. 
 
 
Bleach solution 
2.3ml dH2O 
2ml 4M KOH 
0.7ml NaHypochlorit 
 
 
Microscopic analysis of vulval phenotypes 
 
RNAi experiments that lead to defects in 2° specific defects in egl-17::yfp expression were 
repeated 1-2 times. For clones that gave reproducible defects, the vulval phenotype of L4 
animals was analyzed at the L4 stage with a microscope at high resolution using Nomarski 
optics. For this purpose, worms were mounted on a glass slide on top of a 4% agarose pad in a 
drop of M9 containing 25mM of azide (NaN3). 
 
 
Generation of transcriptional reporters 
 
egl-43 
The plasmid pIR3 is a transcriptional gfp-reporter for egl-43. 2.5kb of the egl-43 promoter 
including the ATG were amplified by PCR and cloned into the vector pPD96.04 (gift from A. 
Fire) via SphI (OIR63) and SalI sites (OIR68). Thereby, the egl-43 promoter drives 
expression of a GFP::LACZ fusion protein that is strictly localized to the nucleus due to the 
presence of NLS sequences (nuclear localization signal) from the SV40 virus. The primers 
used for amplification of the egl-43 promoter are shown in table 2. 
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Primer name Sequence (5’ to 3’) 
OIR63 TTTGCATGCCGAGATGGAGAATGATGCC 
OIR68 AAAGTCGACGGAAACTGTACGTGGGAAG 
Table 2: Primers used for a transcriptional egl-43 reporter 
 
Fusion PCR constructs 
Transcriptional reporters for ttr-11, C39F7.2, srd-49, ctg-1, T03G11.5 and mcm-2 were made 
by the fusion PCR method [31]. The primers for PCR1 were designed to amplify the promoter 
up to the next gene. The Primers for PCR2 (FireC, FireD and FireD*) are from Hobert et al. 
[31] and were used to amplify nls::gfp::lacZ from pPD96.04. Details about the primer 
sequences and combinations for PCR are shown in tables 3 and 4. Approximately 20-15ng of 
the PCR1- and PCR2-products were used as templates for the fusion PCR reaction. 
Importantly, PCR products were not purified since this seems often to impair the fusion PCR 
reaction. 
 
 PCR1 PCR2 Fusion 
Gene Primers Template Primers Template Primers 
C39F7.2 OIR120, 122 N2 Fire C,D pPD96.04 OIR121, Fire D* 
ctg-1 OIR114, 116 N2 Fire C,D pPD96.04 OIR115, Fire D* 
mcm-2 OIR108,110 N2 Fire C,D pPD96.04 OIR109,Fire D* 
srd-49 OIR117, 119 N2 Fire C,D pPD96.04 OIR118, Fire D* 
T03G11.5 OIR123, 125 N2 Fire C,D pPD96.04 OIR124, Fire D* 
ttr-11 OIR111,113 N2 Fire C,D pPD96.04 OIR112, Fire D* 
Table 3: Fusion PCR for generation of transcriptional reporters 
 
Primer name Sequence (5’ to 3’) 
OIR108 TCGGAAATTGAACTTCGGAATG 
OIR109 GAACTTCGGAATGTGGCCTAAC 
OIR110 AGTCGACCTGCAGGCATGCAAGCTGTACTGATCGAGCTCCGGCTGC 
OIR111 GCAGTAAACATCTATGGCTTACTG 
OIR112 GTAAACATCTATGGCTTACTGACAG 
OIR113 AGTCGACCTGCAGGCATGCAAGCTGTCACATACCGCGTTCATTTTCTTTGC 
OIR114 GCTTACTTGACAGCTTTCAGTTAC 
OIR115 CTTGACAGCTTTCAGTTACAACTG 
OIR116 AGTCGACCTGCAGGCATGCAAGCTCTGTTCGATGGACGTTGCAGC 
OIR117 CGAAACGTCAGACTCTGCCATTC 
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Primer name Sequence (5’ to 3’) 
OIR118 CGTCAGACTCTGCCATTCGTCAG 
OIR119 AGTCGACCTGCAGGCATGCAAGCTCCGATAGTAGAATACATGAACAATTG 
OIR120 GTATCGGTGAATTAGATCTTCATC 
OIR121 CGGTGAATTAGATCTTCATCTGG 
OIR122 AGTCGACCTGCAGGCATGCAAGCTTGATAGCTTATCACTTTCATGGTC 
OIR123 CAACCGTAACACATAGCTTGGTAC 
OIR124 CACATAGCTTGGTACTTGCTTC 
OIR125 AGTCGACCTGCAGGCATGCAAGCTACCACGCTGCTTGTTATAATGATG 
FireC AGCTTGCATGCCTGCAGGTCGACT 
FireD AAGGGCCCGTACGGCCGACTAGTAGG 
FireD* GGAAACAGTTATGTTTGGTATATTGGG 
Table 4: Primers used for Fusion PCR reactions 
 
 
Generation of transgenic lines expressing the transcriptional gfp-reporters 
 
The reporter constructs were injected without any DNA, injected at a concentration of 10-
100ng/ul into both syncytial gonad arms as described [36]. The injected amount was 
estimated by DNA agarose gel electrophoresis of the PCR products. Generally, transcriptional 
reporters were first injected into unc-119(e2498) animals using punc-119(+) as coinjection 
marker (10-20ng/ul, [35]). For unknown reasons, only weakly gfp-expressing transgenic lines 
could be established for some of the transcriptional reporters. In these cases, the injection was 
repeated using plin-48::gfp as the coinjection marker (50-75ng/ul) and N2 animals. As a 
consequence, transgenic lines that show robust gfp-expression were established for all 
transcriptional reporters. The injection mixture contained besides the transcriptional reporter 
and the coinjection marker a certain amount of the plasmid pBS-KS- to reach at least a total 
DNA concentration of 150ng/ul. Details about the injection of the different reporter constructs 
are shown in table 5. 
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gfp-reporter of zhEx [injected reporter] Coinjection marker (concentration) Injected strain 
C39F7.2 198 40 plin-48::gfp (50) N2 
ctg-1 195 20 plin-48::gfp (50) N2 
egl-43 157, 158 100 punc-119(+) (20) unc-119(e2498) 
mcm-2 199 20 punc-119(+) (25) unc-119(e2498) 
srd-49 196 30 plin-48::gfp (50) N2 
T03G11.5 197 60 plin-48::gfp (50) N2 
ttr-11 200 10 punc-119(+) (7) unc-119(e2498) 
Table 5: Details about generation of transgenic animal 
 
 
Microscopical analysis of expression pattern 
 
For each transcriptional reporter, three to four independent transgenic lines that inherit the 
extrachromosomal array to their progeny were established. For each line, about 20 animals at 
the L3 or L4 stage were observed with a microscope at high resolution to find transgenic lines 
that show strong gfp-expression and to determine the representative expression pattern of the 
construct.  
 
 
Equipment 
 
PCR machines: 
- BioRad MyCycler 
- MJ Research Inc., PTC-100 
 Table centrifuges 
- Eppendorf Centrifuge 5810 (for 15ml Falcon tubes) 
- Eppendorf Centrifuge 5415D (for 1.5ml Eppendorf tubes) 
Sequencing machine: 
- ABI Prism BigDye Terminator 
Spectrophotometer 
- NanoDrop ND-1000 
Microscopes: 
- Leica MS5 (low-resolution dissecting scope, standard worm handling) 
- Leica MZFLIII (dissecting scope equipped with a UV lamp) 
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- Leica DMRA (high resolution Nomarski and fluorescence pictures) 
- Leica DMIRB (high resolution microscope used for injection) 
Camera: 
- Hamamatsu ORCA-ER (Nomarski and fluorescence pictures) 
Software: 
- Improvision, Openlab 3.1 (acquisition of microscopy pictures) 
- Adobe Systems Inc., Adobe Illustrator, Adobe Photoshop (picture processing) 
- Gene Codes Corporation, Sequencher (analysis of DNA sequences, PCR primer 
design) 
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4 Regulation of anchor cell invasion and uterine cell fates by the 
egl-43 Evi1 proto-oncogene in C. elegans 
 
Abstract 
 
During normal animal development, specific cells adopt for a limited time the ability to 
migrate and invade distant tissues. This invasive behavior is also a key property of cancer 
cells. As a consequence, cancer cells are able to invade distant tissues and to form metastases 
throughout the animal body. Due to its importance in metastasis formation cellular invasion is 
an intensively studied process. In vertebrates, the transcription factor c-Fos is a well-known 
activator of invasive cellular behavior. c-Fos regulates transcription of a number of genes that 
are involved in invasion. 
C. elegans has just recently been established as a model for cellular invasion. During normal 
development, the AC (anchor cell), a specialized cell from the gonadal tissue, invades the 
neighboring vulval tissue. Thus C. elegans allows studying invasion at single cell resolution. 
Interestingly, fos-1 the C. elegans homolog of c-Fos is necessary for AC invasion. fos-1 Fos 
has been shown to activate transcription of the invasion effectors zmp-1, cdh-3 and him-4. 
In this study, the transcription factor egl-43 has been found as a new component of the AC 
invasion pathway. Transcription of the long isoform, egl-43L in the AC is positively regulated 
by fos-1 Fos. Identification of a conserved, putative fos-1 binding site in the egl-43L 
promoter, which is shown to be necessary for AC-specific expression, proposes a direct 
regulation of egl-43 by fos-1. In addition, analysis of the URS (upstream regulatory region) 
and the first intron of the egl-43 locus suggests a general regulation by the transcription 
factors fos-1, lin-12 and GATA-like factors. Furthermore, rescue experiments of a putative 
egl-43 knockout allele show that egl-43L is sufficient and necessary for AC invasion. 
Moreover, egl-43 regulates AC invasion by transcriptional activation of the effector genes 
zmp-1 and cdh-3. Besides its role in AC invasion, egl-43 is also necessary for cell fate 
specification in the gonad. egl-43 is necessary to induce the -cell fate in ventral uterine cells 
and acts downstream of or in parallel with lin-12 Notch. Analysis of transcriptional reporters 
for egl-43 in ventral uterine cells does not support regulation by lin-12 Notch but a positive 
regulation by fos-1 Fos. 
The role of egl-43 in AC invasion could be of particular interest in the context of its 
vertebrate homologs. EGL-43 belongs to the family of EVI1 proteins. All EVI1 family 
members encode a full-length isoform that contains the PR-domain (PRD1-BF1/RIZ1) and 
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one or several shorter isoforms that lack this domain. The PR-lacking isoform, EVI1 is 
involved in leukemia while the PR-containing isoform, MDS1-EVI1 has not been linked to 
leukemia or it is even speculated that it has tumor suppressive effect. Interestingly, a recent 
publication shows that elevated transcription of each isoform in leukemia patients correlates 
with a poor prognosis.  In this work, the long isoform of C. elegans, egl-43L is shown to be 
involved in cellular invasion, a process important for cancer cells. Thus, the study of egl-43 
Evi1 in AC invasion of C. elegans raises the hypothesis that MDS1-EVI1 could be a target of 
c-Fos during cellular invasion of vertebrate cells. 
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4.1 Introduction 
 
4.1.1. The significance of cellular invasion in cancer cells 
 
During vertebrate development, cells are kept in position due to interactions with the 
extracellular matrix (ECM). Only specific cells gain for a limited time the ability to break the 
physical boundaries, namely the ECM and to migrate into a different position in the animal. 
Examples for this invasive behavior are found during migration of neural crest cells, 
extravasation of leukocytes and trophoblast implantation (see general introduction for more 
details). 
 
The invasive behavior is tightly controlled. DNA lesions that lead to loss of this control have 
devastating consequences for the organism. Benign tumors are formed by hyper-proliferating 
cells that do not invade other tissues. Benign tumors turn into malign tumors if the control 
over the invasive behavior is lost. These cancer cells are able to digest the ECM, thereby 
evading the tissue of origin and invading distant tissues. Thus, loosing the control over 
invasive cellular behavior is the basis of metasis formation. 
 
4.1.2. The genetic program of cellular invasion 
 
Various transcription factors are involved in tumor invasion [1]. Often, these transcription 
factors induce invasive behavior by an epithelial to mesenchymal transition (EMT). EMT is 
important during normal embryonic development, such as neural tube formation, and also in 
adult animals during wound healing. During development, growth factors such as 
transforming growth factor-ß (TGF-ß), hepatocyte growth factor (HGF) and epidermal growth 
factor (EGF) induce EMT. Thereby, epithelial cells loose their corresponding markers, 
express mesenchymal markers and become invasive. EMT leads to morphological changes of 
the cell. Cells that undergo EMT change the focal adhesions activity and form cellular 
protrusions, called pseudopods that are the leading edge for cell migration. 
 
The transcription factor activator protein 1 (AP1) is involved in both EMT and tumor 
invasion. AP1 is a dimeric transcription factor that primarily consists of c-FOS and c-JUN. If 
rat fibroblasts are transformed with v-fos, the viral homolog of the cellular proto-oncogene 
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c-fos, these cells become invasive [2]. Transformation of fibroblasts depends on functional 
AP1 since knock-down of c-jun suppresses the invasive behavior. Gene expression analysis of 
v-fos transformed cells suggests that AP1 activates a multigenic invasion program [3, 4]. 
Moreover, AP1 activation leads to upregulation of invasion effectors and downregulation of 
invasion suppressors [3, 4]. Many AP1 regulated genes are involved in ECM degradation, cell 
adhesion and cell motility. For example, v-fos transformed cells show increased expression of 
CD44, a receptor for the extracellular component hyaluronan [2-4]. In contrast, the 
glycoprotein fibronectin is downregulated by AP1 [4]. Fibronectin is found in the ECM and 
helps to stabilize the interaction between the ECM and cell surface receptors. Interestingly, 
downregulation of target genes depends on histone deacetylase (HDAC), which is a 
component of the nucleosome remodeling deacetylase (NuRD) complex [5]. Moreover, it 
seems that the invasive behavior depends on the concerted action of all regulated components, 
since already the downregulation of one component by antisense oligonucleotides, e.g. CD44, 
abrogates invasion of v-Fos transformed cells [2]. Earlier experiments have also shown that 
AP1 activates the expression of a number of matrix metalloproteinases, such as MMP-9 in 
human smooth muscle cells (SMC, [6]) and murine keratinocyte cells [7]. Nevertheless, for 
most target genes it is unknown whether there is a direct interaction between c-FOS and the 
target promoters. 
 
4.1.3. fos-1 Fos is involved in cellular invasion in C. elegans 
 
Interestingly, also in the invertebrate C. elegans cellular invasion takes place. During vulval 
development, the anchor cell (AC), a cell from the somatic gonad, dissolves a basement 
membrane and invades the vulval tissue [8]. Only recently the first set of genes have been 
described that are involved in AC invasion [8]. Also in C. elegans, a Fos transcription factor, 
namely fos-1 mediates invasive behavior. fos-1 has been shown to transcriptionally activate 
effector genes for AC invasion [8]. The effector genes are cdh-3, a cadherin possibly involved 
in cell-cell interactions, zmp-1, a metalloprotease possibly involved in degrading the ECM, 
and him-4 hemicentin, a component of the ECM. So far, it has not been tested whether these 
effector genes are direct targets of FOS-1. 
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4.1.4. egl-43 Evi1 is an important factor for AC invasion 
 
In this chapter, I present egl-43 as a new component of the AC invasion pathway in C. 
elegans. The first egl-43 alleles, n997 and n1079, were isolated in a genetic screen for 
mutants that are egg-laying defective (Egl) due to defective hermaphrodite-specific neurons 
(HSN, [9]). Garriga et al. characterized these recessive alleles and showed that egl-43 is 
necessary for migration of the HSN neurons [10]. HSN neurons are born in the posterior part 
of the embryo and migrate towards the future position of the vulva. After migration, HSN 
neurons innervate the vulval tissue and are needed for egg-laying. In egl-43 mutants, HSN 
neurons do not migrate but remain in the tail of the animal. As a consequence, larvae hatch 
inside of the mother animal, feed on the mother’s tissue and are trapped in the mother’s 
cuticle. This phenotype is called bag-of-worms. The egl-43 alleles n997 and n1079 have DNA 
lesions in 3’-regulatory region. Interestingly, these alleles show wild-type vulval development 
(data not shown) and AC invasion (data not shown, [11]). Here, I show that egl-43L, the long 
isoform, is transcriptionally upregulated in the AC by fos-1 during the process of invasion. 
Furthermore, egl-43 activates transcription of zmp-1 and cdh-3. This connection between 
egl-43 and fos-1 in C. elegans might be an important clue to test the corresponding interaction 
of their homologs in a vertebrate system. 
 
4.1.5. The family of Evi1 proteins and its biochemical properties 
 
egl-43 encodes a zinc-finger protein that belongs to the family of TFIIIa transcription factors. 
The closest homologs in humans and mice are myelodysplasia syndrome 1-ecotropic viral 
integration site 1 (Mds1-Evi1) and Mds1-Evi1-like gene 1 (Mel1; also known as positive 
regulatory domain 16, Prdm16). EGL-43 is 55% homologous to human Evi1 and 66% 
homologous to murine Mel1 at the protein level (www.wormbase.org). Nishikata et al. 
reported that MDS1-EVI1 and MEL1 are highly homologous at the protein level and 
indistinguishable in functional assays [12].  
In all Evi1 family members, the zinc-fingers are clustered in two domains. While egl-43 has 
3+3, Mds1-Evi1 and Mel1 have 7+3 zinc-fingers. Interestingly, all members give rise to 
several isoforms that differ in the length of the N-terminus [10, 12, 13]. While egl-43 and 
Mel1 have different transcriptional start sites, the Mds1-Evi1 transcript is generated by fusion 
of Mds1 and Evi1. In every case, only the longest isoform contains a PRD1-BF1/RIZ1-
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domain (PR) at the N-terminus (Fig.17). The PR-domain containing isoforms are called 
MDS1-EVI1, MEL1 and EGL-43L. The PR-domain lacking isoforms that are mentioned in 
this text are called EVI1, MEL1S and EGL-43S. In humans Mds1-Evi1 is also called Evi-1c  
and Evi1 is also called Evi-1a [14]. PR-domains were already found in a number of 
transcription factors. The PR-domain is similar to the Suvar3-9, Enhancer-of-zeste, Trithorax-
domain (SET) that harbors histone methyltransferase activity. Also, the PR-domain of RIZ1 
contains histone methyltransferase activity [15]. DNA hypermethylation is frequently 
associated with gene silencing when methylation happens in the promoter region. Another 
study with RIZ1 suggest that the PR-domain is a protein interaction domain. The PR-domain 
of RIZ1 interacts with RIZ1 itself or with the PR-lacking isoform RIZ2 [16]. So far, it is 
unknown whether the PR-domain in Mds1-Evi1, Mel1 or egl-43 have a catalytic function. For 
Mds1-Evi1 it has been shown that the PR-domain inhibits homo-dimerisation and thereby 
recruitment of proteins that are able to bind the PR-lacking isoform, EVI1 [14]. The presence 
or absence of the PR-domain seems to dramatically influence the role of EVI1 as a 
transcription factor. EVI1, the PR-domain lacking isoform, has been shown to act as a 
transcriptional repressor on a promoter that contains a specific EVI1 consensus sequence. In 
 
Fig.17: Protein domain structure of Ev1 family members. 
Each locus of the Evi1 family members Evi1, Mel1 and egl-43 encode one isoform that contains a PR-domain 
(PRD1-BF1/RIZ1) and one or several shorter isoforms that lack the PR-domain. For simplicity only one short 
isoform is shown for Evi1 and Mel1. egl-43 encodes only two isoforms. In each full length protein the zinc 
finger domains are grouped into two clusters. The repressor domain (RD) and the acidic region are conserved 
between Evi1 and Mel1 but not in egl-43. 
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contrast, MDS1-EVI1, the PR-domain containing isoform, acts on the same promoter as a 
transcriptional activator [17]. The zinc-finger and PR-domains are conserved between MDS1-
EVI1, MEL1 and EGL-43. In addition, there are other domains that are not clearly conserved 
in EGL-43. In between the zinc-finger domains of EVI1 and MEL1 lies a repressor domain 
that mediates repressive effects on transcription. Additionally, at the C-terminus of Evi1 is an 
acidic domain of unknown function. 
 
Several lines of evidence support the idea that Evi1 acts as a transcription factor. First of all, 
Evi1 has been found to localize to the nucleus [18]. Moreover, in vitro experiments showed 
that Evi1 binds specific DNA sequences. While the first zinc-finger binds to the sequence 
GACAAGATAA [19] or GAC/TAAGATAAGATAA [20], the second zinc-finger binds to 
GAAGATGAG [21]. In addition, in vivo experiments confirmed the importance of these 
binding sites. Evi1binds via the first zinc-finger domain directly to the promoters of Gata2 
and Itpr-2 [22, 23] and thereby activates its transcription. Finally, Evi1 is known to bind 
cofactors that are general regulators of transcription, such as C-terminal binding protein 1 
(CtBP1, [14]). 
 
4.1.6. Interactions of the EVI protein 
 
The best-studied member of the Evi1-family is Evi1 itself. Overexpression experiments in 
cultured cells show that EVI1 interacts with a variety of factors that are involved in regulation 
of cellular proliferation and apoptosis (Summary of interactions in Fig.18, [24, 25]). 
 
Evi1 has been shown to repress target genes of the TGF-ß signaling pathway [26]. The TGF-ß 
signaling pathway mediates anti-proliferative effects. Activation of TGF-ß receptors leads to 
activation and accumulation of mothers against DPP proteins (Smad), such as SMAD3 in the 
nucleus. Activated Smad3 builds transcriptional complexes with other transcriptional 
regulators. SMAD3 is responsible for recognition and direct binding to SBE sequences (Smad 
binding elements) in the promoter of target genes [27]. Thereby, the complex is recruited to 
target genes and transcription is regulated. 
Repression of TGF-ß target genes by EVI1 depends on direct binding of SMAD3 to the first 
zinc-finger domain [28]. EVI1 seems not to interfere with DNA binding by SMAD3 but 
rather to specifically change the transcriptional activity of target genes [29]. 
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Furthermore, the repressive effect of EVI1 on TGF-ß target genes depends on binding of 
CtBP1, a transcriptional corepressor, to the repressor domain [14]. Interestingly, homo-
dimerisation of EVI1 is a prerequisite for CtBP1 binding. Moreover, CtBP1 binds the histone 
deacetylase HDAC1 [30]. Deacetylation of histones makes the chromatin less accessible for 
transcriptional activators and thereby silences promoters. Strikingly, the TGF-ß repressive 
effect of Evi1 is alleviated by trichostatin A, a specific inhibitor of HDAC proteins [31]. 
Moreover, the endogenous promoter of Smad7, a target gene of TGF-ß signaling, is inhibited 
by EVI1 overexpression. In accordance with the results above the Smad7 promoter shows 
also a reduction in the acetylation status in dependence of functional CtBP1. This strongly 
suggests that EVI1 acts as a transcriptional repressor by recruitment of HDAC1 via CtBP1. 
The cellular output of the effects of EVI1 on TGF-ß signaling is increased proliferation. 
In contrast, Mds1-Evi1 does not suppress but rather support TGF-ß signaling [14]. This is 
consistent with the fact that MDS1-EVI1 does not oligomerize due to the presence of the PR-
domain and hence does not recruit the corepressor CtBP1. 
 
Fig.18 Biochemical and biological functions of EVI1. 
EVI1 interactions cause inhibition of apoptosis, abnormality in growth inhibition and constitutive proliferation. 
The scheme displays the domains of EVI1, its physical interaction partners and the biological consequences. 
ZF1, ZF2 = zinc finger domain 1, 2; RD = repressor domain, JNK = c-Jun N-terminal kinase, Smad3 = mothers 
against Dpp homolog-3, CtBP1 = c-terminal binding protein-1, c-fos = cellular homolog of FBJ osteosarcoma, 
TGF-ß = transforming growth factor-ß, AP1 = activator protein-1. 
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TGF-ß signaling can also induce apoptosis [32]. Recently, Liu et al. published that EVI1 
overexpression in rat intestinal cells does primarily block TGF-ß induced apoptosis [33]. 
Inhibition of apoptosis by EVI1 depends on a process that uses phosphoinosite-3-kinase 
(PI3K) and its effector AKT. But, the molecular nature of this interaction is unknown. 
 
Evi1 has also been found to interact with c-Jun N-terminal kinase-signaling (JNK) [34]. JNK 
is part of a mitogen-activated protein (MAP) kinase cascade that drives cells into apoptosis 
upon cellular stress. Activated JNK activates c-JUN by phosphorylation. Overexpression of 
EVI1 blocks c-JUN phosphorylation [34]. The inhibitory effect of EVI1 is due to direct 
interaction of the first zinc-finger with JNK and thereby specifically inhibits the ability to 
phosphorylate c-JUN [34]. As a consequence apoptosis is blocked. 
 
In addition, Evi1 increases the activity of AP1 and activating transcription of c-fos [35]. This 
effect depends on the second zinc-finger of EVI1, but a direct interaction of EVI1 with the 
target promoter has not been shown. Overexpression of EVI1 in murine cell culture show that 
the activation of AP1 by EVI1 leads to increased proliferation. 
 
In summary, these in vitro experiments show that Evi1 promotes proliferation and blocks 
apoptosis. Both properties are important factors in tumorogenesis. 
 
4.1.7. The role of Evi1 proteins in development and cancer 
 
Evi1 is broadly expressed in mice during embryonic development, suggesting a role of EVI1 
in normal development. This is supported by the fact that EVI1 null mice die as embryos at 
day 10.5 postcoitus and show defects in various tissues. Moreover, expression is seen in 
hematopoietic stem cells (HSC). Analysis of Evi1 null mice shows that Evi1 is necessary for 
proliferation and maintenance of hematopoietic stem cells. However, Evi1 null mice show 
differentiation of HSC cells into erythrocytes and granulocytes. Importantly, in these knock-
out mice both transcripts MDS1-EVI1 and EVI1 are affected. Therefore, some defects might 
account also be due to the lack of MDS1-EVI1. 
 
Originally, the Evi1 locus was identified as a common site of retroviral insertion that caused 
transformation of hematopoietic cells into myeloid, leukemic cells [36]. Insertion of the 
retrovirus in the Evi1 locus leads to transcriptional activation of Evi1 and to leukemic 
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transformation. The transformed cells are still dependent on the growth factor Interleukin-3 
(IL3) but stop differentiation prematurely. 
 
To date, there are many examples in humans and mice showing that inappropriate activation 
of Evi1 expression disturbs hematopoiesis [37]. Evi1 is implicated in hematological 
malignancies as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) [38, 
39]. In patients with MDS, the HSCs do not differentiate into mature erythrocytes, leukocytes 
or thrombocytes and accumulate in the bone marrow at intermediate stages of differentiation. 
In addition, bone marrow cells are hyperproliferating. As a consequence, the level of 
functional cells in the peripheral blood is low. Thus, patients suffer from infections, bleeding 
and increasing tiredness. In approximately 30% of all cases, MDS develops into AML. 
Compared to MDS, AML patients have a much lower survival rate [40]. An important 
diagnostic difference between AML and MDS is the level of immature myeloid cells, 
myeloblasts in the blood. The developmental defect is focused on the myeloid branch of 
hematopoiesis. In the bone marrow, myeloid progenitor cells do not give rise to mature 
erythrocytes, granulocytes, megakaryocytes and monocytes, but enter the blood prematurely 
as blast cells. 
In general, chromosomal aberrations such as translocations or inversions affect Evi1 in human 
leukemias. There are two molecular mechanisms how these DNA alterations affect Evi1 
function. On the one hand, the chromosomal alteration leads to missexpression of Evi1. For 
example, in the inversion (inv3)(3q21q26), the Evi1 locus is put under the control of 
Ribophorin 1 (Rpn1), a housekeeping gene, and thus Evi1 is broadly missexpressed [41]. On 
the other hand, chromosomal alterations can cause expression of a fusion protein between 
EVI1 and another protein. The translocation t(3;21)(q26;q22) leads to fusion of AML1, 
another transcription factor necessary for hematopoiesis, to MDS1-EVI1 [42]. This fusion 
drastically changes the function of MDS1-EVI1 and creates an oncogenic protein. 
Interestingly, a similar translocation has also been found in MDS/AML patients that brings 
the Rpn1 in vicinity to the Mel1 locus [43]. 
 
The model that missexpression of EVI1 leads to leukemic transformation has also been 
confirmed in the mouse system. Buonamici et al. generated mice that overexpress Evi1 in the 
bone marrow [44]. For this purpose, bone marrow cells transfected with an Evi1 expression 
vector were transplanted into recipient mice that do not contain own bone marrow cells due to 
a lethal dose of irradiation. Consistent with the clinical results, these mice developed features 
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of MDS. The bone marrow showed hyperproliferation of erythrocytes and megakaryocytes 
and an accumulation of immature erythroid cells. Furthermore, there was a low peripheral 
blood count of erythrocytes, leukocytes and thrombocytes. RT-PCR experiments indicate that 
these defects in erythropoiesis and platelet formation occur since Evi1 overexpression 
represses certain target genes such as the Epo receptor (EpoR) and the thrombopoietin 
receptor (c-Mpl). 
 
Interestingly, in vitro experiments show that EVI1 and MDS1-EVI1 have antagonistic effects 
on TGF-ß signaling. But, expression analysis of the different Evi1 variants in AML patients 
does not clearly support an antagonistic function of EVI1 and MDS1-EVI1 in leukemia. 
Soderholm et al. reported that in patients with 3q26 rearrangements the PR-containing 
isoform MDS1-EVI1 is not or to a lesser extent induced then the PR-lacking isoform Evi1 
[17]. In contrast, Haas et al. showed that overexpression of each isoform, Mds1-Evi1 and 
Evi1 in AML patients correlates with a poor prognosis [45]. Thus, it is possible that both, PR-
containing and PR-lacking isoforms of EVI1 contribute, maybe by different molecular effects, 
to development of leukemia. 
 
4.1.8. Are the Evi1 family members generally involved in cellular invasion? 
 
Here, I provide a new link between the transcription factors egl-43 Evi1 and fos-1 Fos during 
cell invasion. While the importance of Fos genes for invasive behavior has been known, the 
family of Evi1 genes has not been mentioned in this context [2, 46]. Evi1 genes are reported 
to affect proliferation, differentiation and apoptosis of hematopoietic cells. In C. elegans, 
egl-43 transcriptionally activates target genes such as zmp-1, a putative matrix 
metalloproteinase, and thereby initiates the invasive behavior of the AC. So far, no matrix-
related genes were found among the targets of Evi1. Though, the implication of Evi1 in 
human leukemia could suggest a direct or indirect role of Evi1 in cellular invasion. Cellular 
invasion seems also to be important in leukemia. In healthy humans, hematopoietic cells in 
the bone marrow first differentiate into myeloid or lymphoid cells and further differentiate 
into the various cell types that descend from them. The differentiation of hematopoietic cells 
is regulated by chemokines that are secreted from stromal cells present in the bone marrow 
[47]. Immature lymphocytes remain in the bone marrow by expression of integrins that 
mediate strong interactions with its environment [48]. Mature lymphocytes show weaker 
interactions and are therefore able to leave the bone marrow into the blood stream [48]. For 
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this purpose, mature cells have to degrade the ECM of blood vessels to transmigrate into the 
vessel lumen. In AML patients, myeloid cells do not properly mature in the bone marrow, but 
are able to enter the blood stream. In agreement with this invasive behavior, AML patients 
show abnormally high levels of the matrix metalloproteinase MMP2 in bone marrow 
mononuclear cells, a subtype of leukocytes [49]. Moreover, a common method to collect 
HSCs for therapeutical treatment of leukemia patients involves mobilization of HSC by 
treatment with cytokines, such as G-CSF. Interestingly, mobilized HSCs show, compared to 
HSC residing in the bone marrow, enhanced levels of MMP-2 and MMP-9 and it has been 
shown that MMP-2 and MMP-9 are necessary for transendothelial migration [50, 51]. In this 
context, it would be interesting to see whether the reported overexpression of Evi1 in 
hematopoietic cells of MDS/AML patients correlates with increased levels of matrix 
metalloproteinases, such as MMP2 and MMP9. 
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4.2 Results 
4.2.1. Publication: Regulation of anchor cell invasion and uterine cell fates by the 
egl-43 Evi1 proto-oncogene in Caenorhabditis elegans. 
Rimann I. and Hajnal A., Dev. Biol. 2007 Aug 1;308(1):187-95.  
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Abstract
Cell invasion is a tightly controlled process occurring during development and tumor progression. The nematode Caenorhabditis elegans
serves as a genetic model to study cell invasion during normal development. In the third larval stage, the anchor cell in the somatic gonad first
induces and then invades the adjacent epidermal vulval precursor cells. The homolog of the Evi-1 oncogene, egl-43, is necessary for basement
membrane destruction and anchor cell invasion. egl-43 is part of a regulatory network mediating cell invasion downstream of the fos-1 proto-
oncogene. In addition, EGL-43 is required to specify the cell fates of ventral uterus cells downstream of or in parallel with LIN-12 NOTCH.
Comparison with mammalian Evi-1 suggests a conserved pathway controlling cell invasion and cell fate specification.
© 2007 Elsevier Inc. All rights reserved.
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Introduction
Invasion of cells across a basal lamina into another tissue is a
tightly regulated process occurring during diverse develop-
mental processes such as trophoblast implantation, gastrulation
or neural crest cell migration (Ozanne et al., 2006; Sherwood,
2006). Activation of cell invasion is also thought to be the first
step during the progression of a benign sessile into a malignant
metastasizing tumor (Yamaguchi et al., 2005). Cell invasion
involves the activation of a specific transcriptional program
(Ozanne et al., 2006). The AP-1 transcription factor complex
plays a key role during the initiation of the invasion program by
integrating the input from different extracellular signaling
pathways. AP-1 usually exists as a heterodimer consisting of
one fos and one jun family member. Activation of AP-1
correlates well with the invasive phenotype and metastasizing
potential of different solid tumors in humans. Moreover, several
genes up-regulated in v-fos-transformed fibroblasts regulate cell
motility and adhesion (Ozanne et al., 2006).
Recently, the vulva of the nematode Caenorhabditis elegans
has been established as a model to study cell invasion during
normal development (Sherwood, 2006; Sherwood and Stern-
berg, 2003). During vulval development, the anchor cell (AC)
in the somatic gonad induces the primary (1°) vulval cell fate in
the nearest vulval precursor cell (VPC) P6.p by secreting an
epidermal growth factor (LIN-3) (Sternberg, 2005). After
induction of the 1° fate at the beginning of the third larval
stage (L3), the AC crosses the two basal laminae separating the
somatic gonad from the vulva and invades the vulval tissue in
between the 1° descendants of P6.p (Sherwood and Sternberg,
2003). The C. elegans fos-1 gene is at the top of a genetic
pathway activating the expression of specific invasion effectors
in the invading AC (Sherwood et al., 2005).
Here, we report the identification of egl-43, the C. elegans
homolog of the mammalian Evi-1 proto-oncogene (Garriga et
al., 1993; Mitani, 2004), as a component of the regulatory
network controlling AC invasion downstream of fos-1. The egl-
43 Evi-1 locus encodes two Zn-finger transcription factors, of
which the shorter isoform has been shown to be required for
HSN neuron migration (Garriga et al., 1993). We find that the
longer of the two isoforms encoded by the egl-43 locus (egl-
43L) specifically promotes AC invasion as a transcriptional
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target of fos-1, while the short isoform (egl-43S) is expressed
independently of fos-1. In addition to its function during AC
invasion, we describe a second function of egl-43 in the ventral
uterine cells where egl-43 acts downstream of or in parallel with
the Notch signaling pathway during the specification of the π-
cell fate (Newman et al., 1995). Comparison with mammalian
Evi-1 suggests that egl-43 may be part of a conserved gene
network regulating cell invasion and fate specification.
Results
egl-43 is required for anchor cell invasion
We have identified the C. elegans Evi-1 homolog egl-43 in
an RNA interference (RNAi) based screen for genes affecting
vulval cell fate execution or vulval morphogenesis (Berset,
2005). Since a loss-of-function mutation in egl-43 (tm1802;
Fig. 2A, gift of S. Mitani and colleagues) causes an L1 larval
arrest phenotype, we first used egl-43 RNAi (egl-43i in Fig. 2A)
to bypass the early larval arrest, allowing us to characterize the
function of egl-43 during vulval development in L3 and L4
larvae. Since egl-43 RNAi animals showed no obvious change
in the vulval cell lineage, egl-43 is probably not required for
vulval cell fate specification or execution (data not shown).
However, egl-43i animals exhibited defects in vulval morpho-
genesis, resulting in a 52% (n=65) penetrant protruding vulva
(Pvl) phenotype. In particular, we noticed that in egl-43i
animals the AC was unable to invade the vulval tissue across the
two basal laminae separating the somatic gonad from the
epidermis (Figs. 1A and C). By the Pn.pxx stage, the basal
laminae under the AC were dissolved in all control RNAi
animals examined (i.e. animals treated with an RNAi feeding
vector lacking an insert, n=8), resulting in a broken line of
mitotracker staining between the two tissues (Fig. 1B).
However, in 75% (n=8) of egl-43i animals mitotracker staining
revealed intact basal laminae, pointing at a defect in AC
invasion (Fig. 1D). Similarly, HIM-4∷GFP, a hemicentin that is
localized to the extracellular matrix (Sherwood et al., 2005),
showed a punctate staining near the AC during vulval
invagination in all 23 control RNAi animals, but no signs of
degradation in 39% (n=31) of egl-43i animals (Figs. 1E to H).
In addition, we noticed that during vulval invagination the AC
in egl-43i animals was often not centered above the forming
cavity (Fig. 1G). The mis-positioning of the AC is likely due to
Fig. 1. egl-43 is required for AC invasion during vulval development. (A) Wild-type larva during AC invasion at the Pn.pxx stage and (B) MitoTracker-red staining of
the basal lamina in the same animal as shown in panel A. (C) Absent AC invasion and (D) no degradation of the basal lamina in an egl-43i animal at the Pn.pxx stage.
(E) and (F) Degradation of HIM-4∷GFP during AC invasion in a wild-type larva at the Pn.pxxx stage. (G) Mis-positioning of the AC and (H) no degradation of HIM-
4∷GFP in an egl-43i larva at the Pn.pxxx stage. The arrowheads in panels A to H point at the AC. (I) Normal invagination and utse (arrow) formation in a wild-type L4
larva. (J) Lack of the utse and invagination defect in an egl-43i L4 larva. A thick layer of tissue remains between the uterine and the vulval lumen (bordered by a dotted
line). (K) and (L) Specific RNAi against egl-43L induces the same AC invasion defects as shown in panels G and H. Scale bars in panels J and K are 10 μm.
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the failure of the AC to invade and connect to the vulval cells.
In wild-type L4 larvae, the uterine and vulval lumen are
separated by a thin laminar process formed by the uterus seam
cell (utse) syncytium (Fig. 1I, n=26). In 29% of egl-43i ani-
mals (n=21), no utse was visible, and a thick layer of tissue
remained between the uterus and vulval tissue (Fig. 1J). As a
consequence of these defects in vulval morphogenesis, the
vulva of egl-43i animals did not invaginate properly, resulting
in a strong Pvl phenotype in the adult animals (data not shown).
The egl-43 locus encodes two isoforms, termed egl-43S and
egl-43L, that are transcribed using two different promoters
(Garriga et al., 1993 and Fig. 2A). Similar AC invasion defects
as in egl-43i animals were observed in egl-43(tm1802)mutants,
in which the early larval arrest phenotype had been rescued by
an egl-43 transgene encoding both egl-43 isoforms (−6-egl-43,
Fig. 2A). In 55% (n=20) of egl-43(tm1802) animals carrying
the −6-egl-43 construct, the basal laminae were removed and
AC invasion occurred. Due to incomplete rescue by the
extrachromosomal array, 45% of the transgenic animals
exhibited no AC invasion. Furthermore, a minigene construct
encoding only the long egl-43L isoform rescued the egl-43
(tm1802) larval arrest phenotype and AC invasion defects (−6-
egl-43L in Fig. 2A). In −6-egl-43L animals in which the L1
larval arrest had been rescued, approximately 70% of the
animals also showed rescue of the AC invasion defect. (Three
independent lines carrying extrachromosomal arrays with −6-
egl-43L were analyzed ; n=10 to 12.) In contrast, transgenes
encoding only the short egl-43S isoform failed to rescue the
larval arrest (−1.3-egl-43S in Fig. 2A). Thus, the egl-43L
transcript is sufficient to promote AC invasion and uterus
development during larval development.
fos-1 activates expression of the long egl-43L transcript in the
anchor cell
The shorter egl-43S transcript was previously found to be
required for HSN neuron migration and to be expressed in HSN
neurons (Garriga et al., 1993), but the expression pattern of the
longer egl-43L transcript has not yet been described. We
therefore determined the expression pattern of both egl-43
isoforms by constructing GFP reporter transgenes containing
either of the two promoters. We focused our analysis of the
expression pattern on the ventral uterine and vulval cells. A
transcriptional reporter consisting of 1.7 kb of 5′ regulatory
sequences upstream of the egl-43L start codon (−1.7-Lp∷gfp,
Fig. 2A) showed GFP expression first in the ventral uterine
(VU) cells of mid L2 larvae (Pn.p stage) and then in the AC
beginning in mid L3 larvae, after the first round of vulval cell
divisions had occurred (Fig. 2B, Pn.px stage). AC expression of
−1.7-Lp∷gfp increased during AC invasion in late L3 larvae,
but remained constant in the VU descendants. −1.7-Lp∷gfp
expression was also observed in the gut and a set of neurons in
the head region (data not shown). However, no expression could
be detected in the vulval cells during vulval cell fate
specification and AC invasion (Figs. 2B and C).
Since egl-43i causes essentially the same AC invasion
defects as observed in fos-1(ar105) mutants (Sherwood et al.,
2005), we tested whether egl-43L expression in the AC is
regulated by FOS-1. In fos-1(ar105) homozygous L3 larvae
carrying the −1.7-Lp∷gfp reporter, no GFP expression could
be detected in the AC, and GFP expression in the VU cells
was also strongly reduced (Figs. 2C, D and data not shown).
To further narrow down the FOS-responsive element (FRE)
in the egl-43L promoter, we progressively shortened the
promoter from the 5′ end. This analysis identified a 139 bp
fragment sufficient to drive expression of GFP in the AC
(−0.14-Lp∷gfp, Figs. 2A and E). The canonical binding site
for mammalian Fos proteins is TGAG/CTCA (Nakabeppu et
al., 1988). Sequence alignment of the 139 bp minimal FRE
with the corresponding 5′ regulatory regions of Caenorhab-
ditis briggsae and Caenorhabditis remanei egl-43L identified
a conserved but imperfect putative FOS-1 binding site
TTACTCA at position −83 relative to the translational start
of egl-43L (Supplementary Fig. 1). Further deletion of the
reporter beyond this site resulted in a complete loss of AC
expression (data not shown), and a point mutation in the
putative fos-1 binding site (changing the site from TTACTCA
to ATACTCA) introduced into the −0.14-Lp∷gfp construct
caused a strong reduction of GFP expression in the AC,
while expression in other tissues such as in the gut was
unaffected (Figs. 2E–G). Thus, fos-1 likely activates egl-43L
transcription in the AC possibly through a non-canonical
binding site.
A reporter for the short egl-43S isoform (−5.1-Sp∷gfp, Fig.
2A) showed similar AC expression as the egl-43L reporter.
However, AC expression of egl-43S was already detected at
the Pn.p stage in mid L2 larvae, soon after the AC had been
specified and before egl-43L expression was observed in the
AC (Fig. 2H). In contrast to egl-43L, egl-43S expression
decreased during invasion in L3 larvae, and AC expression of
egl-43S remained unchanged in fos-1(ar105) mutants (Figs. 2I
and J). Further dissection of the AC-specific element driving
egl-43S expression led to the identification of a 1.6-kb frag-
ment containing the first intron that was capable of driving
GFP expression in the AC from the minimal Δpes-10 promoter
(Figs. 2A and K). It thus appears that the fos-1-independent
AC element in the first intron activates transcription of egl-43S
and also egl-43L before AC invasion. Activation of fos-1
during AC invasion in L3 larvae then shifts the balance in
favor of egl-43L.
egl-43L is necessary for AC invasion
The distinct regulation of the two egl-43 isoforms suggested
that egl-43L might promote AC invasion downstream of fos-1.
To test this hypothesis, we specifically down-regulated egl-43L
expression by feeding dsRNA derived of a DNA fragment
unique to egl-43L (egl-43Li, Fig. 2A). egl-43Li-treated animals
showed the same AC invasion defects as observed after down-
regulation of both isoforms (egl-43i), indicating that egl-43L is
necessary for AC invasion (Figs. 1K and L). The specificity of
the egl-43L dsRNA treatment was tested in transgenic animals
carrying the −5.1-Sp∷gfp construct, a transcriptional reporter
specific for egl-43S that includes the target region of the egl-
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43L specific RNAi clone (Fig. 2A). In egl-43Li-treated animals,
GFP expression in the AC was only slightly reduced compared
to control RNAi animals treated with an empty RNAi feeding
vector. The observed change in reporter expression points at an
indirect effect on EGL-43S levels, possibly through auto-
regulation of egl-43. Thus, the AC invasion defects induced by
egl-43Li are unlikely to be caused by the mild reduction of egl-
43S expression. Furthermore, this experiment also excluded the
possibility of an off-target effect, as RNAi using two non-
overlapping fragments of the egl-43 open reading frame
induced an identical phenotype. Since the entire egl-43S open
reading frame and 3′UTR is also contained in egl-43L, we were
unable to specifically down-regulate egl-43S without affecting
egl-43L expression.
egl-43 promotes anchor cell expression of the invasion
effectors zmp-1 and cdh-3
fos-1 positively regulates expression of the metalloprotease
zmp-1, the FAT-like proto-cadherin cdh-3 and the hemicentin
him-4 during AC invasion (Sherwood et al., 2005). In contrast
to egl-43i, single mutants in zmp-1, cdh-3 or him-4 exhibit only
weak AC invasion defects, indicating that these genes are
genetically redundant. Moreover, it has been unknown whether
zmp-1, cdh-3 and him-4 are direct or indirect fos-1 targets. We
therefore asked whether egl-43 acts upstream of or in parallel
with these previously identified fos-1 targets by examining the
AC expression of zmp-1p∷cfp and cdh-3p∷cfp transcriptional
reporters in egl-43i animals at the Pn.pxx stage. Expression of
zmp-1p∷cfp was reduced in around 50% of egl-43i animals
below the levels detected in any of the control RNAi animals
(Figs. 3A to C). The loss of zmp-1p∷cfp expression in 50% of
the animals is likely because only around half of the animals
were strongly affected by the RNAi treatment in the particular
experiment shown. Loss of fos-1 function only weakly reduces
cdh-3 expression (Sherwood et al., 2005), and egl-43i animals
exhibited a partial reduction in cdh-3p∷cfp expression to a
similar extent as reported for fos-1 (Figs. 3D to F). Interestingly,
in the strongly affected egl-43i animals at the Pn.pxx stage also
the neighboring VU cells expressed cdh-3p∷cfp, although in
mid-L2 larvae just after the AC had been specified, expression
of cdh-3p∷cfp and other AC-specific genes was restricted to the
AC (data not shown). Thus, the ectopic expression of cdh-
3p∷cfp in VU cells at the Pn.pxx stage points at an additional
defect in π-cell fate specification, which takes place during the
L3 stage (see below). Taken together, our data indicate that fos-
1 initiates AC invasion by up-regulating egl-43L expression in
the AC, which in turn activates effector genes such as zmp-1
and cdh-3 that are executing the invasion step (Fig. 4H).
egl-43 is required to specify the π-cell fate in the ventral
uterine cells
The AC is not only required to induce vulval development
and form a connection between the uterus and the vulva but also
to specify the fates of the adjacent VU cells (Newman et al.,
1995). During the late L3 stage, the AC produces an instructive
LAG-2 DELTA signal that activates the LIN-12 NOTCH
pathway in the neighboring VU cells and induces the π-cell fate
(Greenwald, 1998; Newman et al., 1995). Most of the π-cell
descendants then fuse with the AC to form the utse syncytium,
which forms a connection between the uterus and the lateral
seam cells (Fig. 1I). The zinc-finger transcription factor lin-29
has been shown to be necessary for LAG-2 expression in the
AC (Newman et al., 2000). Thus, in lin-29 mutants π-cells are
not formed and as a consequence a thick layer of tissue
separates the uterine and vulval lumen. Since we noticed that
also in egl-43i L4 larvae a proper utse was often not formed
(Fig. 1J), we tested if egl-43 plays a role in π-cell fate
specification besides its function during AC invasion. For this
purpose, we used transcriptional GFP reporters for lin-11 and
egl-13/cog-2 that are expressed in the π-cells (Gupta and
Sternberg, 2002; Hanna-Rose and Han, 1999). In contrast to
lin-29 mutants, π-cells are specified in mutants of egl-13 or
lin-11, but the execution of a proper π-cell fate is impaired
(Cinar et al., 2003; Newman et al., 1999). In most control
animals, there were 12 VU cells expressing lin-11p∷gfp and
egl-13p∷gfp (Figs. 4A, C, E and G). In egl-43i animals, the
number of lin-11p∷gfp- and egl-13p∷gfp-positive cells was
reduced to fewer than four gfp-expressing VU cells, although
there was no obvious change in the total number of cells in the
uterus visible under Nomarski optics (Figs. 4B, C, F and G).
Therefore, egl-43 is not only required to mediate AC invasion
but also to specify the π-cell fate of the VU cells. Since the
defect in π-cell fate specification in egl-43i animals resembles
the defect in lin-29mutants, egl-43might regulate in the AC the
production of the instructive lag-2 delta signal in order to
activate the lin-12 notch pathway in the adjacent VU cells.
Fig. 2. egl-43L is a fos-1 target in the AC. (A) Structure of the egl-43 locus, the rescue and the gfp reporter constructs used. The target region of the RNAi constructs
used and the region deleted in egl-43(tm1802) mutants is indicated. The arrowhead indicates the position of the fos-responsive element (FRE). The star marks a point
mutation in the FRE (T→ATACTCA). The numbers next to the rescue constructs indicate how many transgenic lines showed rescue of the early larval arrest in egl-43
(tm1802)mutants relative to the total number of lines analyzed. The lengths of all parts in this scheme are drawn to scale except for the boxes that represent the egl-43L
cDNA, the nls∷gfp∷lacz and the Δpes-10 coding sequences. (B) Expression of the egl-43L reporter in the AC and VUs of an L3 larva at the Pn.px stage. The arrows
indicate the VU cells visible in this focal plane. (C) egl-43L reporter expression during AC invasion at the Pn.pxx stage in a heterozygous fos-1(ar105)/+ larva. (D) No
AC expression detectable in a homozygous fos-1(ar105) larva at the Pn.pxx stage. The inset in panel D shows an overexposed image of the region around the AC. (E)
A 139 bp upstream element is sufficient to activate AC and VU expression of egl-43L at the Pn.pxx stage. See also Supplementary Fig. 1. (F) A point mutation in the
FRE located in the 139 bp upstream element strongly reduces AC and VU specific expression, while expression in panel G gut cells remains similar to the wild-type
reporter. (H) Expression of the egl-43S reporter in a L2 larva at the Pn.p stage prior to invasion. (I) egl-43S expression during AC invasion at the Pn.pxx stage in a
heterozygous fos-1(ar105)/+ larva. (J) Persisting egl-43S expression in a homozygous fos-1(ar105) larva during AC invasion. (K) The first intron contains an AC-
specific enhancer element activating the heterologous minimalΔpes-10 promoter. The filled arrowheads in panels B to K point at the AC. Open arrowheads in panel G
indicate GFP-positive gut cells. The scale bar in panel K represents 10 μm.
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Alternatively, egl-43 might act in the VU cells and be required
to specify the π-fate downstream of lin-12 notch. To distinguish
between these two possibilities, we tested if egl-43i suppresses
the formation of extra π-cells in lin-12(n137gf) mutants, in
which the Notch pathway is activated independently of the
lag-2 delta signal (Greenwald, 1998; Newman et al., 1995).
The average number of egl-13p∷gfp-expressing VU cells per
animal was significantly reduced in egl-43i-treated lin-12(gf)
animals (Fig. 4D). Moreover, egl-43i did not reduce expression
of a lag-2∷gfp reporter in the AC, indicating that egl-43 is not
required for the transcription of lag-2 delta in the AC (data not
shown). We therefore conclude that egl-43 acts downstream of
or in parallel with lin-12 notch to specify the π-cell fate in the
ventral uterus (Fig. 4H).
Discussion
In summary, our data indicate that the C. elegans Evi-1
homolog egl-43 performs two distinct functions during ventral
uterus development. In the AC, egl-43 acts downstream of the
fos-1 proto-oncogene to promote the invasion of the AC into
the vulval tissue (Fig. 4H). While this work was under review, a
similar function of egl-43 during AC invasion and gonad
patterning has been reported by Hwang et al. (2007). Extending
the findings by Hwang et al. (2007), we show that the long egl-
43L isoform is directly regulated by fos-1 through a conserved
Fos-responsive element immediately upstream of the egl-43L
transcriptional start site and that EGL-43L is both necessary and
sufficient to mediate AC invasion. During AC invasion in L3
larvae, egl-43L up-regulates the expression of the effector genes
zmp-1 and cdh-3 that are required to carry out the invasion step.
egl-43S, on the other hand, is already expressed prior to AC
invasion in L2 larvae, and is not regulated by fos-1. Therefore,
the specific up-regulation of the longer egl-43L isoform by fos-
1 may lead to the initiation of the invasion program, while the
constitutive egl-43S expression in the AC is not sufficient to
induce AC invasion. One possible model is that EGL-43S
competes with EGL-43L by binding to the promoters of the
same target genes and repressing their transcription. Remark-
ably, the human egl-43 ortholog Evi-1 also encodes two factors
that exhibit antagonistic activities (Mitani, 2004). The short
Evi-1a isoform can form hetero-oligomers, and it interacts with
the transcriptional co-repressor CtBP to recruit histone
deacetylases and represses TGF-β-induced gene expression
Fig. 3. egl-43 positively regulates zmp-1 and cdh-3 expression in the AC. (A) zmp-1p∷cfp expression in a control RNAi and (B) egl-43i larva at the Pn.pxx stage. (D)
cdh-3p∷cfp expression in a control RNAi and (E) egl-43i larva at the Pn.pxx stage. (C) Quantification of relative zmp-1p∷cfp and (F) cdh-3p∷cfp expression levels in
control and egl-43i larvae. Scale bar in panel E is 10 μm.
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(Izutsu et al., 2001; Kurokawa et al., 1998; Nitta et al., 2005).
The long Evi-1c isoform does not oligomerize due to the
presence of a PR domain at the N-terminus and cannot interact
with CtBP. Thus, Evi-1c is thought to act as transcriptional
activator. Oncogenic activation of Evi-1 is usually achieved by
overexpression or heterologous fusion of the short Evi-1a
isoform (Mitani, 2004).
The fos oncogene, originally identified in a retrovirus
causing osteosarcoma, encodes a component of the AP-1
transcription factor. Elevated activity of the AP-1 complex
correlates well with increased motility and invasiveness of
different types of human tumors (Ozanne et al., 2006;
Sherwood, 2006). Moreover, the locus of the human Evi-1
ortholog MEL1 is frequently amplified in osteosarcomas (Man
et al., 2004; MEL1 is termed PRDM16 in this reference). It
will therefore be interesting to determine if mammalian Evi-1
is regulated by AP-1 in a similar manner and if the same
regulatory network formed in C. elegans by fos-1 and egl-43
has been conserved in mammalian cells. In addition to
controlling AC invasion, egl-43 plays a distinct role in the
patterning of the VU cells (Fig. 4H). Epistasis analysis
indicates that egl-43 acts downstream of or in parallel with
lin-12 notch to specify the π-cell fate in the VU cells. egl-
43 may render the VU cells competent to respond to the
instructive LAG-2 Delta signal or alternatively, egl-43 activity
may be modulated by lin-12 notch signaling. The 5′
regulatory region as well as the first intron of egl-43L
contains multiple putative Notch responsive CSL binding sites
(Berset, 2005; Hwang et al., 2007), suggesting that lin-12
notch signaling may directly activate egl-43 transcription in
the VU cells. The question whether egl-43 expression in VU
cells is directly regulated by lin-12 notch signaling proved to
be difficult to answer experimentally, as in lin-12 notch(lf)
mutants one or more VU cells are transformed into ACs that
will express egl-43 independently of the lin-12 signal.
Moreover, we observed no obvious up-regulation in VU
cells or ectopic expression of the different egl-43L reporter
transgenes in lin-12(gf) mutants, indicating that lin-12 notch
signaling is not sufficient to induce egl-43 expression (data
not shown). However, it should be noted that activation of
mammalian Evi-1 is involved in various malignancies of the
hematopoietic system, and activating mutations in the
mammalian notch genes cause T-cell-derived leukemia. It is
therefore possible that Evi-1 plays a conserved role in a
mammalian Notch signaling pathway that controls the home-
ostasis of hematopoietic stem cells.
Material and methods
General methods and strains used
Standard methods were used for maintaining and manipulating C. elegans
(Brenner, 1974). The C. elegans Bristol strain, variety N2, was used as the wild-
type reference strain in all experiments. Unless noted otherwise, the mutations
used have been described previously (Riddle and National Center for Bio-
technology Information (U.S.), 2001) and are listed below by their linkage
group. LGII: egl-43(tm1802)/mIn1[mIs14 dpy-10(e128)] (this study), LGIII:
lin-12(n137), lin-12(n137n720), LGV: fos-1(ar105)/nT1[qIs51] (IV;V) (Sher-
wood et al., 2005).
Extrachromosomal arrays (all this study) and integrated arrays: rhIs23(him-
4∷gfp) III (Vogel and Hedgecock, 2001), syIs52[cdh-3p∷cfp, unc-119(+)] X
(Inoue et al., 2002), syIs80[lin-11p∷gfp, unc-119(+)] III (Gupta and Sternberg,
2002), syIs76[zmp-1∷pes-10∷cfp, unc-119(+)] IV (Inoue et al., 2002), qIs56
[lag-2∷gfp, unc-119(+)] IVor V (gift of L. Mathies and J. Kimble), kuIs29[egl-
13p∷gfp, unc-119(+)] V (Hanna-Rose and Han, 1999), zhEx182.1-.3[−1.3-egl-
43S, sur-5p∷gfp], zhEx187.1-.5[W02B7, sur-5p∷gfp], zhEx201.11,.13&.14
[−6-egl-43, sur-5p∷gfp], zhEx216.2[−1.7-Lp∷gfp, unc-119(+)], zhEx217.4
[intron1-Δpes-10∷gfp, unc-119(+)], zhEx218.7[−5.1-Sp∷gfp, unc-119(+)],
zhEx219.2[−1.7-Lp∷gfp, lin-48p∷gfp], zhEx228.17[−5.1-Sp∷gfp, lin-
48p∷gfp], zhEx268.1,.2&.5[−0.14-Lp∷gfp, unc-119(+)], zhEx269.1,.4&.10
[−0.14-L-MUTp∷gfp, unc-119(+)], zhEx270.1,.5&.8[−6-egl-43L, sur-5p∷gfp].
Transgenic lines were generated by injecting the DNA at a concentration of
5–50 ng/μl into both arms of the syncytial gonad as described (Mello et al., 1991).
punc-119 (10 ng/μl), plin-48p∷gfp (75 ng/μl) or psur-5p∷gfp (80–100 ng/μl)
were used as transformation markers (Maduro and Pilgrim, 1995; Yochem et al.,
1997). egl-43 RNAi experiments were done by feeding worms with double-
stranded RNA-producing bacteria as described (Kamath et al., 2001).
The RNAi feeding vector targeting egl-43L was generated by amplification
of a genomic fragment from cosmid W02B7 (Supplementary Tables 1 and 2),
cloning into the SacII and PstI sites of pPD129.36 (gift from A. Fire) and
transformation of the Escherichia coli strain HT115. All RNAi experiments
were conducted at 20 °C on NGM plates containing 5 mM IPTG.
GFP reporter and rescue constructs
All constructs were generated by PCR fusion (Hobert, 2002). The primers
used are listed in Supplementary Table 1. The primer combinations used for each
PCR reaction are listed in Supplementary Table 2. For generating the gfp
reporter constructs, the nls∷gfp∷lacz sequence was amplified from pPD96.04
or pTB11, a derivate of pPD96.04 where the minimal Δpes-10 promoter from
pPD95.21 has been cloned into the BamHI site. cDNAwas prepared from total
RNA preparations of N2 worms using oligodT primers (RevertAid Hminus,
Fermentas).
MitoTracker staining and microscopy of C. elegans
TheMitoTracker staining protocol was adapted from Sherwood et al. (2005).
RNAi-treated worms were incubated for 2 h at RT in a 10 μM solution of
MitoTracker Red CMXRos (Molecular probes) in M9. The initial volume was
diluted 5 times by addition of M9 and pipetted on NGM plates with food.
Animals were allowed to recover for 1 h at RT. For observation under Nomarski
optics, animals of the indicated stages were mounted on 4% agarose pads.
Fluorescent images were acquired on a Leica DMRA wide-field microscope
equipped with a cooled CCD camera (Hamamatsu ORCA-ER) controlled by the
Openlab 3.0 software package (Improvision). For quantification of GFP
intensity in the AC, all gfp images were acquired with the same microscopy and
software settings. The mean intensity of gfp expression in the nucleus of the
anchor cell was measured by using the measurement tool in the Openlab 3.0
software package (Improvision). Each measurement was standardized to the
background intensity in the same picture.
Quantification of basal lamina defects
Synchronized animals were observed at the Pn.pxx or Pn.pxxx stage. Basal
lamina removal was analyzed based on MitoTracker staining or expression of a
translational him-4∷gfp reporter (RNAi experiments) or based on appearance
with Nomarski optics (fos-1 rescue experiments). Animals were judged as
defective if there was no clear gap in the labeled basal laminae (RNAi
experiments) or the vulval and gonadal tissues were not connected (fos-1 rescue
experiments) in the proximity to the AC.
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Suppl. Fig. s1. Sequence alignment of the FOS-responsive element in 
the C. elegans egl-43L promoter/enhancer with C. briggsae and C. 
remanei 
The corresponding 5’ regulatory sequences of C. briggsae (Cbg) and C. 
remanei (Cre) egl-43L were aligned with 139 bp upstream of the initation 
codon of C. elegans (Cel) egl-43L using the ClustalX algorithm. Conserved 
blocks are highlighted in yellow, and the putative FOS-responsive element is 
boxed in red. The red arrow points at the site of divergence from the canonical 
Fos binding site TCAc/gTCA. The letter A indicates the positon of the T→A 
mutation that is present in the –0.14-L-MUTp::gfp reporter. 
 Suppl. table 1: Oligonucleotide sequence of primers used for PCR 
 
Primer  Sequence (5’->3’) 
DEL18 
OUTREV 
CTTCTCCGTCATCAGCTTCC 
FireC AGCTTGCATGCCTGCAGGTCGACT 
FireD AAGGGCCCGTACGGCCGACTAGTAGG 
FireD* GGAAACAGTTATGTTTGGTATATTGGG 
OIR75 TTTCTGCAGGCACATCATGTGTCAAGTGATG 
OIR83 CTACCGCTTCTGGATGAC 
OIR93 GCTTGAAACCAGTGCTCCAG 
OIR94 GCAATACTTCTCAGATGCTGC 
OIR98 CCTCACTCCAAGTGCCTG 
OIR99 CATTCGAGTCGCTGGAGA 
OIR107 CTGGAGCACTGGTTTCAAGC 
OIR126 GAGTAACCTCTAACCCTCATC 
OIR127 GCTCGGAGCAATACATTCGTG 
OIR128 GCATCGACACAGACTTCCTC 
OIR132 GAGCGCTGCTTCGGTCAGC 
OIR135 GCTACACCGAATGATTCGAATGC 
OIR137 AGTCGACCTGCAGGCATGCAAGCTGTCTGTGTCGATGCTCATCCTG 
OIR138 CGTAGACATTGTCTTAGAGGTGTC 
OIR139 AGTCGACCTGCAGGCATGCAAGCTGAATCTAGGATCTACATAAATCGTAG 
OIR142 AGTCGACCTGCAGGCATGCAAGCTCGTTAGTGCCGCTTGTGATGGCAT 
OIR171 TTTCCGCGGGCTACACCGAATGATTCGAATGC 
OIR172 AAACTGCAGGTCATCCAGAAGCGGTAGAATC 
OIR208 TATGACTTCTGGAGAGACATTCG 
OIR209 GCACATCATGTGTCAAGTGATG 
OIR212 CACAAGATGTAaTACTCATCTTTCG 
OIR215 GCCTTGAACAGCCATATCCAAC 
OIR225 CGAAAGATGAGTAtTACATCTTGTG 
OIR233 GCTGACCGAAGCAGCGCTC 
 
 Suppl. table 2: Primer combinations used to generate the RNAi vector 
insert, gfp reporter and rescue constructs. 
 
RNAi Construct PCR 
egl-43Li OIR171 & 1721) 
 
GFP Reporters PCR 1 PCR 2 PCR 3 PCR Fusion 
-1.7-Lp::gfp OIR75 & 1371) FireC, FireD2) - OIR75, FireD* 
intron1-∆pes-10::gfp OIR128 & 1391) FireC, FireD2) - OIR138, FireD* 
-5.1-Sp::gfp OIR128 & 1421) FireC, FireD2) - OIR138, FireD* 
-0.14-Lp::gfp OIR209 & 2151) FireC, FireD2) - OIR 215, FireD* 
-0.14-L-MUTp::gfp OIR208 & 2251) OIR212 & 1371) FireC, FireD2) OIR 215, FireD* 
 
 
Rescue 
Constructs 
PCR 1 PCR 2 PCR 3 PCR 
Fusion 
-1.3-egl-43S OIR93 & 941) - - - 
-6-egl-43 OIR126 & 
DEL18OUTREV1) 
OIR98 & 1071) OIR 83 & 991) OIR126 & 99 
-6-egl-43L OIR126 & 
DEL18OUTREV1) 
OIR135 & 2334) OIR94 & 1321) OIR99 &127 
Templates for PCR:  1) Cosmid W02B7 2) pPD96.04 3) pTB11 4) N2 cDNA 
 
Regulation of anchor cell invasion and uterine cell fates by the egl-43 Evi1 proto-oncogene 
 129 
4.2.2. Additional experiments 
 
The following chapter presents results that were not shown in the publication due to space 
restrictions or because they did not exactly match the focus of the paper or are not complete 
enough to publish. Nevertheless, these results give important information about the role of 
egl-43 in C. elegans development. Therefore, these results may lead to new hypotheses and 
stimulate the design of new experiments to test them. 
 
 
Fig.19: The AC is correctly specified in egl-43 RNAi animals. 
A and B) Shortly after the AC/VU decision, cdh-3::cfp is strongly expressed in the AC of control RNAi animals 
(vectori). C and D) In egl-43 RNAi animals (egl-43i) cdh-3::cfp expression is indistinguishable from expression 
in control animals. The arrowhead in A) to D) points at the AC. The cfp-expression is pseudo-colored in green. 
E) Quantitative analysis of the expression intensity of cdh-3::cfp in the AC. The intensity of cdh-3::cfp 
expression in the AC is similar in egl-43 and control RNAi animals. F) Also the expression intensity of 
lag-2::gfp, another AC-marker is similar in egl-43 and control RNAi animals. 
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4.2.2..a RNAi egl-43 does not affect the AC/VU decision 
 
I have shown in chapter 4.2.1 [52] that in egl-43 RNAi animals the anchor cell (AC) is often 
not able to invade the vulval tissue. The reason for this defect is that egl-43 is necessary to 
express genes in the AC that are needed for AC invasion (zmp-1 and cdh-3). Another possible 
explanation, why reporters for these genes are not properly expressed could be a defect in AC 
generation in RNAi egl-43 animals. For this reason, generation of the AC was evaluated by 
analyzing transcriptional reporters for AC-specific genes in egl-43 RNAi-treated animals at 
the Pn.p-stage. A reporter for the cadherin cdh-3 shows similar expression in control RNAi 
and egl-43 RNAi animals (compare Fig.19 B and D). In control RNAi experiments, the RNAi 
bacteria contain an empty vector. The expression in the AC was also quantified and does 
cover the same range of intensities in control and egl-43 RNAi animals (Fig.19 E). In 
addition, a reporter for lag-2, the lin-12 Notch ligand, was analyzed. Similar to cdh-3 
reporters, expression of the lag-2 reporter was not affected in egl-43 RNAi animals compared 
to control RNAi animals (Fig.19 F). The proof that egl-43 RNAi did work in these 
experiments is the occurrence of Pvl phenotypes among the animals that were grown to 
adulthood (data not shown). Based on these results, I conclude that the AC is properly made 
in egl-43 RNAi animals but later does not gain the ability to invade the vulval tissue. 
 
4.2.2..b AC-specific expression of egl-43 does not rescue the AC invasion defect in fos-
1(ar105) animals 
 
Reporter analysis presented in our publication (manuscript in chapter 4.2.1, [52]) indicated 
that egl-43 is acting downstream of fos-1 to allow AC invasion. The transcription factor fos-1 
transcriptionally activates egl-43 to initiate invasion. Moreover, egl-43 transcriptionally 
activates two effector genes of AC invasion, zmp-1 and cdh-3. It is possible that fos-1 has 
other transcriptional targets besides egl-43 that are needed to initiate AC invasion. 
 
One way to approach this aspect is to compare the invasion defect in fos-1 and egl-43 
mutants. Animals that carry the fos-1a-specific loss-of-function allele (fos-1(ar105)) show 
100% defects in AC invasion at the Pn.pxx stage [8]. In contrast, a triple mutant of all three 
effector genes, zmp-1, cdh-3 and him-4 shows AC invasion defects in only 25% of the cases 
[8]. Unfortunately the only putative loss-of-function allele of egl-43 (egl-43(tm1802)) arrests 
development at the L1 larval stage. Since AC invasion takes place at the L3 stage, the AC 
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invasion defect cannot be quantified in this putative null mutant. Experiments that were 
designed to specifically rescue the larval arrest phenotype in egl-43(tm1802) mutants were not 
successful and are presented later in Fig.22 (see below). Therefore, the role of egl-43 in AC 
invasion was basically investigated by RNAi against egl-43. Interestingly, RNAi against egl-
43 could produce AC invasion defects in up to 80% of the cases. This penetrant defect 
suggests that egl-43 may not be the only but at least a major target of fos-1 in the process of 
AC invasion. 
 
To follow up on this aspect, another approach was taken. If egl-43 was the only target of fos-1 
to initiate AC invasion, then one would expect that AC-specific expression of egl-43 could 
rescue the invasion defect in fos-1(ar105) animals. For this purpose, the cDNAs of egl-43S 
and egl-43L were put under the control of the anchor cell-specific enhancer of lin-3 (ACEL, 
[53]). For each construct, three independent transgenic lines were quantified with Nomarski 
optics for rescue of the AC invasion defect. The transgenes were maintained in a 
heterozygous fos-1(ar105)/nT1 background (nT1 is a homozygous lethal balancer). Thereby, 
it is possible to investigate the effect of the transgene on AC invasion in homozygous 
fos-1(ar105) and heterozygous fos-1(ar105)/nT1 animals. Neither the expression of egl-43S 
nor egl-43L in the AC could rescue the AC invasion defect of fos-1(ar105) mutants (Fig.20 
A). For each transgenic line and genetic background, about 20 animals were observed with 
Nomarski optics. One possible explanation why the rescue does not work is that egl-43 is not 
properly expressed in these constructs. This is likely since the constructs shown in Fig.20 A 
end right after the predicted polyA-addition signal and do not include the cleavage site and 
the GU-rich element [54]. Thus, I redesigned these constructs and added 200nt of genomic 
DNA after the predicted polyA-addition signal. The same procedure was done with constructs 
that were designed to rescue the larval arrest phenotype of egl-43(tm1802). There, the 
construct that ends with the polyA-addition signal did less efficiently rescue than the 
construct with extra 200nt after the polyA-addition signal (in Fig.22 only constructs with the 
extra 200nt are shown). Therefore, it seems that the shorter construct is expressed but less 
efficiently than the longer construct. In the case of the long AC-specific construct, still no 
rescue of the AC invasion defect in fos-1(ar105) animals was obtained (Fig.20 B). In contrast 
to the shorter AC-specific constructs, the rescue was judged only by looking at approximately 
ten transgenic fos-1(ar105) animals per line with Nomarski optics. Thus, it is possible that a 
rescue with a low penetrance, less than 10%, could have been missed by this procedure. If we  
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Fig.20: Expression of egl-43 does not rescue the AC invasion defect in fos-1(ar105) animals. 
In A, B and C the structure of the rescue constructs are illustrated. The ACEL element encodes an AC-specific 
enhancer element and pes-10 is a minimal promoter from the pes-10 promoter region. The numbers next to the 
rescue constructs indicate how many lines of all lines analyzed did rescue the AC invasion phenotype in 
fos-1(ar105) animals. The graphs in A) represent quantifications of the AC invasion defect in the different 
transgenic lines. Each bar represents the quantification of about 20 animals. The difference between the 
constructs in A) and B) is the length of the 3’-UTR. While the constructs in A) end with the polyA-addition 
signal the constructs in B) have extra 200 nucleotides beyond the polyA-addition signal. Rescue experiments of 
egl-43(tm1802) propose that the constructs in B) should be more efficiently transcribed than the constructs in A) 
(see text for details). For each construct transgenic lines were generated in a fos-1(ar105)/nT1 background. 
Afterwards, the percentage of animals with an AC invasion defect for fos-1(ar105) and fos-1(ar105)/nT1 
animals with and without the transgene was quantified. For the constructs in B) the evaluation of the invasion 
defect was of more qualitative nature (¶, see text for details). Thus, rescue at low penetrance cannot be excluded 
for these lines. A) Neither, AC-specific expression of egl-43S or egl-43L rescues the AC invasion defect in fos-
1(ar105) animals. Moreover, expression of egl-43S but not of egl-43L leads to penetrant AC invasion defects in 
fos1(ar105)/nT1 animals of all lines analyzed. B) Qualitative analysis proposes that egl-43S or egl-43L 
expression in the AC does not rescue the invasion defect of fos-1(ar105) animals. 
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assume that the constructs are functional, this would indicate that egl-43 is not the only target 
of fos-1 during AC invasion. 
 
Interestingly, presence of the AC-specific egl-43S construct led to AC invasion defects in the 
heterozygous fos-1(ar105)/nT1 background (Fig.20 A). This effect could be due to titration 
effects by the ACEL promoter or due to overexpression of egl-43S. The ACEL element is 
necessary to drive lin-3 expression in the AC, which in turn induces vulval development.  
Therefore, if factors that normally bind to the endogenous ACEL sequence are titrated away 
by a large number of construct one would expect that lin-3 expression is abrogated and thus 
vulval induction is decreased. But, no defects in vulval induction were observed in transgenic 
fos-1(ar105)/nT1 animals that express egl-43S specifically in the AC. Thus, it is likely that 
the overexpression of egl-43S is responsible for this effect. This result suggests that egl-43S 
is, but not egl-43L, a negative regulator of AC invasion. 
 
4.2.2..c Phenotypic description of egl-43(tm1802) mutants 
 
Animals that are homozygous for the egl-43(tm1802) allele arrest larval development during 
early larval development around the L1 stage (Fig.21 C and D). Since uterus development 
begins during the mid L2 stage the role of egl-43 during this stage could not be directly 
studied with the mutant. It is to date unclear why the animals arrest development. In general, 
it seems that all tissues are formed in egl-43(tm1802) mutants. The only abnormality that was 
found is the appearance of the gut lumen. In arrested animals, the gut lumen was often seen as 
a zigzag-line (Fig.21 BC, E). In contrast, the gut lumen of N2 and egl-43(tm1802)/mIn1 L1 
animals follows a straight line (Fig.21 A and E). Unfortunately, no similar phenotype could 
be found in the literature. Therefore, it is unclear whether this phenotype is responsible for the 
larval arrest. But, it gives important information for tissue-specific rescue experiments with 
egl-43(tm1802). 
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Fig.21: egl-43(tm1802) animals arrest development at L1 larval stage and show abnormalities in the gut 
structure. 
A) Nomarski picture of an N2 animal at the L1 stage. The gut lumen (dotted lines) is visible as a straight line. B) 
GFP-picture of the same animal. The visible green autofluorescence originates from gut particles. C) Nomarski 
picture of an egl-43(tm1802) larva that arrested development at the L1 stage. The gut lumen (dotted lines) shows 
several bends and follows as a zigzag-course. D) GFP-picture of the same animal as in C). The appearance of the 
gut autofluorescence is similar to the N2 animal in B). The dotted lines that follow the gut lumen in A) and C) 
are each time split into two parts since part of the gut lumen is covered by the gonadal primordium. E) 
Quantification of the gut appearance shows that in egl-43(tm1802) animals the gut lumen appears abnormally 
often as a zigzag-line. In contrast, in N2 and egl-43(tm1802)/mIn1 animals the gut lumen was always seen as a 
straight line. 
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4.2.2..d Rescue of the larval arrest in egl-43(tm1802) animals 
 
In order to study uterus development in egl-43(tm1802) animals it is necessary to specifically 
rescue the larval arrest phenotype. Therefore, I performed rescue experiments to study the 
tissue focus of this phenotype. 
 
To test the rescuing activity of different DNA constructs, each DNA was injected into 
heterozygous egl-43(tm1802)/mIn1 animals. egl-43(tm1802)/mIn1 animals develop 
superficially wild-type and become fertile adults. After injection, for each construct several 
independent lines were generated from egl-43(tm1802)/mIn1 animals. From each line, many 
homozygous egl-43(tm1802) animals that contained the transgene were isolated and further 
development was investigated. 
 
The larval arrest phenotype of egl-43(tm1802) animals can be rescued by the cosmid W02B7 
that contains the egl-43 locus and other genes (Fig.22 A). Moreover, a fragment that covers 
6kb of the promoter and the rest of the egl-43 locus was able to rescue the arrest phenotype 
(-6-egl-43). Interestingly, a construct that contains only 2.5kb promoter region is unable to 
rescue (-2.5-egl-43). Obviously, the region that starts 6kb upstream and ends 2.5kb upstream 
of the egl-43L ATG contains sequences necessary for larval development. Also, if 6kb of the 
promoter region are fused to the egl-43L cDNA, the larval arrest can be rescued (-6-egl-43L). 
But, the first generation of rescued animals does not give rise to rescued animals again. Thus, 
no rescued homozygous egl-43(tm1802) line could be established with the egl-43L minigene. 
Interestingly, if the first intron of egl-43L was included in the construct rescued, homozygous 
egl-43(tm1802) lines could be established (-6-intron1-egl-43L). Thus, the first intron is 
necessary for efficient rescue of the larval arrest phenotype. In agreement with the data shown 
so far, a construct that includes 1.3kb of the egl-43S promoter and the cDNA of egl-43S was 
not able to rescue the larval arrest (-1.3-egl-43S). Thus, expression of egl-43L is sufficient to 
rescue the larval arrest phenotype of egl-43(tm1802) animals. 
 
In order to specifically rescue the larval arrest phenotype the egl-43L cDNA was expressed 
under different promoters. On the one hand, different tissue-specific reporters were used 
(Fig.22 B). The selection of these promoters was based on the expression pattern seen with 
transcriptional reporters for egl-43. Besides the gonadal tissue, transcriptional reporters for 
egl-43 are expressed in the gut, the pharynx and many neurons. The opt-2-promoter [55] was  
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Fig.22: Expression of egl-43L rescues the larval arrest in egl-43(tm1802) animals. 
The scheme shows the egl-43 locus drawn to scale, the location of the tm1802 deletion and the structure of 
different rescue constructs. A) Rescue of the larval arrest phenotype by expression of egl-43 under its own 
promoter elements was only successful if 6kb of the upstream regulatory sequence was included (cosmid 
W02B7, -6-egl-43). Moreover, fusion of this 6kb promoter to the egl-43L cDNA was sufficient to rescue the 
larval arrest phenotype. Interestingly, inclusion of the first intron improved the quality of the rescue. 
Homozygous egl-43(tm1802) animals rescued by the -6-egl-43L construct (§) did not give rise to rescued 
progenies and thus no homozygous, rescued lines could be established. In contrast, expression of egl-43S under 
its own promoter did not rescue the larval arrest (-1.3-egl-43S). The red lines label the genomic elements that 
were found to be necessary for efficient rescue. B) Expression of egl-43 under tissue-specific promoters did not 
rescue the larval arrest phenotype. The opt-2 promoter drives expression in the gut, the myo-2 promoter in the 
pharynx and the unc-119 promoter in the neurons. C) Expression of egl-43 under a heat-shock inducible 
promoter was able to rescue the larval arrest. If egl-43L alone or egl-43S and egl-43L were simultaneously 
expressed very few rescued animals were found (‡). The hsp16-41 promoter is an ubiquitous, heat-inducible 
promoter. For each construct transgenic lines were generated in an egl-43(tm1802)/mIn1 background. 
Afterwards, it was investigated whether in these lines the transgene is able to rescue the larval arrest phenotype 
in egl-43(tm1802) homozygous animals. The numbers next to the rescue constructs indicate how many lines of 
all lines analyzed did rescue the larval arrest phenotype. Vertical lines are drawn if combinations of constructs 
where used for rescue experiments. 
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used for gut-, the myo-2-promoter [56] for pharynx- and the unc-119-promoter [57] for 
neuronal-specific expression. On the other hand hsp-16-41, a ubiquitously expressed heat-
inducible promoter was used (Fig.22 C). The idea behind this is to overcome the larval arrest 
by broadly expressing egl-43 only during early development. Before uterus development 
takes place the promoter is kept silent and thereby the role of egl-43 could be investigated in 
the mutant. 
 
Unfortunately, none of the tissue-specific constructs could rescue the larval arrest phenotype 
(Fig.22 B). Also, the combination of different tissue-specific constructs did not lead to any 
rescue. Moreover, because egl-43S is also expressed in the neurons a corresponding neuron-
specific construct was tested as well.  
 
Heat-shock induced expression of egl-43 was able to rescue the larval arrest phenotype, 
although for each rescued line only very few rescued animals were found. At the same time, 
heat-shock led to larval lethality preferentially in transgenic egl-43(tm1802) animals. Thus, 
ubiquitous overexpression of egl-43 seems to be toxic. Rescue was found in lines that 
expressed egl-43L alone or egl-43S and egl-43L together (Fig.22 C). Thus, in agreement with 
the rescue experiments using egl-43 promoter elements, egl-43L is able to overcome the larval 
arrest in egl-43(tm1802) animals. 
 
4.2.2..e Analysis of transcriptional reporters for egl-43 reveals an early and a late 
promoter element for the AC 
 
Already in our publication (chapter 4.2.1, [52]), it is reported that different parts of the egl-43 
are responsible to express egl-43 at different time-points in the AC. In this paragraph, I will 
present the corresponding data. 
 
In order to investigate the transcriptional control of egl-43 in the AC, the gfp-intensity was 
quantified for different transcriptional reporters at four specific time-points. For each reporter, 
several lines were established and one representative line was chosen that is healthy and gives 
relatively strong gfp-expression. The structure of reporters and quantification of gfp-
expression can be seen in Fig.23. Exemplary microscopy pictures for the different constructs 
are presented in Fig.24. 
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Fig.23: Analysis of transcriptional reporters for egl-43 reveals an early and a late promoter element for the AC. 
A) The scheme shows what part of the egl-43 locus was used for building the different transcriptional reporters. The 
arrowhead indicates the putative Fos-binding site (FRE=Fos-responsive element) that is necessary for AC expression 
(Rimann et al., 2007; Chapter 4.2.1). Based on the results shown in B) an early and a late promoter element are 
indicated by red lines in the reporter constructs. The scheme for the egl-43 locus and the reporters are drawn to scale 
with exception of the boxes that represent the nls::gfp::lacZ and the pes-10 elements. B) For each construct the 
expression in the AC was quantitated at four different time-points. Each bar represents at least ten animals. The reporter 
for egl-43L, -6-intron1-Lp::gfp shows increasing levels of GFP in the AC from the 1-cell until the 6-8-cell stage. 
Qualitatively, the same timing is seen with reporters that lack the first intron (-6-Lp::gfp, -1.7-Lp::gfp). Thus, the 
regulatory region upstream of the egl-43L ATG drives expression around the time of AC invasion. In contrast, a 
reporter for the egl-43S transcript (-5.1-Sp::gfp) is maximally expressed in the AC of 1-cell stage animals and decreases 
continuously until the 6-8-cell stage. This expression characteristics seems to depend on the first intron of the egl-43 
locus (intron1-pes-10::gfp). A dotted line in the graphs indicates the onset of AC invasion. Color code of graphs: 
white=no expression, light green=weak expression, dark green=strong expression, black=strong expression with cellular 
GFP-aggregates visible. 
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Analysis of transcriptional reporters for egl-43 that are under the control of different parts of 
the egl-43 promoter revealed that the timing of gfp-expression in the AC varies between 
certain constructs. A reporter that contains 6kb of promoter region and the first intron of 
egl-43L is already clearly expressed in the AC around the 1 cell stage of vulval development 
(Fig.23 A and B, -6-intron1-Lp::gfp). Later, the gfp-intensity increases until the 6-8-cell 
stage. Basically, the same timing is seen with a reporter that lacks the first intron (-6-Lp::gfp). 
Moreover, shortening of the promoter region shows that only 1.7kb of promoter are sufficient 
to drive increasing amounts of gfp from the 1- until the 6-8-cell stage (-1.7-Lp::gfp). 
Interestingly, this promoter element contains the putative fos-1-binding site (Fig.23 FRE, 
[52]) that specifically drives expression in the AC. In contrast, a transcriptional reporter that 
contains 5.1kb upstream of the egl-43S ATG shows a different timing of gfp-expression 
(Fig.23 A and B, -5.1-Sp::gfp). The AC expresses gfp already at the 1-cell stage relatively 
strong and gfp-expression continuously fades afterwards. Since it has been found that the AC 
expression in this construct depends on the presence of the first intron of egl-43L (data not 
shown), a reporter that is under the control of this intron was also analyzed (intron1-
pes-10::gfp). As expected, the course of gfp-expression is identical to the construct with 
5.1kb of promoter. In conclusion, the first intron of egl-43L defines a early enhancer element 
that mainly drives transcription in the AC before AC invasion takes place. This means, that 
both, egl-43S and egl-43L are transcriptionally active before the AC invasion step. The 
promoter sequence upstream of egl-43L contains a late enhancer that only starts expression 
before AC invasion and continuously drives expression after AC invasion. In summary, the 
promoter analysis indicated that egl-43L accumulates in the AC shortly before AC invasion 
takes place to promote invasion. 
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Fig.24: Time-course analysis of different transcriptional gfp-reporters for egl-43 reveals differences in 
timing of expression. 
A) A reporter including 6kb of egl-43 upstream regulatory sequence (URS) and the first intron drives expression 
in the anchor cell (AC) from Pn.p- until Pn.pxxx-stage (-6-Lp-intron1::gfp). B) The promoter upstream of the 
egl-43 ATG drives late gfp-expression in the AC from the Pn.px- until the Pn.pxxx-stage (-6-Lp::gfp, -1.7-
Lp::gfp). C) In contrast, the first intron of egl-43 drives gfp-expression in the AC already at Pn.p stage (-5.1-
Sp::gfp, intron1-pes-10::gfp). Later, the expression fades and is absent at Pn.pxxx stage. The gfp-expression 
surrounding the AC originates from uterine cells. For each reporter representative pictures are shown at four 
different stages of vulval development (Pn.p, Pn.px, Pn.pxx, Pn.pxxx) from a single transgenic strain. The 
molecular structure of these constructs and the quantification of gfp-expression is shown in Fig.23. The 
arrowhead points at the AC. The white lines indicate the position of the vulval cell P.6p and its descendants. 
Since at the Pn.pxxx stage most of the P6.p descendants are not in the focal plane shown the bars are missing. 
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4.2.2..f The egl-43 promoter contains evolutionary conserved promoter elements that 
are putative binding sites for fos-1, lin-12 and GATA factors 
 
Promoter elements that are involved in transcriptional regulation of a gene are less likely to be 
affected by evolutionary changes than sequences that have no specific function [58]. 
Therefore, in order to find important regulatory sequences it is helpful to compare the 
sequence of interest to evolutionary closely related species. To find regulatory sequences in 
the egl-43 promoter, the C. elegans sequence was compared to corresponding sequences in C. 
briggsae and C. remanei. C. briggsae and C. remanei are together with C. brenneri most 
closely related to C. elegans among all known Caenorhabditis species. Genome comparison 
has shown that C. elegans and C. briggsae are a little bit less similar to each other than mouse 
and human, respectively [59]. To compare the sequences, the alignment software ACANA 
(ACcurate ANchoring Alignment) was used [60]. ACANA performs pairwise alignment of 
divergent sequences. The sequences are aligned by an anchoring method, where the program 
first tries to find near optimal blocks of conserved nucleotides and afterwards extends the 
alignment from these blocks. Huang et al. showed that the ACANA program is compared to 
other anchor-based alignment softwares a powerful tool for aligning divergent sequences and 
to find functional elements. 
 
The complete upstream intergenic region and the first intron of egl-43 were compared to the 
corresponding regions of its orthologs in C. briggsae and C. remanei by pairwise alignment in 
ACANA. Afterwards, the conserved blocks were manually searched for known sequence 
motifs. In general, conservation of motifs was first searched for in alignments between C. 
elegans and C. briggsae. Since C. briggsae is generally better described than C. remanei, 
conservation to C. briggsae was chosen as the primary criterion over conservation to C. 
remanei. 
Reporter analysis presented in our publication (chapter 4.2.1, [52]) indicated that fos-1 
regulates egl-43 transcription. In vertebrates, the Fos binding site, also known as TRE (TPA 
response element), is TGASTCA (S=G or C). In total, 3 conserved sequences were found that 
resemble this motif (Fig.25 A and B FOS#1-3). FOS#1 fully corresponds to the vertebrate 
consensus sequence and is completely conserved between C. elegans, C. briggsae and C. 
remanei. FOS#2 and FOS#3 are similar to the vertebrate consensus sequence (1 mismatch). 
FOS#2 is fully conserved between C. elegans and C. remanei but has one mismatch between 
C. elegans and C. briggsae. In contrast, FOS#3 is fully conserved between C. elegans, C. 
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briggsae and C. remanei. ACANA was not successful in finding the conserved FOS#3 site 
when the complete URS of egl-43 (8’199nt) was used. This site was only found in conserved 
boxes if shorter fragments were provided to ACANA. This alignment was done because 
experiments with transcriptional gfp-reporters indicated that there must be a fos-1-responsive 
site (FRE) close to the egl-43L ATG. FOS#3 is called FRE in our publication (chapter 4.2.1, 
[52]). 
Since egl-43 was identified in a screen for putative lin-12 Notch target genes the alignment 
 
Fig.25: The egl-43 promoter contains evolutionary conserved promoter elements that are putative binding sites 
for fos-1, lin-12 and GATA-factors. 
A) Schematic representation of the egl-43 locus and its conserved, putative fos-1 (FOS#1-3), lin-12 (CSL#1) and 
GATA-factor (GATA#1-4) binding sites. To find the proposed binding sites the URS of egl-43L up to the next gene and 
the first intron of egl-43L were aligned to the corresponding regions in C. briggsae and C. remanei by using the 
software ACANA [60]. Afterwards, the alignment files were manually searched for conserved sequences of interest. 
Only motifs that are at least conserved between C. elegans and C. briggsae are shown. Motifs that are only conserved 
between C. elegans and C. remanei are not shown. The motifs that were looked for are “TGASTCA” sites for FOS, 
“GATA” and “TATC” for GATA-sites and “RTGGGAA” and TTCCCAY for CSL-sites. The color code is explained in 
the figure itself. The scheme is drawn to scale. B) The conserved regions from (A) that contain consensus sequences of 
interest are shown. For color-coding, the conserved regions, originally found by pairwise-alignment in ACANA, were 
realigned in AlignX (VectorNTI) by aligning all three sequences together.  For the sites GATA#1 and GATA#3 the C. 
remanei sequence is not shown since it is not clear where these parts are located in the promoter of the C. remanei 
homolog. In red letters and yellow shading are nucleotides conserved in C. elegans, C. briggsae and C. remanei. 
Nucleotides that are identical in two of the three compared species are written and shaded in blue. 
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was scanned for conserved binding sites of lag-1 CSL, the Notch transcription factor. The 
lag-1 CSL transcription factor has been shown to bind the consensus sequence RTGGGAA in 
enzyme mobility shift assay (EMSA, [61]). Moreover, this motif is necessary for lin-12 
Notch-dependent transcription of the lin-12 Notch target gene lip-1 in 2° vulval cells [62]. In 
the upstream intergenic region of egl-43, there are six and in the first intron four lag-1 CSL 
motifs present. But, only one motif, which resides in the first intron, is conserved between C. 
elegans and C. briggsae (Fig.25 A and B, CSL#1). CSL#1 is fully conserved between C. 
elegans, C. briggsae and C. remanei. 
Intriguingly, all transcriptional reporters for egl-43 that were built showed expression in gut 
cells. Therefore, the egl-43 locus might contain binding sites for transcription factors that are 
active in gut cells. elt-2 and end-1 are involved in gut development and belong to the family 
of GATA transcription factors [63, 64]. elt-2 recognizes the sequence WGATAR and end-1 
the sequence GATA. In total, the sequence GATA was found 72 times in the promoter and 15 
times in the first intron of egl-43. According to ACANA analysis, four of these sites are 
conserved (Fig.25 A and B, GATA#1-4). GATA#1-3 are conserved between C. elegans and 
C. briggsae while GATA#4 is additionally conserved to C. remanei. 
 
4.2.2..g Defining tissue-specificity for conserved, non-coding regions of egl-43L 
 
The information that is gained by analyzing conserved transcription factor binding sites in 
non-coding regions is particularly powerful if this information is combined with expression 
analysis of transcriptional reporters that are under the control of different promoter or 
enhancer elements. 
Transcriptional gfp-reporters for egl-43 show a broad expression pattern. For this analysis, we 
focused on the expression in certain cells. The gfp-expression of the Pn.p-stage animals was 
monitored in uterine (AC=anchor cell, VU=ventral uterine cell), somatic gonadal 
(DTC=distal tip cell), neuronal (PVD) and gut cells as well in unidentified cells in the tail 
region. The reporters that were tested are described in Fig.26 A, and the gfp-expression 
analysis is summarized in Fig.26 B. 
Although gfp-expression in the AC and VU-cells was observed for all constructs, a more 
subtle difference was found. In constructs, where the first intron was missing, the gfp-
intensity in the AC was relatively to the VU-cells dramatically reduced. This phenomenon 
was already shown in Fig.23, where transcriptional reporters for egl-43S and egl-43L were 
compared. 
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Interestingly, gfp-expression in the DTCs, the leader-cells of the growing gonad arms, 
depends on a promoter element that is located between 6kb and 2.5kb upstream of the egl-43L 
ATG. 
The PVD neurons are sensory neurons for harsh touch and are located laterally on the 
posterior half of the worm. Based on the position and morphological features, the cell that is 
gfp-positive in certain egl-43 reporters was identified as the PVD neuron. Enhancers that 
drive egl-43 expression in the PVD cells are in the URS element that is between 6kb and 
2.5kb upstream of the egl-43L ATG and in the first intron. 
In contrast, expression in unidentified cells in the tail region depends solely on the presence of 
the first intron.  
 
Fig.26: Comparison of different transcriptional reporters for egl-43L allows defining enhancer elements driving 
expression in specific tissues. 
A) Schematic representation of the egl-43 locus and its conserved, putative fos-1 (FOS#1-3), lin-12 (CSL#1) and 
GATA-factor (GATA#1-4) binding sites (see Fig.25 for details). The color code is explained in the figure itself. 
Beneath the scheme for the egl-43 locus the structure of the different transcriptional reporters is shown. At the bottom of 
the scheme the location of identified enhancer elements is indicated red, dotted lines. The definition of these elements is 
based on the expression pattern described in B). The scheme is drawn to scale except the green boxes that represent the 
nls::gfp::lacZ coding element. B) Expression analysis of Pn.p-stage animals identifies enhancer elements for distal tip 
cell (DTC), PVD-cells (touch neurons) and for unidentified cells in the tail region. The table summarizes the expression 
pattern for each reporter construct in different tissues. In general, the table discriminates, whether the indicated tissue is 
gfp-positive (green box) or negative (white box). But, the expression in the AC (anchor cell) is shown also in relation to 
the expression in the ventral uterine cell (VU). Therefore, the light-green color indicates that the corresponding reporter 
is dramatically lower expressed in the AC than the VU-cells. nd = expression not determined. 
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As expected from the analysis of conserved transcription factor binding sites, gut-specific 
expression of egl-43 seems to be controlled by several elements. Gut-specific gfp-expression 
was seen in all constructs analyzed. In accordance with this result, all constructs also contain 
conserved GATA-factor binding sites. 
 
4.2.2..h The egl-43 promoter contains a conserved Fos-like binding site (FOS#3), which 
is necessary for AC-expression of transcriptional gfp-reporters for egl-43 
 
This paragraph contains results that were mentioned in the publication, but the actual data 
could not be shown due to space restrictions. 
 
 
Fig.27: The egl-43 promoter contains a conserved Fos-like binding site (FOS#3), which is necessary for AC-
expression of transcriptional gfp-reporters for egl-43. 
The first line of the scheme represents 1.7kb of upstream regulatory sequence and the first exon of egl-43. The 
promoter contains two conserved Fos-like binding sites (FOS#2 and FOS#3). Below the egl-43 scheme the structure 
of the transcriptional gfp-reporters is shown. The scheme is drawn to scale except the green boxes that represent the 
nls::gfp::lacZ coding sequences. This expression analysis shows that the FOS#2, a putative fos-1 binding site is not 
necessary for AC-specific expression. The promoter element that is necessary for AC-specific expression is indicated 
by a red rectangle at the bottom of the figure. This region contains a conserved, putative fos-1 binding site (FOS#3), 
which is necessary for AC expression. In addition, expression in the AC depends also on a short conserved element 
that is only few nucleotides upstream of FOS#3 (see -0.09-Lp::gfp). But, so far no factor is known that could 
recognize this sequence element. In reporters, where a putative Fos-binding site was mutated the consensus sequence 
is shown with the mutated nucleotide in red. 
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The transcriptional reporter -1.7-Lp::gfp that includes 1.7kb of egl-43L promoter region 
drives gfp-expression in the AC. This expression depends on fos-1a. In order to test whether 
fos-1 directly regulates egl-43L transcription, the promoter region was consecutively 
shortened. Comparison of this promoter between C. elegans and C. briggsae revealed two 
conserved sites that resemble the vertebrate Fos binding site (FOS#2 and FOS#3). Promoter 
truncation and introduction of point-mutations showed that FOS#2 is not necessary for 
transcriptional activity in the AC (Fig.27). Further promoter truncation showed that AC-
expression depends on the FOS#3 site and a closely located sequence element. This sequence 
is also conserved but shows no similarity to already described transcription factor binding 
sites. The necessity of FOS#3 is also proven by introduction of a point-mutation, which 
specifically abrogated expression in the AC. In contrast, expression in the gut cells was 
unaffected. 
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5 General Discussion 
 
5.1 Screens to find components of the lin-12 Notch pathway during vulval 
development 
 
5.1.1. Screening for defects in 2° cell fate-specific marker expression identifies 
genes involved in vulval development 
 
In the first part of my thesis, screens were designed and performed to find components of the 
lin-12 Notch pathway. In forward genetic screens, twelve mutants were identified that change 
the expression of a 2°-specific cell fate marker. Based on their vulval defect, five of them 
seem not to directly affect 2° cell fate specification but an earlier step in vulval development. 
Finally, complementation tests, mapping and sequencing experiments were performed for the 
seven remaining candidates to determine the affected gene. Thereby, five lin-11 and one 
dep-1 allele was found. Both genes are involved in vulval development, but are not reported 
being part of the vulval lin-12 Notch pathway [1, 2]. The last unidentified candidate is located 
on chromosome I and has been mapped to a region of maximally 585 candidate genes. 
Obviously, the screening principle is able to isolate alleles of genes that are involved in vulval 
development.  
Moreover, experience with this screening principle was also collected in a reverse genetic 
screen. In this screen, a group of putative lin-12 Notch target genes were individually knocked 
down by RNAi, and interesting candidates were selected based on the influence on the same 
2° cell fate-specific marker as used for the EMS screen. Seven of the eight candidate genes 
that were identified by this procedure are expressed in the vulva, indicating a role in vulval 
development.  
 
5.1.2. The probability to isolate a gene involved in vulval lin-12 Notch signaling is 
low 
 
In the best case, one of twelve candidates isolated in the EMS screen are involved in lin-12 
Notch signaling in the vulva. Thus, the probability to isolate an allele of a gene that is 
involved in lin-12 Notch signaling is low. A similar experience has also been reported by Tax 
et al. in a screen for lin-12 Notch components. In this screen for suppressors of lin-12(gf), 
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75’000 haploid genomes were screened to identify 14 extragenic suppressors of lin-12(gf) 
defining seven different genes [3]. In general, around 1’000 haploid genomes have to be 
mutagenized to isolate a null mutation in one specific gene [4]. Tax et al. calculated that the 
rate of finding a null mutation in a extragenic suppressor of lin-12(gf) is 30 times lower. One 
possible reasons is that suppressors are homozygous sterile or lethal and are not isolated due 
to the screening procedure. For comparison, in this work only 3’200 haploid genomes were 
screened and 12 homozygous viable mutants were isolated. Although the probability to isolate 
a gene involved in lin-12 Notch signaling is low, twelve mutants were found in this screen. 
Since screening for genes involved in lin-12 Notch signaling based on a cell fate marker has 
not been performed before, there was no experience about the sensitivity of this approach. It 
is reasonable that we could have found weak alleles of genes that are lethal or sterile as 
homozygous mutants. Thus, time was invested to analyze these twelve mutants before 
screening larger number of genomes. 
 
5.1.3. Are candidate genes involved in lin-12 Notch signaling homozygous lethal 
or sterile? 
 
Also, the EMS screens in this work support the speculation that genes involved in lin-12 
Notch signaling could be homozygous lethal or sterile. Approximately 90% of the isolated 
mutants were sterile or lethal and could not be maintained because the screen was performed 
in a non-clonal fashion. For this reason, Raphael Sacher, a former diploma student, performed 
under my supervision screens that allow to isolate mutants affecting expression of a 2° cell 
fate-specific marker. So far, the sterile alleles from this screen were not mapped. Thus, it 
cannot be answered yet whether components of the vulval lin-12 Notch pathway were found 
by screening for defects in expression of a 2° cell fate-specific marker. 
 
5.1.4. Is the screen specific enough for defects in lin-12 Notch signalling? 
 
Among the twelve candidates isolated in the EMS screen are five that, based on the vulval 
defect, act in a early step of vulval development and are thus probably not part of lin-12 
Notch signaling. In comparison, the screen by Tax et al. for suppressors of lin-12(gf) 
identified exclusively genes that are involved in lin-12 Notch signaling. Thus, it seems that 
using egl-17::gfp alone as a read-out for acquisition of the 2° cell fate does not confer enough 
specificity for defects in lin-12 Notch signaling. For this reason, future screens should use a 
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marker for the 1° and another for the 2° cell fate. This should allow to discriminate between 
direct and indirect defects in 2° cell fate specification. For example, reporters for the DSL-
ligands, apx-1, dsl-1 or lag-2 could be used to test acquisition of the 1° cell fate in P6.p [5]. 
 
5.2 C. elegans as a model to study cellular invasion 
 
In the second part of my thesis, egl-43 Evi1 is presented as a new component of the AC 
invasion pathway in C. elegans. egl-43 is shown to be activated by fos-1 during AC invasion. 
As a consequence, egl-43 activates expression of the AC invasion effectors, zmp-1 and cdh-3. 
 
The study of AC invasion in C. elegans is a relatively new field [6]. Up to now only five 
genes are known being involved in this process. Mutant analysis suggests that there are still 
important components to be found. The study of cellular invasion in C. elegans is attractive 
for several reasons. 
 
First of all, AC invasion is a relatively simple model since it is a single cell that adopts 
invasive behavior during normal development. Defects in this behavior generates a 
phenotype, namely persistence of the basement membrane, that is easily detectable by 
Nomarski optics.  
 
Second, the study of cellular invasion in C. elegans benefits from many unique properties that 
make C. elegans a successful model organism in developmental biology (mentioned in the 
general introduction, Chapter 1). For example, there are many tools available to identify new 
genes involved in AC invasion and to study their function. One of the most important 
arguments is that components that have been found to be involved in C. elegans AC invasion 
are also involved in cellular invasion in the vertebrate systems. For example, C. elegans 
ZMP-1 belongs, like the vertebrate MMP proteins that are crucial for cellular invasion, to the 
family of zinc-metalloproteinases. Moreover, C. elegans fos-1 is like its vertebrate counterpart 
involved in cellular invasion. Therefore, the study of AC invasion should produce knowledge 
about cellular invasion that can be applied in vertebrate systems. 
 
There are still many gaps in the AC invasion pathway in C. elegans. A possible way to 
identify new components is a mutagenesis screen. For this purpose, it is important to screen 
for an easily detectable phenotype. The two transcription factors fos-1 and egl-43 generate a 
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protruding vulva phenotype (Pvl), which is easily detectable with a dissecting microscope. 
This fact has been used by Sara Vassalli, a PhD student in our lab, to identify genes involved 
in AC invasion in an EMS mutagenesis screen. In contrast, mutants of zmp-1 or cdh-3 do not 
show a comparable phenotype [6, 7]. A possible reason is that fos-1 and egl-43 are not only 
involved in AC invasion but also in uterine seam cell (utse) formation. Therefore, AC 
invasion defects may not produce a Pvl phenotype. An alternative explanation, which is also 
supported by mutant analysis, could be that the function of AC effector genes is highly 
redundant. Thus, one approach to find new AC effector genes would be to perform an EMS 
screen in a sensitized background, e.g. the loss-of-function allele zmp-1(cg115). 
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